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ABSTRACT 
 
Sequential transformations in a single reaction have the potential to dramatically 
increase efficiency with respect to resources, time, and number of steps to access key 
intermediates.  When sequential C-H bonds are activated a bifunctional handle arises 
from seemingly inert functionality.  This work describes a one-pot sequential allylic C-H 
esterification, vinylic C-H arylation.  A previously reported Pd(II)/sulfoxide system is 
used to generate branched allylic esters from α-olefins with only the addition of an aryl 
boronic acid to the reaction mixture.  Styrenyl allylic esters are generated in good overall 
yield and excellent selectivities.  The wide functional group tolerance and mild 
conditions of this three-component coupling reaction provide an attractive manifold for 
the rapid build-up of dense functionality around terminal olefins with minimal protecting 
group strategies or undesirable oxidation/reduction reactions.  The synthetic utility of this 
reaction has been demonstrated through the synthesis of several intermediates to 
biologically active molecules.  
 The ready availability and inertness of α-olefins relative to the oxidized 
precursors required for other C—C bond forming methods means that fewer steps are 
required for their installation and maintenance throughout a synthetic sequence.  
Previously, allylic esters served as non-resonance directing groups on terminal olefin for 
the vinylic C—H arylation (Heck reaction). This manifold is unique because previous 
intermolecular Heck reaction conditions require an excess of resonance activated olefin 
coupling partner.  Further exploration of directing groups to determine the underlying 
directing factors led to the discovery of several terminal olefin classes with diverse 
 iii 
directing elements.  A general and highly selective intermolecular Heck arylation of non-
resonance stabilized α-olefins with aryl and stryenyl boronic reagents has been 
developed. The Pd(II)/sulfoxide catalyzed Heck reaction is performed under oxidative, 
acidic conditions and proceeds with good yields and excellent regio- and 
stereoselectivities to generate linear E-arylated olefins. 
 Polyenes are prevalent motiefs in natural products and pharmaceuticals.  Polyene 
functionality often requires mild and selective synthetic methods.  The Heck vinylation 
uses orthogonally reactive C-H bonds and these bonds are often easy to carry through 
synthetic sequences.  Despite this advantage, the synthetic potential of the intermolecular 
Heck reaction has not been realized in complex molecule formation.  A method has been 
developed which overcomes the previous intermolecular Heck-vinylation shortcomings 
of excess terminal olefin and required resonance activation for regio- and 
stereoselectivities.  The Pd(II)/sulfoxide catalyzed oxidative Heck vinylation proceeds 
under mild conditions to give polyene products with a variety of substitution patterns 
amid diverse functionality.  The polyenes are formed in synthetically relevant yields with 
excellent stereoselectivities.  Overall, the oxidative Heck vinylation compares favorably 
with many of the methods commonly used to synthesize polyunsaturated hydrocarbon 
segments.  This method increases the synthetic potential of the intermolecular Heck 
reaction closer to that of other classic palladium cross-couplings. 
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CHAPTER 1 
 
SEQUENTIAL HYDROCARBON FUNCTIONALIZATION: ALLYLIC C-H 
 
OXIDATION/VINYLIC C-H ARYLATION  
 
 
1.1 INTRODUCTION 
 
Complex molecule synthetic strategies often rely heavily on the presence of 
heteroatom functionality that can be activated as nucleophiles via deprotonation or serve 
to make adjacent sites electrophilic centers.  Carbanion synthetic strategies are prominent 
C-C bond forming methods employed during the construction of biologically active 
molecules which generally demonstrate high yields and great stereoselectivities.1  
Alternatively, transition metal based cross coupling reactions provide direct access to 
hydrocarbon frameworks without the requirement of adjacent heteroatom functionality 
for reactivity.  However, both methods often rely on pre-activation of both coupling 
partners and this pre-activation often lengthens routes to important molecules due to (1) 
introducing the functionality and (2) adding additional steps to maintain functionality 
throughout a synthetic sequence.  Ideally, C-H bonds could be used to both install the 
valuable heteroatom functionality commonly used in carbanion synthesis and as coupling 
partners for transition metal couplings (TMCs) to build carbon frameworks from inert 
functionality.  
Sequential functionalizations performed in a single-pot enable the rapid build up 
of molecular complexity with minimal resources, time investment, and functional group 
manipulations.2  Both linear and divergent sequential reactions have specific key 
advantages over standard single reaction sequences (figure 1).  Linear sequential  
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Figure 1. One-pot sequential reactions
 
reactions allow access to reactive intermediates without difficult isolation procedures.  
Divergent sequences enable the build up of molecular complexity at distinctly different 
sites generating compounds with two new functional handles in a single reaction pot.   
 The development of mild, selective C-H activation reactions is gaining increasing 
attention.3  C-H bonds are ubiquitous in pharmaceuticals and natural products and are 
commonly considered unreactive without adjacent oxygen or nitrogen functionality.  Due 
to the inert nature of C-H bonds they can be carried through traditional synthetic 
sequences without the need for protecting groups or changes in oxidation state commonly 
needed for oxygen based strategies.4 Foregoing these functional group manipulations 
(FGMs) can dramatically affect the number of synthetic steps and yield of the overall 
sequence.   
Sequential one-pot functionalizations and C-H bond transformations both have 
the potential to dramatically streamline the synthesis of small molecules.  Combining the 
two reaction pathways into a single reaction could greatly increase the rate of access to 
complex small molecules.  When differentiable C-H bonds are transformed to distinctly 
different functionalities, a bifunctional handle arises from seemingly inert functionality.  
For maximal efficiency, a single catalyst capable of facilitating both C-H 
functionalization events may be selected if the desired reactions are paired properly.  We 
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envisioned oxygenation of an allylic C-H bond followed by vinylic C-H bond activation 
via an oxidative Heck arylation with a single electrophilic palladium catalyst.   
The White lab initially focused on the development of mild, selective C-H 
activation methods for the installation of allylic oxygen functionality with electrophilic 
palladium (II) catalysts (figure 2).5  Based on catalyst choice either the branched or linear 
R
R
O
O
R'
R O
O
R'
SS
O O
PhPh
Pd(OAc)2
1
PdII, DMSOO
R'HO
Figure 2. C-H bond oxygenation with electrophile PdII catalysts.
linearbranched  
ester product could be selectively synthesized.  Both catalysts are believed to generate 
highly electrophilic palladium intermediates as the active species which upon 
coordination to a terminal olefin weaken the allylic C—H bond to deprotonation.  
Importantly, the branched and linear products retain a now allylic functionalized olefin 
which is tremendously useful for further functionalizations. 
 Transition metal based cross-couplings often require prior activation of both 
coupling partners, typically via a carbon-metalated reagent and a halide or triflate.  
Unique among palladium-based TMCs is the Heck reaction which couples a vinylic C-H 
bond with either 1) a halide or triflate under reductive conditions or 2) a carbon-metalated 
intermediate under oxidative conditions to form C-C bonds (figure 3).  Palladium (0)  
Suzuki, Stille, Negishi, Hiyama, Kumada Reactions
R' X+
Pd0
[M]
R
R'
R
Heck Reaction
R' X
+
Pd0
H
R
R'
R
[M] = BR2, SnR3, ZnX2
         SiR3, MgX
X = halide
      OTf
X = halide
      OTf
Figure 3. Palladium Mediated Cross Couplings.
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based reductive Heck couplings begin the catalytic cycle with an oxidative addition into 
either a halide or triflate, followed by olefin insertion, β-hydride elimination, and 
reductive elimination/deprotonation6 to regenerate the palladium (0) catalyst (figure 4).  
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PdII PhBr
O
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O
OR
PdII
Ph
Br
Oxidative Addition
Olefin Insertion!-Hydride Elimination
Deprotonation
O
OR
Ph
PdII HBr
Pd0 HBr+
NEt3
Br-+HNEt3
Figure 4. Comparison of Pd(0) vs Pd(II) catalytic cycles.
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The oxidative palladium (II) based counterpart has a similar catalytic cycle with the 
exception of the palladium catalyst beginning with a transmetalation event and ending in 
a reoxidation.  Importantly, the oxidative Heck reaction relies on an electrophilic 
palladium (II) source as opposed to the nucleophilic palladium (0) source in the reductive 
conditions to begin the catalytic cycle.  A highly electrophilic palladium (II) catalyst is 
required for both the allylic esterification and the vinylic arylation.  We envisioned 
sequential allylic, vinyl C-H bond transformations with a single catalyst by finding 
conditions suitable for both reaction to occur in a single pot. 
We recognized several key challenges to performing an oxidative Heck arylation 
on branched allylic ester intermediates.  The intermolecular Heck reaction is usually 
limited to resonance activated olefins for 1) increasing reactivity to olefin insertion and 2) 
controlling the regioselectivity for aryl insertion. Furthermore, olefins are typically not 
the limiting reagents for Heck arylations (3-5 equiv.) making the reactions impractical on 
valuable olefin starting materials.  Significantly, electrophilic palladium (II) is known to 
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rapidly transmetalate arylsiloxane, aryltin, and arylboron reagents in the presence of base 
to promote transmetalation/catalyst regeneration.7  Cationic palladium (II) complexes 
have been shown to be highly active catalysts for aryl boronic acid transmetalation and 
C=C bond insertions in conjugate additions reactions of aryl boronic acids to enones 
under neutral conditions.8  However, the allylic C-H esterification is carried out under 
acidic reaction conditions and, to the best of our knowledge the transmetalation of 
boronic acids under these conditions has not been demonstrated.  Providing these two 
significant challenges could be overcome, a novel sequential allylic C—H 
oxidation/vinylic C—H arylation would be possible using catalyst 1.   
We were able to develop a novel vinylic C—H arylation reaction on electronically 
unbiased olefins with aryl boronic acids that proceeds under mildly acidic, oxidative 
conditions.  Importantly, the oxidative Heck arylation proceeds with the same palladium 
(II)/sulfoxide catalyst 1 as the branched allylic esterification with high regioselectivities 
and E/Z selectivities at mild temperatures (r.t.).  This represents the first example of a 
palladium (II) mediated cross-coupling reaction with boronic acids under acidic, 
oxidative conditions. 
 
1.2 RESULTS AND DISCUSSION  
1.2.1 Developing a Sequential Allylic C—H Oxidation/Vinylic C—H Arylation: Boronic 
Acid Scope 
 The development of this sequential allylic, vinylic C-H functionalization reaction 
began by simply adding 1.5 equivalents of phenyl boronic acid to the branched allylic 
oxidation reaction upon complete consumption of the terminal olefin starting material. 
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We were delighted to find that in the presence of carboxylic acids with no additional 
catalyst, the corresponding E-arylated allylic esters were generated in good yields with 
R
R
O
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2 equiv.
BQ, 45oC
Pd II/Sulfoxide+
H
H
R
O
O
R'
B(OH)2
R''
1.5 equiv.
AcOH
45oC or r.t.
R''
Figure 5.  One-pot, three component coupling.
52%-77% yields
>20:1 int.:term.
>20:1E:Z
56-83% yield
16:1-46:1 B:L
broad scope  
high stereo- and regio- selectivities (>20:1 E:Z, >20:1 internal:terminal olefin, figure 5).  
This one-pot, three component coupling reaction of α-olefins, carboxylic acids, and aryl 
boronic acids furnishes a wide range of E-arylated allylic esters in great selectivities and 
good yields (table 1). 
 We found 10 mol% palladium/bis-sulfoxide catalyst 1 effects sequential allylic  
C-H esterification/vinylic C-H arylation for a variety of α-olefins as well as 
electronically and sterically diverse carboxylic acids and boronic acids.  The E-arylated 
allylic ester products were furnished in good yields as single isomers by crude 1H NMR 
spectroscopy.  Compounds 2-6 (table 1) demonstrate compatibility with both electron 
withdrawing and electron donating groups on the aryl boronic acids in this reactions.  
Significantly, electron rich boronic acids are known to undergo protodeboronation in 
acidic conditions; however, under these mild conditions preparatively useful yields of the 
desired products 3, 9, and 13 were isolated when the arylation was performed at room 
temperature.9  As previously mentioned, oxidative Heck arylation conditions are typically 
basic which is often problematic for protodeboronation of electron withdrawn aryl 
boronic acids.  However, under these novel acidic conditions electron deficient aryl 
boronic acids couple efficiently as seen for compounds 4-6 and 11-12.  Furthermore, 
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olefinentry isolated yielda
Table 1.  Sequential three-component coupling reaction.
1
2
3
4
5
product
TBDPSO
n=2
TBDPSO
n=2
OAc
X
2, H = 74%
3, OMeb = 
52%
4, Cl = 63%c
5, F = 74%
O
H
= 60%
PhtN
n=2
PhtN
n=2
OAc X
n=2 n=2
OAc
Cl
6 7, 63%d
7
8
10
PMBO
n=2
O
N
OMe
n=2
O
N
OMe
n=2
CN
O2C(C6H4-pNO2)
11
O
O
Br
C(O)OEt
12
O
O
O2N
NO2 OPMB
n=2
R
S S
Ph Ph
OO
Pd(OAc)2
(10 mol%)
R'CO2H (2-4 equiv.)
BQ (2 equiv.), air,
 dioxane, 24-48h, 45oC
1
ArB(OH)2
(1.5 equiv.)
R
OC(O)R'
Ar
8, Me = 73%d,e
9, OMe = 55%b,d
10, 53%d
11, 77%d
12, 62%c,d
9
4-7h
aAverage yields of isomerically pure material for two runs at 1.0 mmol. b
Arylation performed at rt. c Arylation run for 24h. d BQ (1 equiv.), AcOH (1
equiv.) added for arylation when oxidation run >24h. e2.0 equiv. o-MePhB(OH)2
6,
C8H17 C8H17
O
O
NHBoc
O
O
13, 69%b
X:
X:
>20:1 E:Z
>20:1 internal:terminal
 
extremely electron withdrawn 2-nitro, 4-nitro, 4-trifluoromethyl, and 3,5-
di(trifluoromethyl) boronic acids all react smoothly in our system.  Ortho-substituted aryl 
boronic acids are often problematic in coupling reactions due to both low reactivity and 
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deboronation pathways but they couple smoothly under these mild conditions 
(compounds 8 and 9).  Aryl halides are reactive through oxidative addition pathways 
under palladium (0) mediated reductive Heck conditions.  The palladium (II) mediated 
oxidative conditions described herein do not react with aryl bromide and chloride 
functionalities (compounds 4, 7, and 15), which establishes the complementarity of this 
oxidative reaction with standard palladium (0) based reductive reactions.  Overall, 
dramatically few aryl boronic acids were found to be problematic in this system with the 
few notable exceptions being 1) aryl iodides because oxidative addition of the transient 
palladium (0) species to the C-I bond being competitive with benzoquinone reoxidation 
which leads to polymerizations, 2) significantly sterically encumbered aryl boronic acids 
(i.e. 2,6-dimethylaryl boronic acid), and 3) heteroaromatic boronic acids due to facile 
protodeboronation.  
 
1.2.2 Developing a Sequential Allylic C—H Oxidation/Vinylic C—H Arylation: α-
Olefin and Carboxylic Acid Scope 
 The scope of the α-olefin and carboxylic acid components were explored to 
demonstrate the utility of this three-component coupling.  A wide range of polar 
functional group handles may be present including silyl and benzyl ethers, phthalimides 
and Weinreb amides (compounds 2-6 and 8-10).  Chemoselectivity was illustrated with 
the synthesis of compound 7 whereas the internal olefin remained unaffected throughout 
the sequential reaction.  Although not required for reactivity, substitution proximal to the 
α-olefin is well tolerated as demonstrated when allylcyclohexane was used as a coupling 
partner (compound 12).  It is important to note the terminal olefin is the limiting reagent 
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in all cases which is dramatically different than previous intermolecular Heck reactions 
demanding 2-5 equivalents.   
Interestingly, proximal functionality has little influence on the diastereoselectivity 
of the allylic C-H esterification reaction.  When examining bis-homoallylic substituted α-
olefins, only slight diastereoselectivity was observed for lactone substrate 14 (1.4:1 
anti:syn, scheme 1).  This result indicates the catalyst is not strongly influenced by 
adjacent functionality during the C-H esterification and offers a good opportunity for 
development of an asymmetric version capable of overriding inherent substrate bias.  
O
O
sequential, dual
C-H activation O
O
OAc O
O
OAc
+
1.4 : 1.0
Scheme 1. Inherent reaction bias is minimal for bishomoallylic substitution.
14
 
 A diverse array of carboxylic acid coupling components were observed to give 
good reactivity.  Both alkyl and aryl carboxylic acids readily couple with α-olefins and 
are tolerated during the Heck arylation.  Once coupled, the allylic esters provide a 
functional handle for a number of reactions including several asymmetric reactions.  
Arylated 3,5-dinitrobenzoate and 2-bromoacetate allylic esters 10 and 12 may be further 
elaborated via asymmetric palladium (0) π-allyl substitution reactions and enolate-type 
Claisen rearrangements, respectively.10  Esters such as arylated p-nitrobenzoate 11 which 
are readily hydrolyzed during basic workup affording the corresponding arylated allylic 
alcohols may be synthesized via this reaction manifold.  Amino acid derivatives 13 and 
15 were synthesized in good yields with only two equivalents of the carboxylic acid 
component.  The three-component coupling reaction was found to proceed with higher 
yields with excess carboxylic acids.  For valuable carboxylic acids, acetic acid may be 
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added after the allylic esterification has completed which allows for low loadings of 
complex acids.   
Catalyst loadings were also explored in this reaction manifold.  Lowering 
loadings below 10% is possible for some carboxylic acids (scheme 2).  Catalyst loadings 
of 5% gave preparatively useful yields of the desired product but catalyst death became 
problematic whereas the yield is diminished in comparison to the 10% loading and 
significant amounts of non-arylated intermediate are observed.  A loading of 2.5% gave 
only the non-arylated allylic ester in 62% yield with no desired product.   
C8H17
sequential, dual
C-H activation
C8H17
O
O
NHBoc
10%
5.0%
2.5%
catalyst 
loading product
84%
60% (12% branched ester)
0%   (62% branched ester)
Scheme 2. Catalyst loading effects.
 
 
1.2.3 Synthetic Applications 
 A key benefit of this methodology is the ability to use inexpensive hydrocarbon 
starting materials to rapidly generate densely functionalized intermediates for complex 
molecule synthesis.  Beginning with a hydrocarbon, a bifunctional handle is installed in a 
single step which is readily elaborated to medicinally important molecules.  
Pharmacologically relevant E-arylated allylic N-Boc glycine ester intermediates 13 and 
15 were each synthesized in one-pot from a commercial hydrocarbon, an amino acid and 
an aryl boronic acids as single regio- and stereoisomers (>20:1 E:Z, >20:1 
internal:terminal olefin, table 1 and scheme 3, respectively).  Compound 15 serves as an 
intermediate which readily undergoes elaboration to a pharmaceutically important  
 11 
C8H17
O
O
NHBoc
Me
( )
n = 8
Br
15, 75% yield
>20:1 E:Z
>20:1 internal:terminal
3-component
coupling
ref. 11
N
F
O
NH3
+
Ar
O OH
TFA
-
dipeptidyl peptidase
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Scheme 3. Hydrocarbon to dense functionality in a single step.
 
dipeptidyl peptidase IV inhibitor via enolate-Claisen rearrangement of the amino ester to 
the γ,δ-unsaturated amino acid, Suzuki cross-coupling of the aryl bromide to a biaryl, and 
ozonolysis of the olefin to a carboxylic acid moiety.11  This example nicely demonstrates 
the complementary nature of palladium (II) based catalytic cycles with palladium (0) 
based catalytic cycles, where as the aryl bromide would be difficult to preserve under 
palladium (0) reaction conditions. 
 Allylic alcohol 16 was synthesized in 77% yield directly from butene gas as 
limiting reagent (scheme 4).  Significantly, improved yields of cinnamyl alcohol 16 were 
obtained when the reaction was run under an O2 atmosphere (1 atm) instead of an air 
atmosphere which presumably aids in reoxidation of the palladium (II)/bis-sulfoxide 
catalyst 1.  The E-arylated allylic alcohol was further elaborated via enantioselective 
Me
Scheme 4. Butene gas conversion to a valuable synthetic intermediate in one step.
3-component
coupling
Me
OH
OMe
O
OMe
OHOH
OH C21-C27
bryostatin 1
ref. 12
16, 77% yield
1 isomer
butene 
gas  
epoxidation resolution of the olefin and a Birch reduction, ozonolysis sequence of the 
meta-substituted anisol ring to form the β-ketoester in Evans synthesis of the C21-C27 
segment of bryostatin 1.12  This series of selective reduction reactions can be used to 
convert molecules analogous to 16 to 1,3-diol subunits found in polyacetate-derived 
natural products.  
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1.2.4 The Oxidative Heck Reaction: Substrate Scope, Selectivities and Necessary 
Reaction Components 
 The selective vinylic C-H arylation step of the sequential reaction proceeds via an 
electrophilic palladium (II) promoted transmetalation and alkene bond insertion.  A series 
of substrates were examined in the oxidative Heck arylation reaction to determine why 
this catalyst promotes vinylic C-H arylation in high regio- and stereoselectivities.  The 
possible arylated product isomers are named based on the position/stereochemistry of the 
olefin (scheme 5).  Allylic acetoxy and small alkoxy substituents undergo highly  
R
oxidative Heck
R Aryl
internal olefin 
(int., E)
R
R Aryl
Aryl
terminal olefin 
(term.)
internal olefin 
(int., Z)
R Aryl
ArylB(OH)2 allylic olefin
(allyl)
Scheme 5. Definitions of olefin selectivities in the oxidative Heck arylation.
 
siteselective vinylic C-H arylations to yield internal olefin products (table 2, entries 1-3).  
Substrates with small allylic alkyl substituents give a mixture of internal:terminal and 
internal:allylic olefin products significantly favoring the internal olefin isomer (table 2, 
entries 4 and 7).  Large allylic substitution such as the allylic gem-dimethyl substituted 
substrate 25 or allylic OTBPDS substrate 21 gave excellent yields with great selectivities 
(table 2, entries 9 and 5).  Consistent with a steric argument, a simple straight chain 
terminal alkene substrate 22 gave an inseparable mixture of internal, allylic, and terminal 
olefin isomers in low selectivity (4:1:1, table 2, entry 6).  Finally, homoallylic benzyl 
(compound 24) gave selectivities similar to those seen for small allylic alkyl substitutions 
indicating allylic ethers are much better substrates than homoallylic ethers (table 2, entry 
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8).  The terminal olefin substrate scope and hypothesis about the origins of selectivities 
will be addressed more thoroughly in chapter 2. 
 
X
alkyl
X = OAc, 17
      OMe, 18
      OBn, 19
      Me, 20
      OTBDPS, 21
      H, 22
O
OBn
O
23
24
entry
1
2
3
4
5
6
7
8
9
substrate isolated yielda int.:term.b int.:allylb E:Zb
98%
95%
92%
75%
94%
64%
88%
97%
100%
41:1c
>20:1
>20:1
8:1
>20:1
4:1
8:1
9:1
>20:1
>20:1
>20:1
>20:1
8:1
>20:1
1:1
8:1
1:1
---
>20:1
>20:1
>20:1
>20:1
>20:1
>20:1
>20:1
>20:1
>20:1
aAverage yield for 2 runs done at 1.0 mmol.  bDetermined via 1H NMR on crude reaction 
mixture unless noted.  c Determined by GC analysis of crude material.
R
X 10 % 1, 1.5 equiv. PhB(OH)2,
4 equiv. AcOH, 2 equiv. BQ
dioxane, 4hrs, 45oC, air
R
X
Ph
Table 2.  Substrate selectivities and scope of the oxidative Heck reaction.
25
 
 Since the newly developed oxidative Heck arylation had only been performed as 
part of a tandem sequence, experiments varying the components for the vinylic C-H 
arylation reaction were necessary to better understand the catalytic cycle.  Catalyst 1, 
carboxylic acid, and benzoquinone were all necessary for efficient vinylic C-H activation.  
Palladium acetate has been shown to undergo transmetalation with aryl boronic acids 
stoichiometrically in the absence of activators; however, the bis-sulfoxide ligand proved 
necessary under these conditions for efficient transmetalation of aryl boronic acids (37% 
vs 98% yields, table 3, entries 1 and 2).  Consistent with a palladium (II) based catalytic 
cycle, benzoquinone was found to be necessary since only stoichiometric reactivity was   
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entry
1
2
3
4
5
catalyst isolated yielda
98%
37%
8%
71%
94%
1
Pd(OAc)2
1
1
1
AcOH
4 equiv.
4 equiv.
4 equiv.
---
1 equiv.
BQ
2 equiv.
2 equiv.
---
2 equiv.
2 equiv.
a Average yields for 2 rungs at 1.0 mmol.
R
OAc 10 % cat., 1.5 equiv. PhB(OH)2,
X equiv. AcOH, X equiv. BQ
dioxane, 4hrs, 45oC, air
R
OAc
Ph
Table 3. Testing the importance of each component in the 
oxidative Heck-arylation.
 
observed in the absence of an oxidant (table 3, entry 3).  Increased reactivity was 
observed in the presence of excess carboxylic acid and removal of the acid gave 
diminished and variable yields (71-24% yield, table 3, entries 1, 4, and 5).  The 
diminished yield is likely due to carboxylic acid being necessary to regenerate the 
palladium carboxylate catalyst during reoxidation with benzoquinone (2 HX + Pd(0) + 
BQ  DHQ + PdX2).   
 
1.3 CONCLUSIONS 
 A novel one-pot three component coupling has been developed which converts α-
olefin hydrocarbons, carboxylic acids, and arylboronic esters to E-arylated allylic esters 
with high regio- and E:Z selectivities.  Densely functionalized building blocks are 
constructed from robust C-H bonds in a single step making this method suitable for high-
throughput applications.  A new reaction manifold has been explored using a 
palladium/bis-sulfoxide catalyst 1 to effect Heck-arylation of terminal olefins baring 
allylic oxygenates with arylboronic acids.  This reaction manifold is complementary to  
B(OH)2
Br
Pd(0) Pd(II)/bisSO 1
B(OH)2
BrPd
PdOAc
Br
Scheme 6. Complementary reactivity of palladium (0) vs palladium (II).
 
 15 
the standard basic, reductive manifold for generating palladium-aryl intermediates for 
cross-coupling reactions (scheme 6). 
 
 
1.4 EXPERIMENTAL SECTION 
General Information:  All commercially obtained reagents for the allylic 
oxidation, Heck arylation reaction were used as received: 1,4-benzoquinone (Sigma-
Aldrich); 2-methoxyphenylboronic acid, 4-methoxyphenylboronic acid, 4-
chlorophenylboronic acid, 4-fluorophenylboronic acid, 4-formylphenylboronic acid, 3-
chlorophenylboronic acid, o-tolylboronic acid, 2-methoxyphenyl boronic acid, 3-
cyanophenylboronic acid, and 4-methoxycarbonylphenylbornic acid (Frontier Scientific); 
phenylboronic acid (Sigma-Aldrich); Pd(OAc)2 (Strem Chemicals).  Pd(OAc)2 was stored 
in a glove box under an argon atmosphere and weighed out in the air prior to use.  Bottles 
of Pd(OAc)2 that were found to give suboptimal yields for the Heck arylation were 
recrystalized according to the procedure provided below.  Solvents tetrahydrofuran 
(THF), diethyl ether (Et2O), and methylene chloride (CH2Cl2) were purified prior to use 
by passage through a bed of activated alumina (Glass Contour, Laguna Beach, 
California).  Anhydrous N,N-dimethylformamide (DMF) (Sure Seal) was obtained from 
Sigma-Aldrich and used as received.  All allylic oxidation, Heck arylation reactions were 
run under air with no precautions taken to exclude moisture.  An exception to this is the 
1-butene reaction run under an atmosphere of O2.  Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized 
with UV and potassium permanganate staining.  Flash column chromatography was 
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performed as described by Still et al.13 using EM reagent silica gel 60 (230-240 mesh).  
1H NMR spectra were recorded on a Varian Unity-400 (400 MHz) or Varian Unity-500 
(500 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3 at 7.26 ppm).  Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p 
= pentet, m = multiplet, b = broad, ap = apparent; coupling constant(s) in Hz; integration.  
Proton-decoupled 13C NMR spectra were recorded on a Varian Unity-400 (100 MHz) or 
Varian Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an 
internal standard (CDCl3 at 77.23 ppm).   Regioselectivity of the Heck addition was 
determined by GC analysis with authentic terminal olefin standard.  IR spectra were 
recorded as thin films on NaCl plates on a Perkin-Elmer Spectrum BX and are reported in 
frequency of absorption (cm-1).  High-resolution mass spectra were obtained at the 
University of Illinois Mass Spectrometry Laboratory. 
 
1,2-bis(phenylsulfinyl)ethane: A 50 mL round bottomed flask (RBF) 
was charged with a stir bar, 2 g (7.19 mmol, 1 equiv.) of 1,2-bis(phenylthio)ethane, and 
12.2 mL of acetic acid.  A solution of H2O2 (50 wt%, 14.38 mmol, 0.978 mL, 2 equiv.) in 
acetic acid (6.7 mL) was added dropwise at room temperature.  After approximately 15 
minutes the solution became homogeneous and turned a pale yellow.  An additional 8 mL 
of acetic acid was then added and the solution allowed to stir for 24 hours at room 
temperature.  The acetic acid was removed with mild heating (45oC) under high vacuum. 
The pale yellow solid was emulsified in cold ethanol and cold filtered to yield a mixture 
of the meso and racemic 1,2-bis(phenylsulfinyl)ethane in 92% yield (2.088g). Meso-1,2-
bis(phenylsulfinyl)ethane 1H NMR (500 MHz, CDCl3) δ 7.56-7.52 (m, 10H), 3.05 (s, 
SS
Ph Ph
OO
 17 
4H).  13C NMR (500 MHz, CDCl3) δ 142.29, 131.55, 129.63, 124.10, 47.06.  IR (neat) 
3048.84, 2970.01, 2922.41, 1442.10, 1036.34, 745.45, 695.70 cm-1.; racemic-1,2-
bis(phenylsulfinyl)ethane. 1H NMR (500 MHz, CDCl3) δ 7.51-7.48 (m, 10H), 3.40 (m, 
2H), 2.74 (m, 2H).  13C NMR (125 MHz, CDCl3) δ 142.55, 131.53, 129.64, 124.08, 
47.94.  IR (neat, cm-1) 3053.16, 2911.39, 1443.77, 1084.88, 1042.50, 748.52.  HRMS 
(ESI) m/z calculated for C14H14O2S2Na [M+Na]+: 301.0333, found 301.0320. 
 
Catalyst 1:  A flame dried 250 mL flask was charged with 2.53g (9.1 
mmol) of 1,2-bis(phenylsulfinyl)ethane, 101 mL of CH2Cl2, and 2.04g 
(9.1 mmol) of Pd(OAc)2.  The mixture was stirred at 40oC for 24h.  The reaction becomes 
a dark red homogenous reaction during the reaction time.  The solution was concentrated 
in vacuo and dried with a stream of N2 for 6 h to give a dark red solid used without 
further purification.  Note: The catalyst must be stored at below 4oC.  The catalyst 
slowly decomposes at ambient temperature; however, may be stored for prolonged 
periods (months) at reduced temperatures.  1H NMR and IR data of this catalyst look like 
1,2-bis(phenylsulfinyl)ethane ligand and Pd(OAc)2.  Trace amounts of phenyl vinyl 
sulfoxide can be observed by 1H NMR (usually ~10% but can vary by +/-5%).  We have 
noted suboptimal yields (e.g. 70% vs 90%) of Heck arylation with old bottles of 
Pd(OAc)2.  Recrystalization of Pd(OAc)2 prior to complexation using the following 
procedure restores full activity of the catalyst. 
 
Pd(OAc)2 Recrystalization:  “Old” Pd(OAc)2 was dissolved in minimal refluxing 
benzene.  A black precipitate was removed by hot Acrodisc® filtration.  The resulting 
Pd(OAc)2
 1
SSPh Ph
OO
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solution was cooled to room temperature without further manipulation.  Amber crystals 
began to form after ~2 hours.  After 24 hours the solution was filtered to give the 
recrystalized Pd(OAc)2.  A difference in NMR purity was noted between “old” and 
recrystalized Pd(OAc)2 samples.  Reported hydrogen values are normalized ratios of the 
smallest peak in the acetate region.  “Old” Pd(OAc)2 (see attached) 1H NMR (500 MHz, 
CDCl3) δ 2.17 (s, 1H), 2.10 (s, 3.6H), 2.07 (s, 6.1H), 2.06 (s, 6.1H), 2.03 (m, 15.3H), 
2.00 (m, 95.7H), 1.97 (s, 5.7H), 1.95 (s, 6.3), 1.89 (s, 9.4H).  Recrystalized Pd(OAc)2 
(see attached) 1H NMR (500 MHz, CDCl3) δ 2.10 (s, 1H), 2.03 (s, 2.8H), 2.00 (s, 40.1H), 
1.97 (s, 1.2H), 1.90 (s, 2.3H).  
 
General Procedure for Tandem Allylic Oxidation/Vinylic Arylation:  To a 40 mL 
borosilicate vial was added catalyst 1 (10 mol%, 0.1 mmol) and benzoquinone (2 equiv, 2 
mmol).  Olefin (1 equiv, 1 mmol) in dioxane (0.33M, 3mL), carboxylic acid (2-4 equiv, 
2-4 mmol), and a stir bar were added sequentially.  The olefin was weighed out in a 1 
dram vial and transferred via dioxane (3 x 1 mL).    The vial was capped and stirred at 
45oC for 24-48 hours.  The allylic oxidation was run until complete conversion of the α-
olefin starting material was observed by GC or TLC.  The vial was cooled to room 
temperature, and boronic acid (1.5 equiv, 1.5 mmol) was added to the reaction mixture 
using weighing paper.  The vial was capped and stirred at room temperature for the 
indicated time.  The reaction mixture was diluted with saturated aqueous NH4Cl and 
extracted with CH2Cl2 or hexane (2 times).  The combined organics were washed with 
5% aqueous K2CO3 (1 time), H2O (1 time), and dried over MgSO4.  The mixture was 
 19 
filtered and concentrated in vacuo.  Purification by flash chromatography 
(EtOAc/hexanes mixtures) provided the pure product. 
 
 (E)-5-(tert-butyldiphenylsilyloxy)-1-phenylpent-1-en-3-yl 
acetate:  To a 40 mL borosilicate vial was added catalyst 1 
(0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 216.2 
mg, 2 equiv.), tert-butyl(pent-4-enyloxy)diphenylsilane (1 mmol, 325 mg, 1 equiv.) in 
dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 equiv.), and a stir bar.  The mixture was 
heated to 45oC for 24 hours.  Phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.) was 
added and heated to 45oC for 4 hours.  The mixture was diluted with 40 mL of sat. aq. 
NH4Cl and extracted with CH2Cl2 (2 x 75 mL).  The organic layers were combined, 
rinsed with H2O (75 mL) and dried over MgSO4.  After concentration, the crude product 
was purified via silica chromatography (140 mL SiO2) with 4% ethyl acetate/hexanes as 
eluent to yield (E)-5-(tert-butyldiphenylsilyloxy)-1-phenylpent-1-en-3-yl acetate as a 
clear oil.  Run 1 (0.323 g, 0.705 mmol, 71%); run 2 (0.349 g, 0.761 mmol, 76%).  
Average yield = 74%.  1H NMR (500 MHz, CDCl3) δ 7.68 (m, 4H), 7.45-7.31 (m, 9H), 
7.26 (m, 2H), 6.64 (d, J = 16 Hz, 1H), 6.15 (dd, J = 16, 7.5 Hz, 1H), 5.68 (ap q, J = 7 Hz, 
1H), 3.75 (t, J = 6 Hz, 2H), 2.04 (s, 3H), 1.99 (m, 2H), 1.08 (s, 9H).  13C NMR (100 
MHz, CDCl3) δ 170.4, 136.5, 135.8 (ap d), 133.8 (ap d), 132.9, 129.8 (ap d), 128.7, 
128.1, 127.9 (ap d), 127.7, 126.8, 72.2, 60.0, 37.5, 27.0, 21.5, 19.4.  IR (neat, cm-1) 
3070.72, 3050.07, 3027.54, 2957.36, 2931.20, 2857.85, 1738.12. HRMS (ESI) m/z 
calculated for C29H34O3SiNa [M+Na]+: 481.2175, found 481.2171. 
 
TBDPSO
O
O
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 (E)-5-(tert-butyldiphenylsilyloxy) -1- (4-
methoxyphenyl)pent -1- en -3- yl acetate: To a 40 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.3 mg, 
1 equiv.), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), tert-butyl(pent-4-
enyloxy)diphenylsilane (1 mmol, 325 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 
mmol, 240 mg, 4 equiv.), and a stir bar.  The mixture was heated to 45oC for 24 hours.  4-
Methoxyphenylboronic acid (1.5 mmol, 228 mg, 1.5 equiv.) was added and stirred at 
room temperature for 4 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl and 
extracted with CH2Cl2 (2 x 75 mL).  The organic layers were combined, rinsed with H2O 
(75 mL) and dried over MgSO4.  After concentration, the crude product was purified via 
silica chromatography (140 mL SiO2) with 10% ethyl acetate/hexanes as eluent to yield 
(E)-5-(tert-butyldiphenylsilyloxy)-1-(4-methoxyphenyl)pent-1-en-3-yl acetate as a clear 
oil.  Run 1 (0.248 g, 0.508 mmol, 51%); run 2 (0.252 g, 0.515 mmol, 52%).  Average 
yield = 52%.  1H NMR (500 MHz, CDCl3) δ 7.66 (m, 4H), 7.45-7.33 (m, 6H),  7.30 (ap 
d, J = 9 Hz, 2H), 6.85 (ap d, J = 8.5 Hz, 2H), 6.58 (d, J = 16 Hz, 1H), 5.99 (dd, J = 16, 8 
Hz, 1H), 5.64 (ap q, J = 7 Hz, 1H), 3.82 (s, 3H), 3.73 (t, J = 6.5 Hz, 2H), 2.02 (s, 3H), 
1.96-1.88 (m, 2H), 1.06 (s, 9H).  13C NMR (125 MHz, CDCl3) δ 170.5, 159.6, 135.8 (ap 
d), 133.9, 133.8, 133.6, 132.6, 129.8 (ap d), 129.3, 128.0, 127.8, 125.4, 114.1, 72.5, 60.1, 
55.5, 37.6, 27.0, 21.6, 19.4.  IR (neat, cm-1) 3071.10, 3046.59, 2956.80, 2931.89, 
2857.75, 1737.61, 1608.13. HRMS (ESI) m/z calculated for C30H36O4SiNa [M+Na]+:  
511.2281, found 511.2276. 
 
O
O
O
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 (E)-5-(tert-butyldiphenylsilyloxy)-1-(4-
chlorophenyl)pent-1-en-3-yl acetate: To a 40 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.3 mg, 
10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), tert-butyl(pent-4-
enyloxy)diphenylsilane (1 mmol, 325 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 
mmol, 240 mg, 4 equiv), and a stir bar.  The mixture was heated to 45oC for 24 hours.  4-
Chlorophenylboronic acid (1.5 mmol, 235 mg, 1.5 equiv.) was added and stirred at 45oC 
for 24 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl and extracted with 
CH2Cl2 (2 x 75 mL).  The organic layers were combined, rinsed with H2O (75 mL) and 
dried over MgSO4.  After concentration, the crude product was purified via silica 
chromatography (140 mL SiO2) with 3% ethyl acetate/hexanes as eluent to yield (E)-5-
(tert-butyldiphenylsilyloxy)-1-(4-chlorophenyl)pent-1-en-3-yl acetate as a clear oil.  Run 
1 (0.305 g, 0.618 mmol, 62%); run 2 (0.313 g, 0.635 mmol, 64%).  Average yield = 
63%.  1H NMR (400 MHz, CDCl3) δ 7.65 (m, 4H), 7.45-7.33 (m, 6H), 7.27 (bs, 4H), 
6.56 (d, J = 15.5 Hz, 1H), 6.10 (dd, J = 16, 7.5 Hz, 1H), 5.64 (ap q, J = 7.0 Hz, 1H), 3.72 
(t, J = 5.5 Hz, 2H), 2.03 (s, 3H), 2.20-1.88 (m, 2H), 1.05 (m, 9H).  13C NMR (100 MHz, 
CDCl3) δ 170.4, 135.8, 135.7, 135.0, 133.8, 133.7, 131.5, 129.9, 129.8, 128.9, 128.4, 
128.0, 127.9, 72.0, 59.9, 37.4, 27.0, 21.5, 19.4.  IR (neat, cm-1)  3074.93, 3049.09, 
2931.36, 2858.11, 1738.37.  HRMS (ESI) m/z calculated for C29H33O3ClSiNa [M+Na]+:  
515.1785, found 515.1775. 
 
 (E)-5-(tert-butyldiphenylsilyloxy)-1-(4-
fluorophenyl)pent-1-en-3-yl acetate:  To a 40 mL 
Cl
O
O
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borosilicate vial was added catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 
mmol, 216.2 mg, 2 equiv.), tert-butyl(pent-4-enyloxy)diphenylsilane (1 mmol, 325 mg, 1 
equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 equiv), and a stir bar.  The 
mixture was heated to 45oC for 24 hours.  4-Fluorophenylboronic acid (1.5 mmol, 210 
mg, 1.5 equiv.) was added and stirred at 45oC for 7 hours.  The mixture was diluted with 
40 mL of sat. aq. NH4Cl and extracted with CH2Cl2 (2 x 75 mL).  The organic layers 
were combined, rinsed with H2O (75 mL) and dried over MgSO4.  After concentration, 
the crude product was purified via silica chromatography (125 mL SiO2) with 5% ethyl 
acetate/hexanes as eluent to yield (E)-5-(tert-butyldiphenylsilyloxy)-1-(4-
fluorophenyl)pent-1-en-3-yl acetate as a clear oil.  Run 1 (0.3482 g, 0.732 mmol, 73%); 
run 2 (0.3508 g, 0.737 mmol, 74%).  Average yield = 74%.  1H NMR (500 MHz, 
CDCl3) δ 7.05 (m, 4H), 6.79-6.66 (m, 8H), 6.35 (ap t, J = 8.5 Hz, 2H), 5.97 (d, J = 16 Hz, 
1H), 5.43 (dd, J = 16, 7.5 Hz, 1H), 5.05 (ap q, J = 7 Hz, 1H), 3.12 (t, J = 6 Hz, 2H), 1.43-
1.30 (m, 2H), 1.39 (s, 3H), 0.45 (s, 9H).  13C NMR (125 MHz, CDCl3) δ 170.3, 163.6, 
161.6, 135.7 (ap d), 133.7(ap d), 132.6 (ap d), 131.7, 129.8, 128.3 (ap d), 127.8, 127.4, 
115.7, 115.5, 72.1, 59.9, 37.4, 27.0, 21.4, 19.3.  IR (neat, cm-1)  3071.40, 3043.92, 
2950.90, 2931.20, 2858.02, 1737.30, 1601.84.  HRMS (ESI) m/z calculated for 
C29H33O3FSiNa [M+Na]+:  499.2081, found 499.2086. 
 
 (E)-5-(tert-butyldiphenylsilyloxy)-1-(4-
formylphenyl)pent-1-en-3-yl acetate: To a 40 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.3 mg, 
10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), tert-butyl(pent-4-
O
O
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enyloxy)diphenylsilane (1 mmol, 325 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 
mmol, 240 mg, 4 equiv.), and a stir bar.  The mixture was heated to 45oC for 24 hours.  4-
formylphenylboronic acid (1.5 mmol, 225 mg, 1.5 equiv.) was added and heated to 45oC 
for 5 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl and extracted with 
CH2Cl2 (2 x 75 mL).  The organic layers were combined, rinsed with H2O (75 mL) and 
dried over MgSO4.  After concentration, the crude product was purified via silica 
chromatography (140 mL SiO2) with 15% ethyl acetate/hexanes as eluent to yield (E)-5-
(tert-butyldiphenylsilyloxy)-1-(4-formylphenyl)pent-1-en-3-yl acetate as a clear oil.  Run 
1 (0.293 g, 0.602 mmol, 60%); run 2 (0.286 g, 0.588g, 59%).  Average yield = 60%.  1H 
NMR (500 MHz, CDCl3) δ 9.99 (s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 7 Hz, 4H), 
7.49 (d, J = 8.5 Hz, 2H),  7.43-7.34 (m, 6H), 6.65 (d, J = 16.5 Hz, 1H), 6.31 (dd, J = 16.0, 
7.0 Hz, 1H), 5.68 (ap q, J = 7.0 Hz, 1H), 3.75 (t, J = 5.5 Hz, 2H), 2.05 (s, 3H), 2.06-1.91 
(m, 2H), 1.06 (s, 9H).  13C NMR (125 MHz, CDCl3) δ 191.9, 170.4, 142.6, 135.8, 135.7, 
133.7, 133.6, 131.6, 131.3, 130.3, 129.9 (ap d), 127.9, 127.3, 71.8, 59.9, 37.4, 27.0, 21.4, 
19.4.  IR (neat, cm-1) 3071.13, 3048.95, 2957.46, 2931.26, 28.57.81, 2737.53, 1738.21, 
1698.58. HRMS (ESI) m/z calculated for C30H34O4SiNa [M+Na]+:  509.2124, found 
509.2125. 
 
 (E)-1-(3-Chlorophenyl)-7-methylocta-1,6-dien-3-yl 
acetate:  To a 40 mL borosilicate vial was added catalyst 1 
(0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 
216.2 mg, 2 equiv.), 7-methyl-1,6-octadiene (1 mmol, 124 mg, 1 equiv.) in dioxane 
(3mL), acetic acid (4 mmol, 240 mg, 4 equiv.), and a stir bar.  The mixture was heated to 
O
O
Cl
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45oC for 48 hours.  3-Chlorophenylboronic acid (1.5 mmol, 235 mg, 1.5 equiv.), 
benzoquinone (1 mmol, 183 mg, 1 equiv.), acetic acid (1 mmol, 60 mg, 1 equiv.) were 
added and heated to 45oC for 6 hours.  The mixture was diluted with 40 mL of sat. aq. 
NH4Cl and extracted with hexanes (2 x 75 mL).  The organic layers were combined and 
dried over MgSO4.  After concentration, the crude product was purified via silica 
chromatography (140 mL SiO2) with 4% ethyl acetate/hexanes as eluent to yield (E)-1-
(3-Chlorophenyl)-7-methyl-1,6-octadien-3-acetate as a clear oil.  Run 1 (0.178 g, 0.606 
mmol, 61%); run 2 (0.193 g, 0.654 mmol, 65%).  Average yield = 63%.  1H NMR (400 
MHz, CDCl3) δ 7.36 (s, 1H), 7.22 (m, 3H), 6.35 (d, J = 15.6 Hz, 1H), 6.13 (dd, J = 16.4, 
7.6 Hz, 1H), 5.38 (ap q, J = 6.4 Hz, 1H), 5.10 (t, J = 7.2 Hz, 1H), 2.08 (s, 3H), 2.05 (m, 
2H),1.77 (m, 2H), 1.69 (s, 3H), 1.58 (s, 3H).  13C NMR (100 MHz, CDCl3) δ 170.6, 
138.5, 134.7, 132.7, 131.2, 130.0, 129.5, 128.0, 126.6, 125.0, 123.3, 74.2, 34.6, 25.9, 
23.9, 21.5, 17.9.  IR (neat, cm-1) 2967.04, 2928.00, 2858.35, 1738.54, 1594.59, 1566.65. 
HRMS (ESI) m/z calculated for C17H21O2ClNa [M+Na]+: 315.1128, found 315.1133. 
 
 (E)-5-(1,3-dioxoisoindolin-2-yl)-1-o-tolylpent-1-en-3-yl 
acetate: To a 40 mL borosilicate vial was added catalyst 1 
(0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 
216.2 mg, 2 equiv.), 2-(pent-4-enyl)isoindoline-1,3-dione (1 mmol, 325 mg, 1 equiv.) in 
dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 equiv.), and a stir bar.  The mixture was 
heated to 45oC for 48 hours.  o-Tolylphenylboronic acid (2 mmol, 272 mg, 1.5 equiv.), 
benzoquinone (1 mmol, 108 mg, 1 equiv.), and acetic acid (1 mmol, 60 mg, 1 equiv.) 
were added and heated to 45oC for 4 hours.  The mixture was diluted with 40 mL of sat. 
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aq. NH4Cl and extracted with CH2Cl2 (2 x 75 mL).  The organic layers were combined, 
rinsed with H2O (75 mL) and dried over MgSO4.  After concentration, the crude product 
was purified via silica chromatography (140 mL SiO2) with 20% ethyl acetate/hexanes as 
eluent to yield (E)-5-(1,3-dioxoisoindolin-2-yl)-1-o-tolylpent-1-en-3-yl acetate as a white 
powder.  Run 1 (0.274 g, 0.749 mmol, 75%); run 2 (0.258 g, 0.706 mmol, 71%).  
Average yield = 73%.  1H NMR (400 MHz, CDCl3) δ 7.83 (m, 2H), 7.69 (m, 2H), 7.36 
(m, 1H), 7.12 (m, 3H), 6.87 (d, J = 16 Hz, 1H), 6.00 (dd, J = 16, 7.2 Hz, 1H), 5.44 (ap q, 
J = 6.4 Hz, 1H), 3.81 (m, 2H), 2.34 (s, 3H), 2.15 (m, 2H), 2.07 (s, 3H).  13C NMR (100 
MHz, CDCl3) δ 170.4, 168.4, 136.0, 135.3, 134.2, 132.2, 131.3, 130.5, 128.1, 127.9, 
126.2, 125.8, 123.4, 72.6, 34.5, 33.1, 21.4, 20.0.  IR (neat, cm-1) 3061.90, 3020.60, 
2946.33, 1772.19, 1738.23, 1714.39. HRMS (ESI) m/z calculated for C22H21O4NNa 
[M+Na]+: 386.1368, found 386.1375. 
 
 (E)-5-(1,3-dioxoisoindolin-2-yl)-1-(2-
methoxyphenyl)pent-1-en-3-yl acetate:  To a 40 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.3 mg, 
10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 2-(pent-4-enyl)isoindoline-1,3-
dione (1 mmol, 325 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 
equiv.), and a stir bar.  The mixture was heated to 45oC for 48 hours.  2-
Methoxyphenylboronic acid (1.5 mmol, 228 mg, 1.5 equiv.), benzoquinone (1 mmol, 108 
mg, 1 equiv.), and acetic acid (1 mmol, 60 mg, 1 equiv.) were added and stirred at room 
temperature for 5 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl and 
extracted with CH2Cl2 (2 x 75 mL).  The organic layers were combined, rinsed with H2O 
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(75 mL) and dried over MgSO4.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 20% ethyl acetate/hexanes as eluent to yield 
(E)-5-(1,3-dioxoisoindolin-2-yl)-1-(2-methoxyphenyl)pent-1-en-3-yl acetate as a clear 
oil.  Run 1 (0.201 g, 0.530 mmol, 53%); run 2 (0.211 g, 0.556 mmol, 56%).  Average 
yield = 55%.  1H NMR (500 MHz, CDCl3) δ 7.81 (dd, J = 5.0, 3.0 Hz, 2H), 7.68 (dd, J = 
5.0, 3.0 Hz, 2H), 7.36 (d, J = 6.5 Hz, 1H), 7.19 (t, J = 8 Hz, 1H), 6.93 (d, J = 16.5 Hz, 
1H), 6.87 (t, J = 7.5 Hz, 1H), 6.82 (d, J = 8.5 Hz, 1H), 6.19 (dd, J = 16, 7.5 Hz, 1H), 5.44 
(ap q, J = 5.5 Hz, 1H), 3.87-3.74 (m, 5H), 2.16-2.07 (m, 5H).  13C NMR (125 MHz, 
CDCl3) δ 170.4, 168.4, 157.1, 134.1, 132.2, 129.2, 128.1, 127.3, 127.2, 125.1, 123.3, 
120.6, 110.9, 72.8, 55.5, 34.5, 33.0, 21.4.  IR (neat, cm-1)  2941.06, 2838.34, 1772.05, 
1738.07, 1714.00, 1598.14.  HRMS (ESI) m/z calculated for C22H21NO5Na [M+Na]+: 
402.1317, found 402.1327. 
 
 (E)-5-(4-methoxybenzyloxy)-1-phenylpent-1-en-3yl 
3,5-dinitrobenzoate): To a 40 mL borosilicate vial 
was added catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), 
benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 5-(4-
methoxybenzyloxy)-1-pentene (1 mmol, 206 mg, 1 equiv.) in dioxane (3mL), 3,5-
dinitrobenzoic acid (4 mmol, 848 mg, 4 equiv.), and a stir bar.  The mixture was heated to 
45oC for 48 hours.  Phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.), benzoquinone (1 
mmol, 108 mg, 1 equiv.), and acetic acid (1 mmol, 60 mg, 1 equiv.) were then added to 
the reaction, followed by heating to 45oC for 4 hours.  The mixture was diluted with 40 
mL of sat. aq. NH4Cl and extracted with methylene chloride (2 x 75 mL).  The organic 
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layers were combined and rinsed with 5% K2CO3 (75 mL), H2O (75 mL), and dried with 
MgSO4.  The filtered organic solution was concentrated via rotary evaporator.  The crude 
yellow oil was further purified via silica chromatography (400 mL SiO2) with 14% ethyl 
acetate/14% methylene chloride/hexanes as eluent to give (E)-1-Phenyl-5-(4-
methoxybenzyloxy)-1-penten-3-(3,5-dinitrobenzoate) as a yellow solid.  Run 1 (0.269 g, 
0.55 mmol, 55%); run 2 (0.253 g, 0.51 mmol, 51%).  Average yield = 53%.  1H NMR 
(500 MHz, CDCl3) δ 9.16 (m, 1H), 9.02 (d, J = 1.5 Hz, 2H), 7.38 (d, J = 8.5 Hz, 2H), 
7.32 (t, J = 8 Hz, 2H), 7.27 (m, 1H), 7.14 (d, J = 8.5 Hz, 2H), 6.74 (d, J = 16 Hz, 1H), 
6.66 (d, J = 8.5 Hz, 2H), 6.23 (dd, J = 16, 7.5 Hz, 1H), 5.93 (m, 1H), 4.40 (d, J = 11.5 
Hz, 1H), 4.34 (d, J = 11 Hz, 1H), 3.70 (s, 3H), 3.61 (m, 2H), 2.27 (m, 1H), 2.15 (m, 1H).  
13C NMR (100 MHz, CDCl3) δ 162.0, 159.1, 148.5, 135.9, 134.5, 134.4, 130.1, 129.7, 
129.5, 128.8, 128.6, 126.9, 126.1, 122.2, 113.6, 75.8, 72.9, 65.7, 55.3, 34.8.  IR (neat, cm-
1) 3101.83, 2934.64, 2863.07, 1730.84, 1544.89. HRMS (ESI) m/z calculated for 
C26H24O8N2Na [M+Na]+: 515.1430, found 515.1436. 
 
 (E)-1-(3-cyanophenyl)-6-(methoxy(methyl)amino)-6-
oxohex-1-en-3-yl 4-nitrobenzoate: To a 40 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.3 
mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 
equiv.), N-methoxy-N-methylhex-5-enamide (1 mmol, 157 mg, 1 equiv.) in dioxane 
(3mL), p-nitrobenzoic acid (2 mmol, 334 mg, 2 equiv.), and a stir bar.  The mixture was 
heated to 45oC for 48 hours.  3-cyanophenylboronic acid (1.5 mmol, 220 mg, 1.5 equiv.), 
benzoquinone (1 mmol, 108 mg, 1 equiv.), and acetic acid (1 mmol, 60 mg, 1 equiv.) 
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were added and heated to 45oC for 7 hours.  The mixture was diluted with 40 mL of sat. 
aq. NH4Cl and extracted with CH2Cl2 (2 x 75 mL).  The organic layers were combined, 
rinsed with 5% K2CO3 (75mL), H2O (75 mL) and dried over MgSO4.  After 
concentration, the crude product was purified via silica chromatography (140 mL SiO2) 
with 50% ethyl acetate/hexanes as eluent to yield (E)-1-(3-cyanophenyl)-6-
(methoxy(methyl)amino)-6-oxohex-1-en-3-yl 4-nitrobenzoate as a clear oil.  Run 1 
(0.320 g, 0.757 mmol, 76%); run 2 (0.328 g, 0.776 mmol, 78%).  Average yield = 77%.  
1H NMR (500 MHz, CDCl3) δ 8.30 (d, J = 8.5 Hz, 2H), 8.23 (d, J = 9 Hz, 2H), 7.66 (s, 
1H), 7.60 (d, J = 8 Hz, 1H), 7.34 (d, J = 7.5 Hz, 1H), 7.43 (ap t, J = 7.5 Hz, 1H), 6.72 (d, 
J = 16 Hz, 1H), 6.31 (dd, J = 16, 7 Hz, 1H), 5.75 (ap q, J = 7 Hz, 1H), 3.63 (s, 3H), 3.14 
(s, 3H), 2.60 (t, J = 7, 2H), 2.27 (m, 2H).  13C NMR (125 MHz, CDCl3) δ 173.1, 164.1, 
150.8, 137.4, 135.7, 131.6, 131.5, 131.0 (ap d), 130.3, 129.7, 129.5, 123.8, 118.7, 113.1, 
75.8, 61.4, 32.4, 29.3, 27.7.  IR (neat, cm-1) 3110.89, 3078.75, 2938.96, 2230.86, 
1724.36, 1660.20. HRMS (ESI) m/z calculated for C22H22O6N3 [M+H]+:  424.1509, 
found 424.1505. 
 
 (E)-methyl 4-(3-(2-bromoacetoxy)-3-cyclohexylprop-1-
enyl)benzoate: To a 40 mL borosilicate vial was added 
catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 
mmol, 216.2 mg, 2 equiv.), allylcyclohexane (1 mmol, 124 mg, 1 equiv.) in dioxane 
(3mL), bromoacetic acid (4 mmol, 556 mg, 4 equiv.), and a stir bar.  The mixture was 
heated to 45oC for 48 hours. 4-methoxycarbonylphenylboronic acid (1.5 mmol, 270 mg, 
1.5 equiv.), benzoquinone (1 mmol, 108 mg, 1 equiv.), and acetic acid (1 mmol, 60 mg, 1 
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equiv.) were added and heated to 45oC for 24 hours.  The mixture was diluted with 40 
mL of sat. aq. NH4Cl and extracted with hexanes (2 x 75 mL).  The organic layers were 
dried over MgSO4.  After concentration, the crude product was purified via silica 
chromatography (140 mL SiO2) with 10% ethyl acetate/hexanes as eluent to yield (E)-
methyl 4-(3-(2-bromoacetoxy)-3-cyclohexylprop-1-enyl)benzoate as a clear oil.  Run 1 
(0.247 g, 0.627 mmol, 63%); run 2 (0.234 g, 0.595 mmol, 60%).  Average yield = 62%.  
1H NMR (500 MHz, CDCl3) δ 7.99 ( d, J = 8 Hz, 2H), 7.44 (d, J = 8 Hz, 2H), 6.66 (d, J = 
15.5 Hz, 1H), 6.23 (dd, J = 15.5, 7.5 Hz, 1H), 5.26 (ap t, J = 7.5 Hz, 1H), 3.91 (s, 3H), 
3.87 (d, J = 3 Hz, 2H), 1.86-1.67 (m, 6H), 1.29-1.02 (m, 5H).  13C NMR (125 MHz, 
CDCl3) δ 167.0, 166.8, 140.8, 133.1, 130.1, 129.6, 128.4, 126.7, 80.9, 52.3, 42.0, 28.9, 
28.7, 26.4 (ap d), 26.0 (ap d).  IR (neat, cm-1) 2929.53, 2853.45, 1720.77. HRMS (ESI) 
m/z calculated for C19H23O4BrNa [M+Na]+;  417.0677, found 417.0683. 
 
 (E)-1-(benzo[d][1,3]dioxol-5-yl) undec -1- en -3- yl 
2-(tert-butoxycarbonyl) acetate:  To a 40 mL 
borosilicate vial was added the following: catalyst 1 
(0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 1-undecene 
(1 mmol, 154 mg, 1 equiv.) in dioxane (3mL), N-Boc-glycine (2 mmol, 350 mg, 2 
equiv.), and a stir bar.  The mixture was heated to 45oC for 24 hours.  3,4-
Methylenedioxyphenylboronic acid (1.5 mmol, 249 mg, 1.5 equiv.) was added and stirred 
at room temperature for 4 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl 
and extracted with hexanes (2 x 75 mL).  The organic layers were combined, rinsed with 
60 mL of 5% K2CO3 (aq.) soluction, and dried over MgSO4.  After concentration, the 
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crude product was purified via silica gel chromatography (125 mL SiO2) with 15% ethyl 
acetate/.5% triethylamine/hexanes as eluent to yield (E)-1-(benzo[d][1,3]dioxol-5-
yl)undec-1-en-3-yl 2-(tert-butoxycarbonyl)acetate as a pale oil.  NOTE:  Product was 
found to be slightly unstable to silica gel unless buffered.  Run 1 (0.3106 g, 0.695 mmol, 
70%); run 2 0.3001 g, 0.671 mmol, 67%).  Average yield = 69%.  1H NMR (500 MHz, 
CDCl3) δ 6.92 (s, 1H), 6.81 (d, J = 8 Hz, 1H), 6.76 (d, J = 8 Hz, 1H), 6.53 (d, J = 16 Hz, 
1H), 5.96 (s, 2H), 5.93 (dd, J = 16, 8Hz, 1H), 5.42 (ap q, J = 7 Hz, 1H), 5.01 (m, 1H), 
3.96 (dd, J = 18.5, 6 Hz, 1H), 3.89 (dd, J = 18, 5.5 Hz, 1H), 1.75-1.65 (m, 2H), 1.45 (s, 
9H), 1.35-1.22 (m, 12H), 0.88 (t, J = 7.5 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ 170.0, 
155.9, 148.2, 147.8, 133.1, 130.8, 125.5, 121.8, 108.5, 105.9, 101.3, 80.1, 76.6, 42.8, 
34.8, 32.0, 29.6, 29.5, 29.4, 28.5, 25.4, 22.9, 14.3.  IR (neat, cm-1) 3392.35, 2928.61, 
2857.15, 1744.28, 1715.64, 1505.27.  HRMS (ESI) m/z calculated for C25H37NO6Na 
[M+Na]+; 470.2519, found 470.2509. 
 
 (E)-1-(4-Bromophenyl)undec-1-en-3-yl 2-(tert-
butoxycarbonyl) acetate:  To a 40 mL borosilicate vial 
was added the following: catalyst 1 (0.1 mmol, 50.3 mg, 
10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 1-undecene (1 mmol, 154 mg, 1 
equiv.) in dioxane (3mL), N-Boc-glycine (2 mmol, 350 mg, 2 equiv.), and a stir bar.  The 
mixture was heated to 45oC for 24 hours.  4-Bromophenylboronic acid (1.5 mmol, 301 
mg, 1.5 equiv.) was added and heated to 45oC for 5 hours.  The mixture was diluted with 
40 mL of sat. aq. NH4Cl and extracted with hexanes (2 x 75 mL).  The organic layers 
were combined and dried over MgSO4.  After concentration, the crude product was 
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purified via silica gel chromatography (140 mL SiO2) with 10% ethyl acetate/hexanes as 
eluent to yield (E)-1-(4-Bromophenyl)-1-undecen-3-N-boc-glycine as a pale oil.  Run 1 
(0.359 g, 0.746 mmol, 75%); run 2 0.360 g, 0.749 mmol, 75%).  Average yield = 75%.  
1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.4 Hz, 2H), 6.54 (d, 
J = 15.6 Hz, 1H),  6.09 (dd, J = 15.6, 7.2 Hz, 1H), 5.42 (ap q, J = 6.8 Hz, 1H), 5.02 (bs, 
1H), 3.92 (m, 2H), 1.70 (m, 2H), 1.44 (s, 9H), 1.34-1.85 (m, 12H), 0.87 (t, J = 6.8 Hz, 
3H).  13C NMR (100 MHz, CDCl3) δ 169.9, 155.8, 135.2, 131.9, 131.8, 128.3, 128.1, 
122.0, 80.1, 76.1, 42.7, 34.6, 32.0, 29.6, 29.5, 29.4, 28.5, 25.3, 22.8, 14.3.  IR (neat, cm-1) 
3369.70, 2928.07, 2856.25, 1747.79, 1716.11, 1508.35.  HRMS (ESI) m/z calculated for 
C24H37NO4Br [M+H]+: 482.1906, found 482.1911. 
 
 (E)-1-(3-Methoxyphenyl)-1-buten-3-ol:  1-Butene (0.112 g, 2 
mmol, 0.178 mL, 1 equiv.) was condensed in a 25 mL graduated 
tube at -78oC.  The liquid was transfered via cannula under a positive pressure of oxygen 
to a 40 mL sealed tube (cooled to -78oC).  Dioxane (3mL, purged with O2 for 30 minutes 
prior to use) was added to the graduated tube at -78oC (to trap any residual butene in the 
cannula), then warmed to the point when it could be transferred with cannule (with a 
positive pressure of O2) to the sealed tube.  To the sealed tube (maintained at -78oC) was 
added the following solids: Benzoquinone (0.432 g, 4 mmol, 2 equiv.), catalyst 1 (101 
mg, 0.2 mmol, 10 mol%), 4-nitrobenzoic acid (1.00 g, 6 mmol, 3 equiv.).  After addition 
of each solid, 1 mL of oxygenated dioxane was added and used to rinse the solid off of 
the sides of the sealed tube (3 mL total).  The tube was sealed under an atmosphere of O2, 
warmed to room temperature with stirring, and then heated to 45oC for 20h.  The mixture 
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was cooled to room temperature, N2 was bubbled through it for 5 minutes (to remove 
unreacted 1-butene).  3-Methoxyphenyl boronic acid (0.456 g, 3 mmol, 1.5 equiv.) was 
then added and heated in the sealed tube at 45oC.  Reaction progress was monitored by 
TLC until disappearance of the allylic ester was observed (~4h).  Upon completion the 
mixture was cooled to room temperature and diluted with 100 mL of a saturated aqueous 
potassium carbonate/methanol mixture (1:1) to effect hydrolysis of the p-nitrobenzyl 
ester.  The reaction progress was again monitored by TLC.  Upon completion (~4h) the 
mixture was diluted with 100 mL H2O and extracted 2 x 100 mL CH2Cl2.  The organic 
layers were combined and dried over MgSO4.  Concentration via rotary evaporator 
yielded a crude mixture which was purified via silica gel chromatography (130 mL SiO2) 
in 20% ethyl acetate/hexanes as eluent to afford (E)-1-(3-Methyoxyphenyl)-1-buten-3-ol 
as a clear oil.  Run 1 (0.276 g, 1.55 mmol, 77%); run 2 (0.269 g, 1.34 mmol, 76%).  
Average yield = 77%.  1H NMR (400 MHz, CDCl3) δ 7.23 (t, J = 8 Hz, 1H), 6.97 (d, J = 
8 Hz, 1H), 6.91 (t, J = 1.6, 1H), 6.80 (ddd, J = 8, 2.4, .4, 1H), 6.53 (d, J = 15.6, 1H), 6.26 
(dd, J = 15.6, 6), 4.48 (ap dp, J = 6.4, .4, 1H), 3.81 (s, 3H),  1.78 (bs, 1H), 1.37 (d, J = 
6.4, 3H).  13C NMR (100 MHz, CDCl3) δ 159.9, 138.3, 134.0, 129.8, 129.4, 119.3, 113.5, 
111.9, 69.1, 55.4, 23.6.  IR (neat, cm-1) 3368.94, 2970.20, 2930.23, 2835.91, 1598.23, 
1580.15.  HRMS (ESI) m/z calculated for C11H14O2Na [M+Na]+: 201.0891, found 
201.0889. 
 
 (E)-1-phenylundec-1-en-3-yl acetate: To a 40 mL borosilicate vial 
was added the following: catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%) 
or palladium acetate (0.1 mmol, 22.4 mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 
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equiv.), undec-1-en-3-yl acetate (1 mmol, 212 mg, 1 equiv.) in dioxane (3mL), acetic 
acid 4 equiv. (4 mmol, 24.0 mg, 0.231 mL) or 1 equiv. ( 1 mmol, 60.0 mg, 58 µl), 
phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.) and a stir bar.  After heating to 45oC 
for 4 hours, the mixture was diluted with 40 mL of sat. aq. NH4Cl and extracted with 
hexanes (2 x 75 mL).  The organic layers were combined, rinsed with 60 mL of 5% 
K2CO3 (aq.) solution, and dried over MgSO4.  After concentration, the crude product was 
purified via silica gel chromatography (125 mL SiO2) with 5% ethyl acetate/hexanes as 
eluent to yield (E)-1-phenylundec-1-en-3-yl acetate as a colorless oil.  All yields are the 
average of 2-3 runs.  1H NMR (400 MHz, CDCl3) δ 7.38 (m, 2H), 7.31 (m, 2H), 7.25 (m, 
1H), 6.59 (d, J = 16 Hz, 1H), 6.12 (dd, J = 15.6, 7.2 Hz, 1H), 5.39 (ap q, J = 7.2 Hz, 1H), 
2.08 (s, 3H), 1.76-1.61 (m, 2H), 1.35-1.22 (m, 12H), 0.87 (t, J = 6.8 Hz, 3H).  13C NMR 
(100 MHz, CDCl3) δ 170.7, 136.6, 132.7, 128.8, 128.1 (ap d), 126.8, 75.1, 34.8, 32.1, 
29.7, 29.6, 29.5, 25.4, 22.9, 21.6, 14.4.  IR (neat, cm-1) 2926.47, 2856.91, 1737.89, 
1237.51  HRMS (EI) m/z calculated for C19H28O2 [M]+; 288.2089, found 288.2088.   
NOTE:  2,6-Dimethylbenzoquinone (2 mmol, 272.0 mg, 2 equiv.) may be used instead of 
benzoquinone to yield (E)-1-phenylundec-1-en-3-yl acetate as a colorless oil (0.268 g, 
0.932 mmol, 93%) with >20:1 E:Z selectivities by crude 1H NMR and 66:1 
internal:terminal olefin selectivities by crude GC analysis. 
 
2-phenylundec-1-en-3-yl acetate:  Terminal olefin standard.  1H NMR 
(400 MHz, CDCl3) δ 7.43 (m, 2H), 7.35-7.29 (m, 3H), 5.67 (t, J = 6 Hz, 
1H), 5.28 (ap d, J = 6 Hz, 2H), 2.12 (s, 3H), 1.61 (ap q, J = 6.4 Hz, 2H), 
1.30-1.20 (m, 12H), 0.86 (t, J = 7.2 Hz, 3H).  13C (125 MHz, CDCl3) δ 170.6, 148.8, 
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139.8, 128.5, 127.9, 127.2, 113.8, 75.8, 34.1, 32.0, 29.6, 29.4 (ap d), 25.6, 22.8, 21.5, 
14.3.  IR (neat, cm-1) 2953.63, 2927.47, 2856.50, 1741.83, 1237.16.  HRMS (EI) m/z 
calculated for C19H28O2 [M]+: 288.2089, found 288.2091. 
 
 (E)-1-((1-phenylundec-1-en-3-yloxy)methyl)benzene: To a 40 mL 
borosilicate vial was added the following: catalyst 1 (0.1 mmol, 50.3 
mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 1-((undec-1-en-3-
yloxy)methyl)benzene (1 mmol, 260 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 
mmol, 240 mg, 4 equiv.), phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.), and a stir 
bar.  The mixture was heated to 45oC for 4 hours.  The mixture was diluted with 40 mL 
of sat. aq. NH4Cl and extracted with hexanes (2 x 75 mL) and rinsed with 5% K2CO3 (1 x 
75 mL).  The organic layers were combined and dried over MgSO4.  After concentration, 
the crude product was purified via silica gel chromatography (125 mL SiO2) with 3% 
ethyl acetate/hexanes as eluent to yield (E)-1-((1-phenylundec-1-en-3-
yloxy)methyl)benzene as a clear oil.  Run 1 (0.308 g, 0.923 mmol, 92%); run 2 (0.305 g, 
0.914 mmol, 91%).  Average yield = 92%.  The Heck arylation may also be performed 
at room temperature for 4h:  run 1 (0.309 g, 0.924 mmol, 92%); run 2 (0.311 g, 0.931, 
93%).  Average yield = 93%.  By crude 1H NMR all selectivities were >20:1 E:Z and 
>20:1 internal olefin : terminal olefin.  1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 7.2 Hz, 
2H), 7.36-7.26 (m, 8H), 6.53 (d, J = 15.6 Hz, 1H), 6.13 (dd, J = 16, 8 Hz, 1H), 4.64 (d, J 
= 12 Hz, 1H), 4.41 (d, J = 12 Hz, 2H), 3.90 (q, J = 8 Hz, 1H), 1.80-1.71 (m, 1H), 1.63-
1.54 (m, 1H), 1.46-1.26 (m, 12H), 0.88 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) 
δ 139.1, 136.9, 132.5, 131.04, 128.9, 128.6, 128.0, 127.9, 127.7, 126.7, 80.4, 70.3, 36.2, 
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32.1, 29.9, 29.8, 29.6, 25.8, 22.9, 14.4.  IR (neat, cm-1) 3025.86, 2952.73, 2926.76, 
2852.95.  HRMS (CI) m/z calculated for C24H33O [M+H]+: 337.2532, found 337.2538. 
 
 (E)-1-(3-methoxyundec-1-enyl)benzene: To a 40 mL borosilicate 
vial was added the following: catalyst 1 (0.1 mmol, 50.3 mg, 10 
mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 3-methoxyundec-1-ene (1 mmol, 
184 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 equiv.), 
phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.), and a stir bar.  The mixture was 
heated to 45oC for 4 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl and 
extracted with hexanes (2 x 75 mL) and rinsed with 5% K2CO3 (1 x 75 mL).  The organic 
layers were combined and dried over MgSO4.  After concentration, the crude product was 
purified via silica gel chromatography (125 mL SiO2) with 3% ethyl acetate/hexanes as 
eluent to yield (E)-1-(3-methoxyundec-1-enyl)benzene as a clear oil.  Run 1 (0.246 g, 
0.946 mmol, 95%); run 2 (0.247 g, 0.951 mmol, 95%).  Average yield = 95%.  Heck 
arylation may also be performed at room temperature for 4h:  run 1 (0.243 g, 0.936 
mmol, 94%); run 2 (0.235 g, 0.904 mmol, 90%).  Average yield = 92%.  By crude 1H 
NMR all selectivities were >20:1 E:Z and >20:1 internal olefin : terminal olefin.  1H 
NMR (400 MHz, CDCl3) δ 7.42 (d, J = 7.2 Hz, 2H), 7.34 (t, J = 7.6 Hz, 2H), 7.26 (t, J = 
7.2 Hz, 1H), 6.54 (d, J = 16 Hz, 1H), 6.06 (d, J = 15.6, 8 Hz, 1H), 3.70 (q, J = 7.6 Hz, 
1H), 3.33 (s, 3H), 1.74-1.66 (m, 1H), 1.60-1.52 (m, 1H), 1.44-1.20 (m, 12H), 0.89 (t, J = 
7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ 136.9, 132.4, 130.7, 128.8, 127.8, 126.6, 
82.9, 56.4, 36.0, 32.1, 29.9, 29.8, 29.5, 25.6, 22.9, 14.3.  IR (neat, cm-1) 2957.02, 
C8H17
O
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2928.01, 2923.33, 2854.66.  HRMS (CI) m/z calculated for C18H29O [M+H]+: 261.2218, 
found 261.2216. 
 
Arylation of 3-methyl-hex-1-ene: To a 40 mL borosilicate vial was added the following: 
catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 3-
methylhex-1-ene (1 mmol, 98.2 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 
mg, 4 equiv.), phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.), and a stir bar.  The 
mixture was heated to 45oC for 4 hours.  The mixture was diluted with 40 mL of sat. aq. 
NH4Cl and extracted with hexanes (2 x 75 mL) and rinsed with 5% K2CO3 (1 x 75 mL).  
The organic layers were combined and dried over MgSO4.  After concentration, the crude 
product was purified via silica gel chromatography (125 mL SiO2) with 100% hexanes as 
eluent to yield an inseparable mixture of isomers as a clear oil.  Note: Due to volatility 
concerns, the hexanes was removed via rotary evaporator at 0oC.  By crude 1H NMR the 
ratio of internal olefin : trisubstituted olefin : terminal olefin at 45oC is 8:1:1.  Run 1 
(0.129 g, 0.742 mmol, 74%); run 2 (0.132 g, 0.759 mmol, 76%).  Average yield = 75%.  
Heck arylation may also be performed at room temperature for 4h:  run 1 (0.134 g, 0.777 
mmol, 78%).  Yield = 78%.  By crude 1H NMR the room temperature ratio of internal 
olefin : trisubstituted olefin : terminal olefin, 10:7:1.  By crude 1H NMR all selectivities 
were >20:1 E:Z.  1H NMR (400 MHz, CDCl3) δ Internal olefin: 6.34 (d, J = 16 Hz, 1H), 
6.10 (dd, J = 16, 8 Hz, 1H), 2.31 (m, 1H).  Trisubstituted olefin:  5.35 (t, J = 7.2 Hz, 1H), 
3.37 (d, J = 7.2 Hz, 2H). Terminal olefin: 5.18 (s, 1H), 5.03 (s, 1H), 2.12 (m, 1H).  13C 
NMR (100 MHz, CDCl3) δ Internal olefin: 138.2, 137.3, 128.7, 128.1, 127.0, 126.2, 39.6, 
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37.3, 20.9, 20.7, 14.4.  HRMS (CI) m/z calculated for C13H19 [M+H]+: 175.1487, found 
175.1488. 
 
 (E)-tert-butyldiphenyl(1-phenylundec-1-en-3-yloxy)silane: To a 
40 mL borosilicate vial was added the following: catalyst 1 (0.1 
mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), tert-
butyldiphenyl(undec-1-en-3-yloxy)silane (1 mmol, 409 mg, 1 equiv.) in dioxane (3mL), 
acetic acid (4 mmol, 240 mg, 4 equiv.), phenylboronic acid (1.5 mmol, 183 mg, 1.5 
equiv.), and a stir bar.  The mixture was heated to 45oC for 4 hours.  The mixture was 
diluted with 40 mL of sat. aq. NH4Cl and extracted with hexanes (2 x 75 mL) and rinsed 
with 5% K2CO3 (1 x 75 mL).  The organic layers were combined and dried over MgSO4.  
After concentration, the crude product was purified via silica gel chromatography (125 
mL SiO2) with 3% ethyl acetate/hexanes as eluent to yield (E)-tert-butyldiphenyl(1-
phenylundec-1-en-3-yloxy)silane as a pale yellow oil. Run 1 (0.459 g, 0.948 mmol, 
95%); run 2 (0.451 g, 0.930 mmol, 93%).  Average yield = 94%.  Heck arylation may 
also be performed at room temperature for 4h:  run 1 (0.478 g, 0.989 mmol, 99%), run 2 
(0.479 g, 0.991 mmol, 99%).  Average yield = 99%.  By crude 1H NMR all selectivities 
were >20:1 E:Z and >20:1 internal olefin : terminal olefin.  1H NMR (400 MHz, CDCl3) 
δ 7.70 (dd, J = 13.6, 7.2 Hz, 4H), 7.43-7.21 (m, 11H), 6.21 (d, J = 16 Hz, 1H), 6.13 (dd, J 
= 15.6, 6.4 Hz, 1H), 4.29 (ap q, J = 5.6 Hz, 1H), 1.65-1.47 (m, 2H), 1.30-1.18 (m, 12H), 
1.09 (s, 9H),  0.88 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ 137.4, 136.2, 
136.1, 135.7, 134.7, 134.5, 133.0, 129.8, 129.7, 129.6, 128.6, 127.7, 127.6, 127.4, 126.6, 
74.8, 38.2, 32.1, 29.7 (app d), 29.5, 27.3, 24.9, 22.9, 19.6, 14.4.  IR (neat, cm-1) 2957.98, 
C8H17
OTBDPS
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2958.12, 2927.73, 2856.35.  HRMS (CI) m/z calculated for C34H45OSi [M+H]+: 
485.3240, found 485.3238. 
 
Arylation of 1-undecene:  To a 40 mL borosilicate vial was added the following: 
catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 1-
undecene (1 mmol, 98.2 mg, 1 equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 
equiv.), phenylboronic acid (1.5 mmol, 183 mg, 1.5 equiv.), and a stir bar.  The mixture 
was heated to 45oC for 4 hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl 
and extracted with hexanes (2 x 75 mL) and rinsed with 5% K2CO3 (1 x 75 mL).  The 
organic layers were combined and dried over MgSO4.  After concentration, the crude 
product was purified via silica gel chromatography (125 mL SiO2) with 100% hexanes as 
eluent to yield (E)-1-(3-methylhex-1-enyl)benzene as a clear oil (0.137 g, 0.603 mmol, 
60%).  Yield = 60%.  By crude 1H NMR the ratio of products was determined to be 
4:1:1.  Heck arylation may also be preformed at room temperature for 4h (0.140 g, 0.612 
mmol, 61%).  Yield = 61%.  By crude 1H NMR the ratio of internal olefin : allylic 
benzene : terminal olefin was found to be 4:3:1.  By crude 1H NMR E:Z selectivities 
were found to be >20:1 in all cases.  1H NMR (400 MHz, CDCl3) δ Internal olefin: 6.43 
(d, J = 15.6 Hz, 1H), 6.28 (dt, J = 16, 6.8 Hz, 1H), 2.25 (q, J = 7.6 Hz, 2H).  Allylic 
benzene:  5.66-5.52 (m, 2H), 3.38 (d, J = 6 Hz, 2H), 2.07 (q, J = 6.4 Hz, 2H).  Terminal 
olefin: 5.31 (s, 1H), 5.10 (s, 1H), 2.55 (t, J = 6.8 Hz, 2H). 
 
 (E)-1-(3,3-dimethylbut-1-enyl)benzene: To a 40 mL borosilicate vial 
was added the following: catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), 
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benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 3,3-dimethyl-1-butene (1 mmol, 84.2 mg, 1 
equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 equiv.), phenylboronic acid 
(1.5 mmol, 183 mg, 1.5 equiv.), and a stir bar.  The mixture was heated to 45oC for 4 
hours.  The mixture was diluted with 40 mL of sat. aq. NH4Cl and extracted with hexanes 
(2 x 75 mL) and rinsed with 5% K2CO3 (1 x 75 mL).  The organic layers were combined 
and dried over MgSO4.  After concentration, the crude product was purified via silica gel 
chromatography (125 mL SiO2) with 100% hexanes as eluent to yield (E)-1-(3,3-
dimethylbut-1-enyl)benzene as a clear oil.  Run 1 (0.158 g, 0.999 mmol, quantitative); 
run 2 (0.158 g, 1.000 mmol, quantitative).  Average yield = quantitative.  By crude 1H 
NMR all selectivities were >20:1 E:Z and >20:1 internal olefin : terminal olefin.  1H 
NMR (400 MHz, CDCl3) δ 7.39 (d, J = 7.6 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.22 (t, J = 
7.2 Hz, 1H), 6.34 (d, J = 16 Hz, 1H), 6.28 (d, J = 16 Hz, 1H), 1.16 (s, 1H).  13C NMR 
(100 MHz, CDCl3) δ 142.0, 138.2, 128.7, 126.9, 126.2, 124.7, 33.6, 29.8.  IR (neat, cm-1) 
3025.38, 2960.48, 2903.23, 2866.92.  HRMS (CI) m/z calculated for C12H17 [M+H]+: 
161.1330, found 161.1330. 
 
Table 3, Entry 1: 
Run 1 (287.1 mg, 0.997 mmol, 100%, 99:1 internal;terminal); run 2 (283.4 mg, 0.984 
mmol, 98%, 97:3 internal:terminal); run 3 (272.6 mg, 0.947 mmol, 95%, 98:2 
internal:terminal).  Average yield = 99%, 98:2. 
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Table 3, Entry 2: 
Run 1 (104.3 mg, 0.362 mmol, 36%); run 2 (107.3 mg, 0.372 mmol, 37%).  Average 
yield = 37%. 
 
Table 3, Entry 3: 
Run 1 (20.2 mg, 0.070 mmol, 7%); run 2 (25.0 mg, 0.0868 mmol, 9%).  Average yield = 
8%. 
 
Table 3, Entry 4: 
Run 1 (193.5 mg, 0.672 mmol, 67%); run 2 (202.3 mg, 0.702 mmol, 70%); run 3 (219.6 
mg, 0.762 mmol, 76%).  Average yield = 71%. Note:  Variation was observed for this 
entry based on catalyst batch.  Batches containing move phenylvinyl sulfoxide (and 
presumably therefore acetic acid) show heightened reactivity toward the arylation without 
acetic acid added. 
 
Table 4, Entry 5: 
Run 1 (265.2 mg, 0.921 mmol, 92%); run 2 (272.6 mg, 0.947 mmol, 95%).  Average 
yield = 94%. 
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CHAPTER 2 
 
A GENERAL AND HIGHLY SELECTIVE CHELATE-CONTROLLED 
 
INTERMOLECULAR OXIDATIVE HECK REACTION 
 
 
2.1 INTRODUCTION 
 
The intermolecular Heck reaction is unique among cross-coupling reactions in 
that it directly transforms vinylic C-H bonds of α-olefins to C-C bonds (figure 3).1  The 
chemically inert nature of α-olefins allows for fewer synthetic steps by forgoing 
installation, protection, and oxidation state changes to preoxidized functionality 
throughout reaction sequences.  Recently, the intermolecular Heck-arylation has enjoyed 
an increase in the scope of the arylating agent; however, the restricted α-olefin scope has 
prevented widespread application in complex molecule synthesis (figure 6).2  Generally,  
Figure 6.  Insertion selectivities of various terminal olefins.
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resonance bias on the α-olefin is necessary for controlling regioselectivity of insertion 
and β-hydride elimination as well as for improved reactivity (figure 7).  The demand for 
resonance bias frequently limits the α-olefin component to α,β-unsaturated carbonyls, 
styrenes and enol ethers.  
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We hypothesized that directing factors other than resonance activation could 
control the siteselectivities of insertion and β-hydride elimination under our oxidative 
Heck arylation conditions.  A coordination event to an arylated palladium species could 
direct the orientation of olefin insertion and the direction of β-hydride elimination by 
restricting bond rotations (figure 8).  Alternatively, steric bulk could control insertion by 
directing the relatively large aryl toward the more accessible terminus.  However, the 
steric repulsion exerted on the palladium must be greater from the adjacent substitution  
X
R
Pd Ph
Chelation
directed
insertion
R
X
PdLn
Ph
directed
elimination
R
X
Ph
R
X
Sterics
PdLn Ph
steric 
repulsion
R
X
Ph
PdLn
steric 
repulsion
R
X
Ph
R
X
Inductive
!+
!-
PdLn Ph
!+ !-
+
dipole
alignment
R
X
Ph
PdLn
R
X
Ph
Figure 8.  Non-resonance modes of selectivity.
 
than from the terminal aryl to guide β-hydride elimination.  Finally, an electron 
withdrawing group could direct insertion and β-hydride elimination by creating electronic 
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dipoles on the olefin.  This charge distribution could be used to align with the 
electronically dissymmetric palladium aryl intermediate. 
An oxidative Heck manifold is well suited for exploring these modes of 
selectivity.  As previously mentioned, oxidative Heck reactions begin catalytic cycles 
with a transmetalation event rather than oxidative addition.3  To effect transmetalation, 
electrophilic palladium (II) sources with weakly donating ligands are often used instead 
of the strongly donating ligands used with nucleophilic palladium (0) complexes.4 A 
more electron deficient palladium aryl intermediate will coordinate more readily to 
heteroatoms and be more sensitive to inductive effects.  Importantly, the remaining 
anionic ligand on the palladium-aryl intermediate will play a crucial role in determining 
the amount of steric influence applied by proximal functionality.  Coordinating non-
halide anionic ligands have the potential to increase the size of the palladium moiety 
compared to the halogen palladium moieties formed during oxidative addition.  Our 
previously reported conditions for the sequential allylic C-H, vinylic C-H activation 
reaction (chapter 1), which uses a palladium (II) acetate complex, seemed amenable to 
these directing factors.   
 
 
2.2 RESULTS AND DISCUSSION  
2.2.1 Understanding and Separating Directing Factors for Heck Arylations of Non-
Resonance Activated Olefins 
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We began our studies of these hypothesized selectivity effects by examining 
allylic functionality and its relation to the siteselectivities of insertion and β-hydride 
elimination (table 4).  A straight-chain hydrocarbon gave a baseline selectivity of 4:1 for 
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X
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X
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Table 4. Effect of allylic substitution on selectivities.
entry X isolated yield
 
internal vs. terminal olefin isomers resulting from insertion and 1:1 styrenyl vs. allylic 
olefin isomers from β-hydride elimination (table 4, entry 1).  As previously reported, 
allylic acetate functionality gave high selectivities possibly due to chelation, induction, 
and sterics (table 4, entry 2).  Inductively withdrawing allylic chelators OMe and NHBoc 
also gave excellent isomer ratios (table 4, entries 3 & 4).  Organofluorine is unlikely to 
strongly coordinate to palladium and also will exhibit a small steric influence.  To test for 
inductive control, allylic difluoride and trifluoromethyl derivatives were tested (table 4, 
entries 5 & 6).  Both furnished good selectivities, indicating that inductive direction is 
operative in controlling olefin selectivities.  An allylic methyl group gave poor selectivity 
for insertion (4:1) but improved selectivities for β-hydride elimination (8:1 vs 1:1, table 
4, entry 7) relative to unsubstituted olefin.  This result suggests the reaction manifold is 
not controlled primarily by sterics, as the methyl group is larger than the allylic difluoride 
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and methoxy ether but gives inferior isomer selectivities.  When the steric bulk is 
increased to an allylic t-butyl or TBPDS ether excellent selectivities are observed which 
indicates substantial steric bulk is tolerated in this system and provides constitutional 
control (table 4, entries 8 & 9).  Significantly, the allylic t-butyl group has little inductive 
effect and no possibility for chelation, suggesting steric control is operative if the 
directing group is large enough. 
 Having shown inductive and steric effects to be contributing directing factors, we 
began to examine the possibility of chelation control guiding the selectivities in this 
reaction.5  Moving the directing functionality to the homoallylic position helps 
distinguish directing factors, since inductive and steric effects decrease dramatically the  
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Table 5. 5-member chelation control.
 
further they are from the reactive site.  Homoallylic acetate and methyl ethers gave olefin 
isomer selectivities slightly better than a straight chained hydrocrabon (table 5, entries 2 
&3).  Employing a Boc protected amine in the same position gave higher selectivities 
(table 5, entry  4).  Interestingly, electron rich homoallylic carbonyls favored β-hydride 
elimination out of conjugation with the aryl moiety to furnish α,β-unsaturated carbonyls 
with good insertion selectivities (table 5, entries 5 & 6). 
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 Moving chelating functionality to the bis-homoallylic position (6-member 
chelate) allows for further examination of chelation control.  Carbonyls in this position 
direct to give good selectivities and preparative yields of the styrenyl isomer (table 6, 
entries 2 and 3).  These results suggest this oxidative Heck manifold is also under 
chelation control from electron rich functionality. 
R
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Pd
"6-member chelate"
1
2
3
NHBoc
O
O
alkyl
OMe
CH3
81%
68%
50%
4:1
12:1
>20:1
1:1
6:1
>20:1
R
X
10 mol% Pd/bis-sulfoxide
BQ, AcOH, dioxane
PhB(OH)2, r.t. R
X
Ph
int.:term. sty.:allyl.entry X yieldR
R
X
Pd
Ph
Table 6. 6-member chelation control.
 
 Finally, to confirm that chelation control is operative in this oxidative Heck-
arylation, a potential 7-member chelate was attempted.  As predicted, poor olefin 
regioselectivities were observed, similar to those for the straightchain hydrocarbon  
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Figure 9. 7-member chelation is not favorable.
 
(figure 9).  This result indicates that no directing effects are operative for functionality 
capable of forming a relatively unfavorable 7-membered palladium chelate. 
 
2.2.2 State-of-the-Art Synthesis of γ-Arylated-α,β-Unsaturated Carbonyls 
 Having found chelation, induction, and sterics to all be directing factors for the 
palladium (II)/bis-sulfoxide catalyzed oxidative Heck-arylation, we began examining the 
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applications of this system in complex molecule synthesis.  β-Amino acids are desirable 
biological structures due to applications as enzyme inhibitors,6 unique peptide folding,7 
and potentially as medicinal agents for overcoming antibiotic resistance. The α,β-
unsaturated carbonyl moiety is known to undergo enantioselective conjugate addition of 
chiral amines and azide anion to form the β-amino acid precursor.8  When trying to 
access a γ-arylated-β-amino acid, workers at Merck attempted to synthesize the γ-
arylated-α,β-unsaturated methyl ester intermediate 26.9  However, useful yields could not 
be isolated due to the instability of the desired product under the reaction conditions used 
since light, base, acid, and heat all isomerize the desired product to the more 
thermodynamically stable styrenyl olefin isomer.  The attempted Horner-Wadsworth-
Emmons (HWE) reaction route relies on condensation of a phosphonate ester with a 
benzyl aldehyde.  Electron deficient benzyl aldehydes are frequently problematic to 
prepare due to facile polymerization, even under seemingly mild conditions.  
Furthermore, the HWE reaction conditions employ potassium tert-butoxide as base to 
promote addition to the benzyl aldehyde.  The strong base used in the HWE reaction 
caused isomerization to the undesired styrenyl isomer giving only 17% of the desired 
α,β-unsaturated isomer as a difficult to separate 1:3 mixture favoring the undesired 
isomer (figure 10).  Ultimately, Merck was forced to abandon the desired route to the 
target compound.  Under the newly discovered oxidative Heck conditions, the desired 
α,β-unsaturated product was formed in preparative yields as a single isomer from two 
commercially available compounds.  The mild nature of this reaction manifold is 
illustrated by no erosion of the desired α,β-unsaturated product to the styrenyl isomer.  
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To the best of our knowledge, this is the only efficient method for forming γ-arylated-
α,β-unsaturated esters with electron withdrawn aryl moieties. 
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 Melanin-concentrating hormone (MCH) antagonist are capable of regulating 
appetite10 and functioning as antidepressants.11  One of the MCH antagonist small 
molecules being investigated is formed via the α,β-unsaturated-γ-arylated ethyl ester 
intermediate 27.12  The Arena group accessed this intermediate by HWE condensation 
with benzyl aldehyde 28 in three steps from commercial materials (figure 11).  Despite a 
poor yield for the key HWE step (26%), the route was still used as it allowed rapid access 
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Figure 11. Synthesis of a MHC through a !-arylated-",#-unsaturated ester intermediate.
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to the desired motif.  In general, HWE reactions are predominantly used to access these 
types of intermediates in spite of poor selectivities and yields for the desired products.  
Under our oxidative Heck arylation conditions, the desired product was formed as the 
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only observed isomer in two steps from commercial materials with the key arylation step 
proceeding in 60% yield.   
 Aspartic proteases help determine the pathogenicity of both viruses and fungi; 
therefore, aspartic inhibitors are possible treatments for HIV and other infections.13  The 
HIV aspartic protease inhibitor intermediate to TS-93, 29, was synthesized in two steps 
with the key HWE reaction proceeding in 50% yield (figure 12).14  α,β-unsaturated-γ-
arylated ketone intermediates to medicinally interesting molecules are often conveniently 
synthesized in preparative yields through HWE reactions due to a weaker base being 
employed (potassium carbonate vs potassium tert-butoxide for ester equivalents).  
However, only electron rich or electron neutral aryls are amenable to this reaction 
because product olefin isomerization is still problematic for electron deficient aryls.  The 
step count and yield are comparable to the oxidative Heck route (2 steps, 60% for the key 
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 52 
arylation step).  However, 2230 aryl boronic acids are commercially available which 
gives a tremendous advantage toward rapid diversification options over the HWE route 
since only 175 benzyl aldehydes are commercially available. 
 Larock has developed a palladium (0)-based naphthalene synthesis from γ-
arylated-α,β-unsaturated carbonyls where the aryl ring must be substituted at the ortho 
position with a halide (figure 13).15  Under our palladium (II)-based conditions, halides 
are preserved through the reaction, which allows for a complementary palladium (0)- 
O
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Br
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R
R'
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PdII*bisSO
(HO)2B
Br
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Pd0
Figure 13. Oxidative Heck Arylation, Larock Naphthalene Sequence
 
based transformations immediately following our reaction.  These transition metal 
reaction sequences have the power to rapidly build complexity from simple starting 
materials. 
 
2.2.3 Six-Member Chelators for Synthesis of Medicinally Relevant Intermediates 
 A number of synthetic advantages became evident when comparing the oxidative 
Heck arylation disconnect with common ways to construct bis-homoallylic substituted 
styrenyl molecules.  Palladium (0) Heck arylation methods may be used to form FK506 
segment anologues bearing bis-homoallylic functionality; however, phosphine ligand 
screening was necessary to achieve preparatively useful selectivities because the olefin 
isomers formed are not easily separable (figure 14).16  Under our oxidative Heck  
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no ligand screens
general catalyst  
conditions the desired coupling takes place with excellent regioselectivity of olefin 
isomers in preparative yields.  The palladium (II)/bis-sulfoxide catalyst 1 has proven to 
be general with a broad range of substrates, which foregoes any need for catalyst or 
ligand screening.  
 A similar attempt to employ a palladium (0) based Heck reaction for the synthesis 
of the green tea catechin metabolite intermediate 30 failed due to the formation of a 
complex mixture of inseparable olefin isomers (figure 15).17  Unfortunately, the direct  
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arylation route had to be abandon and replaced with a Claisen rearrangement route.  This 
required the aryl motif to be incorporated in the starting material, thus preventing facile 
aryl diversification.  However, under our oxidative Heck reaction conditions the bis-
homoallylic ethyl ester couples smoothly to the electron-rich boronic acid in 75% yield.  
Significantly, the aryl moiety may be easily installed from a variety of commercial aryl 
boronic acids, allowing for rapid medicinal screening. 
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 Bis-homoallylic alcohols are also excellent directors in this palladium (II) 
catalyzed reaction.  Previously, alcohols with up to nine methylene spacers between the 
terminal olefin were often oxidized to the ketone during palladium (0) Heck arylations by 
double bond migration to form an enol, which readily tautomerizes to the ketone (figure 
16).18  The extensive double bond migration is due to a long-lived palladium hydride 
species capable of repeatedly inserting into the alkene.  With the palladium (II)/ 
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( )n=2
OH
( )n=2
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( )n=2
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Figure 16. Pd0 vs. PdII olefin-hydride isomerizations.
 
bis-sulfoxide catalyzed arylation conditions, bis-homoallylic alcohols are not oxidized 
and all chiral information is preserved.  The lack of olefin isomerization indicates a short-
lived palladium hydride species.  The short-lived nature of this intermediate is likely due 
to two key differences in our catalytic system when compared to palladium (0) based 
Heck arylations:  1) the palladium hydrido acetate intermediate thermodynamically 
favors reductive elimination to form palladium (0) and acetic acid while the palladium 
hydrido halide intermediates formed in reductive Heck reactions favor the protonated 
palladium instead of palladium (0) and hydrohalic acid; 2) the reoxidation of palladium 
(0) with benzoquinone is a favorable process and further drives the equilibrium away 
from a hydrido palladium species.  These two mechanistic differences allow chiral 
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alcohol substrates as seen in figure 16 to be compatible with our Heck-arylation 
conditions with no oxidation or erosion of optical purity.  
    Selective Heck arylations of amino acid derived pent-4-enoic acid 31 and pent-
4-enoate 32 require different palladium (0) catalyst systems that must be empirically 
determined through extensive ligand and additive screens (figure 17).19  In contrast, the  
S
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Figure 17.  Medicinally relavent six-member chelators.
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35  
versatile palladium (II)/bis-sulfoxide catalyst 1 is general and furnishes a wide range of 
coupled products in good yields and outstanding selectivities.  Significantly, aryl halide 
functionality is preserved throughout the course of the oxidative reaction.  Each of the 
aryl halides in figure 17 were further elaborated via palladium (0) mediated Suzuki 
couplings. 
 Wittig olefination routes to isolated olefins with the straight chain bis-homoallylic 
carboxylic acid 34 and α-chloroketone 35 in figure 17 led to difficult to separate mixtures 
of E:Z olefins.20  Under these mild oxidative Heck-arylation conditions, E-olefin products 
were formed exclusively for all substrates evaluated.  Interestingly, bis-homoallylic 
thioether 33 couples smoothly.  Thioethers are often incompatible moieties with 
palladium (II) mediated reactions due to catalyst binding, but the sulfur functionality 
serve as an excellent directing groups in this reaction. 
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2.2.4 Steric Directors and New Nucleophiles 
 During optimization and the testing of directing factors we found that substantial 
steric bulk adjacent to the olefin is tolerated in this Heck reaction without diminished 
reactivity.  Even an α-olefin in close proximity to a quaternary center and near an 
exocyclic methyl group underwent oxidative Heck arylation to afford a BMS 
glucocorticoid receptor modulator 37 in preparative yields (figure 18).21  Previously, this 
medicinally interesting molecule had been synthesized via a Wittig reaction as the final 
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Figure 18.  Oxidative Heck-arylation on a sterically encumbered olefin.
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step to install the aryl ring.  Our synthetic sequence proceeded through the same aldehyde 
intermediate to generate the terminal olefin 36 via the Wittig reaction, but we have the 
key benefit of a more readily substituted aryl moiety because currently >2200 aryl 
boronic acids and <200 benzylic Wittig reagents are commercially available.   
 Steric bulk was found to be universally tolerated and gave high selectivities for 
the arylated products (figure 19).  Allylic tert-butyl hydrocarbon 38, vinylic quarternary  
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Figure 19.  Steric directed arylation with a PdII/bisSO catalyst.
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hydrocarbon 39 and vinylic protected tetrahedral boron 40 were all found to be good 
steric directors under our arylation conditions.22  Importantly, the protected styrenyl 
boron is easily employed in palladium (0) coupling reactions after deprotection. 
 Synthetically, it is often beneficial to be able to access a variety of transmetalating 
agents to effect the same type of arylation since each nucleophile has different 
characteristics (figure 20).  As previously mentioned, a vast number of aryl boronic acids  
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Figure 20. Importance of arylation and vinylation nucleophile variety.
 
are commercially available, are often stable to air, and easy to weigh out; however, when 
synthesizing arylation compounds aryl tin reagents and potassium trifluoroborates have 
some advantages.  Stannanes are available through a variety of reactions including 
nucleophilic displacements of tributyl stannyl halides and transition metal-based 
synthesis with stannyl dimers.  The aryl tin products of these reactions are often column 
stable which allows for a simplified purification process.  Both aryl tin reagents and aryl 
boronic acids work well under our oxidative Heck condition for allylic substituted 
terminal olefins substrates.   
Potassium trifluoroborates are indefinitely stable crystalline solid compounds 
often isolated through simple filtration.  Characterization of these compounds is 
frequently easier than their boronic acid counterparts since they are monomeric 
structures, whereas both the monomeric and trimeric forms of the aryl boronic acid are 
often present.23  Potassium trifluoroborates are gaining increasing commercial support 
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largely due to these advantages.  Under our palladium (II) catalyzed Heck reaction aryl 
BF3K salts couple efficiently providing boric acid is added to the reaction mixture (figure 
21).  Their synthetic utility was demonstrated in accessing a patented anti-cholesterol  
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agent 41 where the potassium trifluoroborate was formed from the commercially 
available aryl pinacol boronic ester.24  Under our reaction conditions aryl boronic esters 
transmetalate slowly and do not give preparatively useful yields; however, with a simple 
one-step conversion to corresponding aryl borate salt, the reaction proceeds smoothly 
with good yield and selectivities.  The boric acid additive is likely a fluoride acceptor that 
opens a p-orbital on the aryl boron for transmetalation, since addition of boric acid to the 
BF3K salt in an NMR tube rapidly converts the salt to the boronic acid and two other aryl 
species (presumably the mono- and difluorinated boron aryls).  A similar observation was 
reported for the addition of TMSCl to BF3K salts.25 
Vinyl boronic esters are much more stable than their vinyl boronic acid 
counterparts, simple to access synthetically, and can often be isolated through column 
chromatography.  Employment of vinyl boronic esters in our oxidative Heck manifold 
would allow for access to a new class of nucleophiles to complement an already broad 
substrate scope.  While longer reaction times were necessary due to sluggish reactivity, 
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preparative yields and selectivities were observed for diene products at higher molarities 
providing the vinyl boronic ester is styrenyl.  The arylated diene functionality proved to 
be valuable synthetically as a variety of medicinally interesting compounds posses this 
motif.  Importantly, the oxidative Heck vinylation compares favorably with existing 
methodologies used to access these products.  We directly compared our method to the 
olefination route employed for the synthesis of an intermediate to a myosin light chain 
kinase inhibitor 44 used for smooth muscle relaxation (figure 22).26  The commonly used 
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Julia olefination route begins with N-Boc-protected phenyl alanol 42 and requires 5 steps 
to access the key arylated diene intermediate 43.  Beginning from the same amino alcohol 
42, only three steps were required to access the identical diene intermediate 43 as a single 
isomer in good yield with no erosion of optical purity.  Significantly, an overall 20% 
boost in yield was observed for the oxidative Heck arylation route which requires 
minimal oxidation state changes and foregoes installation of an activating group that must 
be removed later. 
 Several other arylated dienes were synthesized in good yields as single isomers 
with no erosion of optical purity (figure 23).  The allylic ether 45 was previously  
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synthesized via a Suzuki coupling which required the selective oxidative addition of the 
palladium catalyst into a vinyl bromide bond over an aryl bromide bond.  While the 
selective transformation was achieved in the synthesis of this potent anti-inflammatory 
lipoxin analogue, an oxidative Heck vinylation manifold forgoes all competing oxidative 
addition reactions and the aryl bromide is preserved throughout the reaction.27 
 Under the oxidative Heck vinylation conditions only the E-olefin isomer is 
observed likely due to our transformation occurring mildly at room temperature.  Other 
olefination methods commonly used such as the Wittig olefination often erode E:Z ratios, 
as was the case for the chiral amine 46.  In contrast, the oxidative Heck reaction afforded 
a single isomer in good yields. 
 
2.3 CONCLUSIONS  
 We have developed a general oxidative Heck reaction catalyzed by the versatile 
palladium (II)/bis-sulfoxide catalyst 1, which proceeds with excellent selectivities for a 
broad range of non-resonance biased olefins.  The catalyst is sensitive to chelation from 
proximal oxygen, nitrogen and sulfur moieties, steric encumbrance, and inductive 
direction.  These directing events result in excellent regioselectivities for olefin insertion 
and β-hydride elimination for a variety of substrates.  Palladium hydride isomerization of 
olefins is not observed under these mild, oxidative conditions as evidenced by excellent 
E:Z selectivities, no erosion in optical purity for proximal stereocenters, and a tolerance 
for unprotected alcohol moieties.  We have significantly expanded the scope for the 
intermolecular Heck reaction with respect to terminal olefins and therefore have 
broadened its synthetic applications. 
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2.4 EXPERIMENTAL SECTION  
General Information: All commercially obtained reagents for the Heck arylation 
reaction were used as received: 1,4-benzoquinone and 2,6-dimethylbenzoquinone 
(Sigma-Aldrich); 5-bromoindole (Frontier Scientific Inc.); 4-
methoxycarbonylphenylbornic acid, 2,5-difluorophenylboronic acid (Frontier Scientific 
Inc.); phenylboronic acid and 2-bromophenylboronic acid (Sigma-Aldrich);  1,2-
Bis(phenylsulfinyl)ethane palladium(II) acetate “Catalyst 1” (Sigma-Aldrich). Catalyst 1 
was stored in a glove box under an argon atmosphere and weighed out in air prior to use.  
Solvents dioxane, tetrahydrofuran (THF), diethyl ether (Et2O), and methylene chloride 
(CH2Cl2) were purified prior to use by passage through a bed of activated alumina (Glass 
Contour, Laguna Beach, California).  Anhydrous N,N-dimethylformamide (DMF) (Sure 
Seal) was obtained from Sigma-Aldrich and used as received.  All Heck arylation 
reactions were run under air with no precautions taken to exclude moisture.  Thin-layer 
chromatography (TLC) was conducted with E. Merck silica gel 60 F254 precoated plates 
(0.25 mm) and visualized with UV and potassium permanganate staining.  Flash column 
chromatography was performed as described by Still using EM reagent silica gel 60 (230-
240 mesh).28  1H NMR spectra were recorded on a Varian Unity-400 (400 MHz) or 
Varian Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an 
internal standard (CDCl3 at 7.26 ppm).  Data reported as: s = singlet, d = doublet, t = 
triplet, q = quartet, p = pentet, m = multiplet, b = broad, ap = apparent; coupling 
constant(s) in Hz; integration.  Proton-decoupled 13C NMR spectra were recorded on a 
Varian Unity-400 (100 MHz) or Varian Unity-500 (125 MHz) spectrometer and are 
reported in ppm using solvent as an internal standard (CDCl3 at 77.23 ppm).   19F NMR 
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spectra were recorded on a Varian Unity-400 (376 MHz) or Varian-500 (470 MHz) 
spectrometer and are reported in ppm using a 1% C6F6/CDCl3 standard referenced to -
164.3 ppm.  Regioselectivity of the Heck addition was determined by NMR analysis of 
the crude mixture.  IR spectra were recorded as thin films on NaCl plates on a Perkin-
Elmer Spectrum BX and are reported in frequency of absorption (cm-1).  High-resolution 
mass spectra were obtained at the University of Illinois Mass Spectrometry Laboratory.  
Optical rotations were obtained using a JAS.CO DIP-370 digital polarimeter and a 3.5 x 
100 mm cell. 
 
General Procedure for Heck Arylation:  To an 8 mL borosilicate vial were added 
sequentially: Catalyst 1 (10 mol%, 0.1 mmol), benzoquinone (2 equiv, 2 mmol), dioxane 
(0.33M, 3 mL), acetic acid (4 equiv, 4 mmol), olefin (1 equiv., 1 mmol), boronic acid 
(1.5 equiv., 1.5 mmol), and a stir bar.  The vial was capped and stirred at room 
temperature with the reaction progress monitored by TLC or NMR aliquot (4hrs).  The 
reaction mixture was diluted with H2O and extracted with CH2Cl2 or hexane (2 times).  
The combined organics were dried over MgSO4.  The mixture was filtered and 
concentrated in vacuo.  Purification by flash chromatography (EtOAc/hexanes mixtures) 
provided the pure product. 
 
The only deviation from standard conditions have been increasing aryl boronic acids 
loadings for compounds 2, 3, 5, and 14.  Increasing aryl boronic acids loading (from 1.5 
to 2.0 equiv.) was found to improve internal:terminal product ratios due to further 
arylation of the minor terminal product to generate trisubstituted olefins. Increasing 
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reaction times (from 4hrs to 24hrs) for compound 5, 6, 7, 9, and 10 (48h) was found to 
give better styrenyl:allylic ratios due to erosion of the minor allylic isomer.  
 
Diene Formation Conditions:  Following the General Procedure with 2 equiv. 2,6-
dimethylbenzoquinone, 1.0 M dioxane, and reaction time of 48 hours.  Drastically 
diminished yields are observed when benzoquinone is used, which was determined to be 
due to Diels-Alder reactions with the diene products and benzoquinone. 
 
 (E)-methyl 4-(6-chloro-5-oxohex-1-enyl)benzoate:  To 
an 8 mL borosilicate vial was added catalyst 1 (0.1 mmol, 
50.2 mg, 10 mol%), benzoquinone (2.0 mmol, 216.0 mg, 
2 equiv.), dioxane (3 mL, 0.33 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), 1-
chlorohex-5-en-2-one (1.0 mmol, 133.0 mg, 1 equiv.), 4-methoxycarbonylphenylboronic 
acid (2.0 mmol, 360.0 mg, 2.0 equiv.) and a stir bar sequentially under ambient 
conditions.  The vial was capped and stirred at room temperature for 4 hours.  The 
mixture was diluted with CH2Cl2 (50 ml) and rinsed with H2O (50 ml).  The aqueous 
layer was extracted with CH2Cl2 (50 ml) and the combined organic layers were dried over 
MgSO4. After concentration, the crude product was purified via silica chromatography 
(125 mL SiO2) with 15% ethyl acetate/hexanes then further purified via silica 
chromatography (125 mL SiO2) with 100% methylene chloride as eluent to yield (E)-
methyl 4-(6-chloro-5-oxohex-1-enyl)benzoate as a white solid.  Run 1 (172.7 mg, 0.65 
mmol, 65%, >20:1 E:Z, 16:1 int.:term., >20:1 int.:allyl, 13:1 styrenyl:diene); run 2 (166.6 
mg, 0.62 mmol, 62%, >20:1 E:Z, 16:1 int.:term., >20:1 styrenyl:allyl, 13:1 
Cl
O
OMe
O
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styrenyl:diene).  Average Yield = 64%.  1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 8.4 
Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 6.46 (d, J = 16 Hz, 1H), 6.32 (dt, J = 16, 6.4 Hz, 1H), 
4.10 (s, 2H), 3.90 (s, 3H), 2.81 (t, 6.8 Hz, 2H), 2.56 (ap q, J = 6.8 Hz, 2H).  13C NMR 
(100 MHz, CDCl3) 202.01, 167.12, 141.85, 131.16, 130.72, 130.12, 128.88, 126.13, 
52.28, 48.40, 39.22, 27.06. IR (neat, cm-1) 3011.79, 2991.84, 2947.42, 2910.79, 1725.83, 
1716.12. HRMS (ESI) m/z calculated for C14H16O3Cl [M+H]+:  267.0788, found 
267.0795. It is known the Pd(II) and benzoquinone can convert carbonyl compounds to 
α,β-unsaturated carbonyls.29 
 
 (E)-5-(4-(methoxycarbonyl)phenyl)pent-4-enoic acid: 
To an 8 mL borosilicate vial was added catalyst 1 (0.1 
mmol, 50.2 mg, 10 mol%), benzoquinone (2.0 mmol, 216.0 
mg, 2 equiv.), dioxane (3 mL, 0.33 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), 4-
pentenoic acid (1.0 mmol, 100.0 mg, 1 equiv.), 4-methoxycarbonylphenylboronic acid 
(2.0 mmol, 360.0 mg, 2.0 equiv.) and a stir bar sequentially under ambient conditions.  
The vial was capped and stirred at room temperature for 4 hours.  The mixture was 
diluted with methylene chloride (50 ml) and rinsed with 10% aq. H3PO4 (50 ml).  The 
aqueous layer was extracted with methylene chloride (50 ml) and the combined organic 
layers were dried over MgSO4.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 20% acetone/hexanes as eluent to yield (E)-5-
(4-(methoxycarbonyl)phenyl)pent-4-enoic acid as a white solid.  Run 1 (184.9 mg, 0.79 
mmol, 79%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.); run 2 (187.7 mg, 0.80 mmol, 
80%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.).  Average Yield = 80%.  1H NMR 
HO
O
O
OMe
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(400 MHz, CDCl3) δ 7.96 (d, J = 8.4 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H), 6.48 (d, J = 16 
Hz, 1H), 6.34 (m, 1H), 3.90 (s, 3H), 2.56 (s, 4H).  13C NMR (100 MHz, CDCl3) δ 178.74, 
167.18, 141.92, 131.12, 130.63, 130.12, 128.85, 126.16, 52.29, 33.62, 28.15. IR (neat, 
cm-1) 3119.86, 3010.62, 2926.10, 1719.65, 1693.39. HRMS (ESI) m/z calculated for 
C13H14O4Na [M+Na]+:  257.0790, found 257.0783.  Spectra taken in d6-DMSO matches 
reported assignments.30 
 
 (E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate: To a 
4 mL borosilicate vial was added catalyst 1 (0.05 mmol, 
25.1 mg, 10 mol%), benzoquinone (1 mmol, 108.0 mg, 2 
equiv.), dioxane (1.5 mL, 0.33 M), acetic acid (2.0 mmol, 120.0 mg, 4 equiv.), ethyl pent-
4-enoate (0.5 mmol, 64.0 mg, 1 equiv.), 3,4,5-trimethoxyphenylboronic acid (0.75 mmol, 
127.3 mg, 1.2 equiv.), and a stir bar sequentially under ambient conditions.  The vial was 
capped and stirred at 45oC for 4 hours.  The mixture was diluted with CH2Cl2 (50 ml) and 
rinsed with H2O (50 ml).  The aqueous layer was extracted with CH2Cl2 (50 ml) and the 
combined organic layers were dried over MgSO4. After concentration, the crude product 
was purified via silica chromatography (125 mL SiO2) with 20% ethyl acetate/hexanes as 
eluent to yield (E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate as a white solid.  Run 1 
(111.5 mg, 0.38 mmol, 75%, >20:1 E:Z, 8:1 int.:term., >20:1 sty.:allyl.); run 2 (108.8, 
0.37 mmol, 74%, >20:1 E:Z, 8:1 int.:term., >20:1 sty.:allyl.).  Average Yield = 75%.  1H 
NMR (400 MHz, CDCl3) δ 6.55 (s, 2H), 6.35 (d, J = 15.6 Hz, 1H), 6.12 (dt, J = 15.6, 6.8 
Hz, 1H), 4.14 (q, J = 6.8 Hz, 2H), 3.86 (s, 6H), 3.82 (s, 3H), 2.55-2.45 (m, 4H), 1.25 (t, J 
= 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ 173.22, 153.48, 137.58, 133.40, 131.07, 
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128.29, 103.19, 61.16, 60.66, 56.25, 34.25, 28.42, 14.50.  IR (neat, cm-1) 2979.87, 
2938.51, 2837.43, 1730.54. HRMS (ESI) m/z calculated for C16H23O5 [M+H]+:  295.1545, 
found 295.1537.  A known compound however no spectral data is reported.31 
 
Alternative Oxidants: 
Oxygen: 
(E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate: To a 4 mL borosilicate vial was 
added catalyst 1 (0.05 mmol, 25.1 mg, 10 mol%), dioxane (1.5 mL, 0.33 M), acetic acid 
(2.0 mmol, 120.0 mg, 4 equiv.), ethyl pent-4-enoate (0.5 mmol, 64.0 mg, 1 equiv.), 3,4,5-
trimethoxyphenylboronic acid (0.75 mmol, 127.3 mg, 1.5 equiv.), an oxygen balloon, and 
a stir bar sequentially under ambient conditions.  Nitrobenzene was added as an internal 
standard.  The vial was capped and stirred at 45oC for 4 hours.  GC analysis revealed a 
11% conversion with a 5% yield of (E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate 
(response factor corrected). 
 
Air: 
Replacing the oxygen balloon with an air balloon in the above procedure yielded a 10% 
conversion with a 4% yield of (E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate 
(response factor corrected). 
 
Hydrogen Peroxide: 
(E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate: To a 4 mL borosilicate vial was 
added catalyst 1 (0.05 mmol, 25.1 mg, 10 mol%), dioxane (1.5 mL, 0.33 M), acetic acid 
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(2.0 mmol, 120.0 mg, 4 equiv.),  hydrogen peroxide (1.0 mmol, 68 µL, 2 equiv., 50% aq. 
solution), ethyl pent-4-enoate (0.5 mmol, 64.0 mg, 1 equiv.), 3,4,5-
trimethoxyphenylboronic acid (0.75 mmol, 127.3 mg, 1.5 equiv.), and a stir bar 
sequentially under ambient conditions.  Nitrobenzene was added as an internal standard.  
The vial was capped and stirred at 45oC for 4 hours.  GC analysis revealed a 100% 
conversion with a 6% yield of (E)-ethyl 5-(3,4,5-trimethoxyphenyl)pent-4-enoate 
(response factor corrected). 
 
 (S,E)-1-(2-(5-(4-(benzyloxy)phenyl)pent-4-
enoyl)pyrrolidin-1-yl)-3,3-dimethylpentane-1,2-
dione: To a 4 mL borosilicate vial was added 
catalyst 1 (0.05 mmol, 25.1 mg, 10 mol%), benzoquinone (1.0 mmol, 108.0 mg, 2 
equiv.), dioxane (1.5 mL, .33 M), acetic acid (2.0 mmol, 120.0 mg, 4 equiv.), (S)-3,3-
dimethyl-1-(2-pent-4-enoylpyrrolidin-1-yl)pentane-1,2-dione (0.5 mmol, 139.5 mg, 1 
equiv. derived from N-(tert-Butoxycarbonyl)-L-proline N’-methoxy-N’-methylamide), 4-
(benzyloxy)phenylboronic acid (1.0 mmol, 228.1 mg, 2.0 equiv.) and a stir bar 
sequentially under ambient conditions.  The vial was capped and stirred at room 
temperature for 24 hours.  The mixture was diluted with methylene chloride (50 mL) and 
rinsed with 5% K2CO3 (50 ml).  The aqueous layer was extracted with methylene chloride 
(50 mL) and the combined organic layers were dried over MgSO4.  After concentration, 
the crude product was purified via silica chromatography (125 mL SiO2) with 20 % ethyl 
acetate/petroleum ether as eluent to yield (S,E)-1-(2-(5-(4-(benzyloxy)phenyl)pent-4-
enoyl)pyrrolidin-1-yl)-3,3-dimethylpentane-1,2-dione as a white solid.  Run 1 (177.7 mg, 
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0.39 mmol, 77%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.); run 2 (175.4 mg, 0.38 
mmol, 77%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.).  Average yield = 77%. 1H 
NMR (500 MHz, CDCl3) δ 7.42 (d, J = 7.0 Hz, 2H), 7.38 (t, J = 7.5 Hz, 2H), 7.32 (t, J = 
7.5 Hz, 2H), 7.25 (d, J = 8.5 Hz, 1H), 6.90 (d, J = 8.5 Hz, 2H), 6.36 (d, J = 15.5 Hz, 1H), 
6.05 (dt, J = 16.0, 7.0 Hz, 1H), 5.05 (s, 2H), 4.61 (dd, J = 9.0, 5.0 Hz, 1H), 3.57 – 3.45 
(m, 2H), 2.80 – 2.65 (m, 2H), 2.54 – 2.46 (m, 2H), 2.20 – 2.13 (m, 1H), 1.98 – 1.76 (m, 
4H), 1.71 – 1.63 (m, 1H), 1.25 (s, 3H), 1.21 (s, 3H), 0.87 (t, J = 7.0 Hz, 3H),  minor 
rotamer: 4.74 (dd, J = 8.5, 5.0 Hz, 1H), 3.67 – 3.64 (m, 2H), 2.33-2.26 (m, 1H), 1.29 (s, 
3H), 1.14 (s, 3H), 0.80 (t, J = 7.5 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ 207.04, 
165.28, 158.20, 137.16, 130.69, 130.62, 130.43, 128.95(rotamer), 128.78, 128.16, 
127.67, 127.33, 126.77, 126.54(rotamer), 115.34(rotamer), 115.05, 70.19, 
66.01(rotamer), 64.21, 47.64, 47.20, 47.13(rotamer), 40.06, 39.40(rotamer), 
33.11(rotamer), 32.50, 30.75(rotamer), 27.88, 26.81, 24.98, 24.23(rotamer), 24.00, 23.28, 
22.28(rotamers), 9.17. IR (neat, cm-1): 3030.11, 2964.43, 2923.88, 2879.91, 1721.50, 
1699.12, 1634.63, 1606.08, 1508.52.  HRMS (ES) m/z calculated for C29H36NO4 [M+H]+: 
462.2644, found 462.2649. [α]25D = -37.1 (c = 1.0, CHCl3).  Spectral data matches 
reported assignments.32 
 
 (S,E)-2-(tert-butoxycarbonyl)-5-(3-[3-
bromobenzene]phenyl)pent-4-enoic acid: To a 2 mL 
borosilicate vial was added catalyst 1 (0.022 mmol, 11.0 mg, 10 mol%), benzoquinone 
(0.44 mmol, 47.5 mg, 2 equiv.), dioxane (0.66 mL, .33 M), acetic acid (0.88 mmol, 52.8 
mL, 4 equiv.), (S)-2-(tert-butoxycarbonyl)pent-4-enoic acid (0.22 mmol, 47.3 mg, 1 
BrHO
O
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equiv., derived from L-allylglycine), 3-(3-bromobenzene)phenyl boronic acid (0.327 
mmol, 90.0 mg, 1.5 equiv.) and a stir bar sequentially under ambient conditions.  The vial 
was capped and stirred at room temperature for 24 hours.  The mixture was diluted with 
ether (50 mL) and rinsed with 1 M H3PO4 (50 ml).  The aqueous layer was extracted with 
ether (50 mL) and the combined organic layers were dried over MgSO4.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 30% ethyl acetate/petroleum ether/1% acetic acid as eluent to yield (S,E)-2-(tert-
butoxycarbonyl)-5-(3-[3-bromobenzene]phenyl)pent-4-enoic acid as a white solid.  Run 1 
(58.9 mg, 0.13 mmol, 60%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.); run 2 (59.9, 
0.13 mmol, 61%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.).  Average yield = 61%. 
1H NMR (500 MHz, CHCl3) δ 7.72 (s, 1H), 7.50-7.47 (m, 3H), 7.42-7.36 (m, 3H), 7.30 
(t, J = 8.0 Hz, 1H), 6.55 (d, J = 15.5 Hz, 1H), 6.19 (dt, J = 15.5, 7.5 Hz, 1H), 5.05 (d, J = 
7.0 Hz, 1H), 4.48 (m, 1H), 2.81-2.70 (m, 2H), 1.43 (s, 9H).  13C NMR (125 MHz, CHCl3) 
δ 176.99, 155.78, 143.39, 140.30, 137.68, 134.15, 130.51 (2 C), 130.42, 129.34, 126.60, 
126.04, 125.99, 125.42, 124.55, 123.13, 80.71, 53.29, 36.10, 28.54.  IR (neat, cm-1-): 
3426.17, 3115.84, 2975.37, 2530.59, 1713.05.  HRMS (ESI) m/z calculated for 
C22H25NO4Br [M+H]+: 446.0967, found 446.0969.  [α]27D = +9.1o (c = 0.44, CHCl3).  A 
known compound however no spectral data is reported.33 
 
 (S,E)-methyl 5-(4-bromophenyl)-2-(2,6-
difluorobenzamido)pent-4-enoate: To a 2 mL 
borosilicate vial was added catalyst 1 (0.025 mmol, 12.5 mg, 10 mol%), benzoquinone 
(0.5 mmol, 54.0 mg, 2 equiv.), dioxane (0.75 mL, .33 M), acetic acid (1.0 mmol, 60.0 
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mg, 4 equiv.), (S)-methyl 2-(2,6-difluorobenzamido)pent-4-enoate (0.25 mmol, 67.3 mg, 
1 equiv., derived from L-allylglycine), 4-bromophenylboronic acid (0.375 mmol, 74.6 
mg, 1.5 equiv.) and a stir bar sequentially under ambient conditions.  The vial was capped 
and stirred at room temperature for 24 hours.  The mixture was diluted with ether (50 
mL) and rinsed with H2O (50 ml).  The aqueous layer was extracted with ether (50 mL) 
and the combined organic layers were dried over MgSO4.  After concentration, the crude 
product was purified via silica chromatography (125 mL SiO2) with 35% ethyl 
acetate/petroleum ether as eluent to yield (S,E)-methyl 5-(4-bromophenyl)-2-(2,6-
difluorobenzamido)pent-4-enoate as a white solid.  Run 1 (63.3 mg, 0.15 mmol, 60%, 
>20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.); run 2 (65.1 mg, 0.15 mmol, 60%, >20:1 
E:Z, >20:1 int.:term., >20:1 sty.:allyl.).  Average yield = 60%. 1H NMR (500 MHz, 
CDCl3) δ 7.42 (d, J = 8.5 Hz, 2H), 7.38 (m, 1H), 7.20 (d, J = 8.5 Hz, 2H), 6.95 (t, J = 8.0 
Hz, 2H), 6.61 (br d, J = 7.0 Hz, 1H), 6.45 (d, J = 15.5 Hz, 1H), 6.09 (dt, J = 16.0, 7.0 Hz, 
1H), 5.00 (q, J = 7.5, 1H), 3.81 (s, 3H), 2.94 (m, 1H), 2.76 (m, 1H).  13C NMR (100 MHz, 
CDCl3) δ 171.79, 160.27 (dd, J1 19F-13C = 251.1, 6.8 Hz, 1C), 160.06, 135.96, 133.59, 
132.24 (t, J3 19F-13C = 9.9 Hz, 1C), 131.84, 128.04, 124.11, 121.55, 113.89 (t, J2 19F-13C = 
19.5 Hz, 1C), 112.31 (d, J2 19F-13C = 25.8 Hz, 1C), 52.97, 52.65, 35.95.  19F (376 MHz, 
CDCl3) -112.36.  IR (neat, cm-1) 3336.51, 3272.50, 3081.23, 3060.90, 2967.34, 2924.14, 
1743.88, 1676.48, 1514.27, 1223.17. HRMS (ESI) m/z calculated for C19H17NO3F2Br 
[M+H]+:  424.0360, found 424.0354.  [α]27D = +44.2o (c = 0.44, CHCl3).  A known 
compound however spectral data is not reported.34 
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  (S,E)-6-phenylhex-5-en-2-ol: To a 8 mL borosilicate vial was 
added catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), benzoquinone (2.0 
mmol, 216.0 mg, 2 equiv.), dioxane (3.0 mL, .33 M), acetic acid (4.0 mmol, 240.0 mg, 4 
equiv.), S-(+)-2-hexenol (1.0 mmol, 100.0 mg, 1 equiv.), phenylboronic acid (1.5 mmol, 
183.0 mg, 1.5 equiv.) and a stir bar sequentially under ambient conditions.  The vial was 
capped and stirred at room temperature for 2.5 hours.  The mixture was diluted with 
methylene chloride (50 mL) and rinsed with 3M NaOH (50 ml).  The aqueous layer was 
extracted with methylene chloride (50 mL) and the combined organic layers were dried 
over MgSO4.  After concentration, the crude product was purified via silica 
chromatography (125 mL SiO2) with 20 % ether:pentroleum ether as eluent to yield (E)-
6-phenylhex-5-en-2-ol as white solid.  Run 1 (107.6 mg, 0.61 mmol, 61%, >20:1 E:Z, 
>20:1 int.:term., >20:1 sty.:allyl.); run 2 (105.8 mg, 0.60 mmol, 60%, >20:1 E:Z, >20:1 
int.:term., >20:1 sty.:allyl.).  Average yield = 61% 1H NMR (400 MHz, CDCl3) δ 7.33 (t, 
J = 7.2 Hz, 2H), 7.29 (t, J = 7.6 Hz, 2H), 7.20 (tt, J = 7.2, 1.2 Hz, 1H), 6.42 (d, J = 16.0 
Hz, 1H), 6.24 (dt, J = 15.6, 6.8 Hz, 1H), 3.88 (sex, J = 6.4 Hz, 1H), 2.40-2.24 (m, 2H), 
1.70–1.57 (m, 2H), 1.39 (br s, 1H), 1.23 (d, J = 6.0 Hz, 3H).  13C NMR (125 MHz, 
CDCl3) δ 130.57, 130.52, 128.78, 127.23, 126.23 (2C), 67.93, 39.01, 29.66, 23.87.  IR 
(neat, cm-1): 3645.89-3151.87, 3079.26, 3057.15, 3023.31, 2963.55, 2926.95, 2871.97, 
2853.80, 1648.31, 1596.93.  HRMS (CI) m/z calculated for C12H17O [M+H]+: 177.1280, 
found 177.1277. [α]25D = +12.4o (c = 1.0, CHCl3).  Spectral peaks are similar to reported 
peaks (spectrum reported in CCl4).35 
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 (E)-butyl (6-phenylhex-5-en-2-yl)sulfane: To an 8 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.2 mg, 10 
mol%), benzoquinone (2.0 mmol, 216.0 mg, 2 equiv.), dioxane (3.0 mL, 0.33 M), acetic 
acid (4.0 mmol, 240.0 mg, 4 equiv.), butyl (hex-5-en-2-yl)sulfane (1.0 mmol, 170.0 mg, 1 
equiv.), phenylboronic acid (1.5 mmol, 183.0 mg, 1.5 equiv.) and a stir bar sequentially 
under ambient conditions.  The vial was capped and stirred at room temperature for 24 
hours.  The mixture was diluted with methylene chloride (50 mL) and rinsed with H2O 
(50 ml).  The aqueous layer was extracted with methylene chloride (50 mL) and the 
combined organic layers were dried over MgSO4.  After concentration, the crude product 
was purified via silica chromatography (125 mL SiO2) with 5 % ether/petroleum ether as 
eluent to yield (E)-butyl (6-phenylhex-5-en-2-yl)sulfane as light yellow oil.  Run 1 (138.0 
mg, 0.56 mmol, 55%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.); run 2 (138.0 mg, 
0.56 mmol, 56%, >20:1 E:Z, >20:1 int.:term., >20:1 sty.:allyl.).  Average yield = 56%.  
1H NMR (500 MHz, CDCl3) δ 7.34 (d, J = 8.5 Hz, 2H), 7.29 (t, J = 8.0 Hz, 2H), 7.20 (t, J 
= 7.5 Hz, 1H), 6.42 (d, J = 16.0 Hz, 1H), 6.20 (dt, J = 15.5, 7.0 Hz, 1H), 2.79 (sex., J = 
7.0 Hz, 1H), 2.53 (t, J = 7.5 Hz, 2H), 2.35 (m, 2H), 1.73 (m, 1H), 1.64 (m, 1H), 1.56 (q, J 
= 8.0 Hz, 2H), 1.41 (m, 2H), 1.30 (d, J = 6.5 Hz, 3H), 0.91 (t, J = 7.5 Hz, 3H).  13C NMR 
(100 MHz, CDCl3) δ 137.90, 130.50, 130.31, 128.71, 127.13, 126.13, 39.53, 36.69, 
32.20, 30.66, 30.16, 22.39, 21.69, 13.96.  IR (neat, cm-1) 3059.47, 3023.77, 2956.85, 
2926.52, 2870.53, 2858.22.  HRMS (ESI) m/z calculated for C16H25S [M+H]+:  249.1677, 
found 249.1687. 
 
 
S
 73 
 (S,E)-tert-butyl 3-oxo-1,6-diphenylhex-4-en-2-ylcarbamate: 
To an 4 mL borosilicate vial was added catalyst 1 (0.05 mmol, 
25.0 mg, 10 mol%), benzoquinone (1.0 mmol, 108.0 mg, 2 equiv.), dioxane (1.5 mL, .33 
M), acetic acid (2.0 mmol, 120.0 mg, 4 equiv.), (S)-tert-butyl 3-oxo-1-phenylhex-5-en-2-
ylcarbamate (0.5 mmol, 144.5 mg, 1 equiv., derived from N-Boc-L-phenylalanine), 
phenylboronic acid (0.75 mmol, 92.0 mg, 1.5 equiv.) and a stir bar sequentially under 
ambient conditions.  The vial was capped and stirred at 45oC for 48 hours.  The mixture 
was diluted with ether (50 mL) and rinsed with H2O (50 ml).  The aqueous layer was 
extracted with ether (50 mL) and the combined organic layers were dried over MgSO4.  
After concentration, the crude product was purified via silica chromatography (125 mL 
SiO2) with 20% ethyl acetate/petroleum ether as eluent to yield (S,E)-tert-butyl 3-oxo-
1,6-diphenylhex-4-en-2-ylcarbamate as a clear solid.  Run 1 (111.8 mg, 0.31 mmol, 61%, 
>20:1 E:Z, >20:1 int.:term., <1:20 sty.:allyl.); run 2 (113.3 mg, 0.31 mmol, 62%, >20:1 
E:Z, >20:1 int.:term., <1:20 sty.:allyl.).  Average yield = 62%. 1H NMR (500 MHz, 
CDCl3) δ 7.32 (t, J = 7.5, 2H), 7.27-7.20 (m, 4H), 7.10 (ap t, J = 6.5 Hz, 4H), 7.03 (dt, J 
= 15.5, 6.5 Hz, 1H), 6.09 (d, J = 16.0 Hz, 1H), 5.26 (d, J = 7.5 Hz, 1H), 4.79 (ap q, J = 
6.5 Hz, 1H), 3.49 (d, J = 7.0 Hz, 2H), 3.07 (dd, J = 13.5, 7.0 Hz, 1H), 2.98 (dd, J = 13.5, 
6.0 Hz, 1H), 1.41 (s, 9H).  13C NMR (125 MHz, CDCl3) δ 197.69, 155.32, 147.94, 
137.41, 136.30, 129.68, 129.03, 128.97, 128.64, 128.15, 127.08, 127.02, 79.90, 58.57, 
39.04, 38.70, 28.49. IR (neat, cm-1) 3420.31, 3346.22, 3085.09, 3061.84, 3027.95, 
2976.31, 2929.68, 1711.23, 1692.91. HRMS (ESI) m/z calculated for C23H28NO3 [M+H]+:  
366.2069, found 366.2068.    [α]27D = +51.3o (c = 1.0, CHCl3), -5.6o (c = 1.0, MeOH).  
Spectral data matches that of the reported compound.36 
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 (E)-ethyl 4-(2-bromophenyl)but-2-enoate: To an 8 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.2 mg, 10 
mol%), benzoquinone (2.0 mmol, 216.0 mg, 2 equiv.), dioxane (3.0 mL, 0.33 M), acetic 
acid (4.0 mmol, 240.0 mg, 4 equiv.), ethyl but-1-enoate (1.0 mmol, 114.0 mg, 1 equiv.), 
2-bromobenzeneboronic acid (1.5 mmol, 300.0 mg, 1.5 equiv.) and a stir bar sequentially 
under ambient conditions.  The vial was capped and stirred at room temperature for 4 
hours.  The mixture was diluted with Et2O (50 ml) and rinsed with H2O (50 mL).  The 
aqueous layer was extracted with Et2O (50 ml) and the combined organic layers were 
dried over MgSO4. After concentration, the crude product was purified via silica 
chromatography (125 mL SiO2) with 15% diethyl ether/pentane as eluent to yield (E)-
ethyl 4-(2-bromophenyl)but-2-enoate as a clear oil.  Run 1 (131.8 mg, 0.49 mmol, 49%, 
>20:1 E:Z, >20:1 int.:term., 1:20 sty.:allyl); run 2 (134.5 mg, 0.50 mmol, 50%, >20:1 
E:Z, >20:1 int.:term., 1:17 sty.:allyl); run 3 (137.2 mg, 0.51 mmol, 51%, >20:1 E:Z, 
>20:1 int.:term., 1:19 sty.:allyl).  Average Yield = 50%.  1H NMR (500 MHz, CDCl3)  δ 
7.59 (d, J = 8 Hz, 1H), 7.28 (m, 1H), 7.22 (d, J = 7.5 Hz, 1H), 7.15 (d, J = 7.5 Hz, 1H), 
7.09 (dt, J = 15.5, 7 Hz, 1H), 5.79 (d, J = 16 Hz, 1H), 4.20 (q, J = 7.5 Hz, 2H), 3.68 (d, J 
= 6.5 Hz, 2H), 1.30 (t, J = 7.5 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ 166.62, 145.64, 
137.57, 133.21, 130.97, 128.70, 127.94, 124.81, 123.10, 60.56, 38.79, 14.45.  IR (neat, 
cm-1) 3.055.85, 2979.23, 2935.80, 2903.09, 1717.18. HRMS (ESI) m/z calculated for 
C12H14O2Br [M+H]+:  269.0177, found 269.0172.  Spectral data matches that of the 
reported compound.37 
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 (E)-methyl 4-(2,5-difluorophenyl)but-2-enoate: To an 8 mL 
borosilicate vial was added catalyst 1 (0.1 mmol, 50.2 mg, 10 
mol%), benzoquinone (2.0 mmol, 216.0 mg, 2 equiv.), dioxane (3 
mL, 0.33 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), methyl but-3-enoate (1.0 mmol, 
100.0 mg, 1 equiv.), 2,5-difluorophenylboronic acid (1.5 mmol, 237.0 mg, 1.5 equiv.) 
and a stir bar sequentially under ambient conditions.  The vial was capped and stirred at 
room temperature for 4 hours.  The mixture was diluted with Et2O (50 ml) and rinsed 
with H2O (50 ml).  The aqueous layer was extracted with Et2O (50 mL) and the combined 
organic layers were dried over MgSO4. After concentration, the crude product was 
purified via silica chromatography (125 mL SiO2) with 15% ether/pentane as eluent to 
yield (E)-methyl 4-(2,5-difluorophenyl)but-2-enoate as a clear oil.  Run 1 (110.0 mg, 
0.52 mmol, 52%, >20:1 E:Z, >20:1 int.:term., 1:17 sty.:allyl.); run 2 (106.6 mg, 0.50 
mmol, 50%, >20:1 E:Z, >20:1 int.:term., 1:17 sty.:allyl.).  Average Yield = 51%.  1H 
NMR (500 MHz, CDCl3) δ 7.08-6.99 (m, 2H), 6.94-6.86 (m, 2H), 5.83 (d, J = 15.5 Hz, 
1H), 3.74 (s, 3H), 3.53 (d, J = 6 Hz, 2H).  13C NMR (125 MHz, CDCl3) δ 166.81, 145.13, 
122.99, 117.41 (d, J = 4.9 Hz), 117.22 (d, J = 4.9 Hz), 116.78 (d, J = 7.8 Hz), 116.58 (d, 
J = 8.8 Hz), 115.22 (d, J = 8.8 Hz), 115.04 (d, J = 8.8 Hz), 51.79, 31.68.  19F NMR (470 
MHz, CDCl3) δ -119.27, -124.52.  IR (neat, cm-1) 3036.60, 2995.61, 2953.20, 2851.99, 
1724.78.  HRMS (ESI) m/z calculated for C11H11O2F2 [M+H]+:  213.0727, found 
213.0723.  Previously reported compound however no spectral data is reported.38 
 
 (E)-methyl 4-phenylbut-2-enoate and (E)-methyl 4-phenylbut-3-
enoate: To an 8 mL borosilicate vial was added White Catalyst (0.1 
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mmol, 50.2 mg, 10 mol%), benzoquinone (2.0 mmol, 216.0 mg, 2 equiv.), dioxane (3 
mL, 0.33 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), methyl but-3-enoate (1.0 mmol, 
102.0 mg, 1 equiv.), phenylboronic acid (1.5 mmol, 183.0 mg, 1.5 equiv.) and a stir bar 
sequentially under ambient conditions.  The vial as capped and stirred at room 
temperature for 4 hours. The mixture was diluted with diethyl ether (50 mL) and rinsed 
with 5% K2CO3 (50 ml).  The aqueous layer was extracted with diethyl ether (50 mL) and 
the combined organic layers were dried over MgSO4. The crude product was purified via 
silica chromatography (125 mL SiO2) with 10% diethyl ether/petroleum ether as eluent to 
yield (E)-methyl 4-phenylbut-2-enoate and (E)-methyl 4-phenylbut-3-enoate as a clear oil 
(125.0 mg, 0.71 mmol, 71%, >20:1 E:Z, 1:4 styrenyl:α,β-unsaturation). Silica gel 
chromatography was performed with liberal fraction collection.  Crude product ratios are 
close to those of the purified material. 1H NMR (500 MHz, CDCl3) δ α,β-unsaturated: 
7.12 (dt, J = 15.5, 6.0 Hz, 1H), 5.83 (d, J = 15.0 Hz, 1H), 3.73 (s, 3H), 3.54 (d, J = 6.5 
Hz, 2H).  Styrene: 6.51 (d, J = 15.5 Hz, 1H), 6.31 (dt, J = 15.5, 6.5 Hz, 1H), 3.27 (d, J = 
7.5 Hz, 2H).   
 
 
 (E)-ethyl 4-(4-bromo-2-(trifluoromethoxy))phenyl)but-2-
enoate: To a 4 mL borosilicate vial was added catalyst 1 (0.05 
mmol, 25.0 mg, 10 mol%), benzoquinone (1.0 mmol, 108.0 mg, 
2 equiv.), THF (1.5 mL, .33 M), acetic acid (2.0 mmol, 120.0 mg, 4 equiv.), ethyl but-3-
enoate (0.5 mmol, 57.0 mg, 1 equiv.), 4-bromo-2-(trifluoromethoxy)phenylboronic acid 
(0.75 mmol, 213.0 mg, 1.5 equiv.) and a stir bar sequentially under ambient conditions.  
OCF3
Br
EtO
O
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The vial was capped and stirred at room temperature for 4 hours.  The mixture was 
diluted with ether (50 mL) and rinsed with H2O (50 ml).  The aqueous layer was 
extracted with ether (50 mL) and the combined organic layers were dried over MgSO4.  
After concentration, the crude product was purified via silica chromatography (125 mL 
SiO2) with 10% ether/petroleum ether as eluent to yield (E)-ethyl 4-(4-bromo-2-
(trifluoromethoxy))phenyl)but-2-enoate as a yellow oil.  Run 1 (159.1 mg, 0.3 mmol, 
60%, >20:1 E:Z, >20:1 int.:term., <1:20 sty.:allyl.); run 2 (105.9 mg, 0.3 mmol, 60%, 
>20:1 E:Z, >20:1 int.:term., <1:20 sty.:allyl.).  Average yield = 60%. 1H NMR (500 
MHz, CHCl3) δ 7.42 (t, J = 2.0 Hz, 1H), 7.40 (dd, J = 8.0, 2.0 Hz, 1H), 7.12 (d, J = 8.0 
Hz, 1H), 6.98 (dt, J = 15.5, 6.5 Hz, 1H), 5.78, (dt, J = 15.5, 1.5 Hz, 1H), 4.18 (q, J = 7.0 
Hz, 2H), 3.52 (dd, J = 6.5, 1.5 Hz, 2H), 1.28 (t, J = 7.5 Hz, 3H).  13C NMR (125 MHz, 
CDCl3) δ 166.34, 144.67, 132.37, 130.50, 129.76, 124.30, 124.28, 123.55, 121.89, 
121.06, 60.68, 32.18, 14.43.  19F NMR (376 MHz, CDCl3) δ -57.67.  IR (neat, cm-1) 
3051.79, 2980.89, 2960.98, 2934.69, 2908.87, 2873.52, 1721.71, 1255.02, 1214.04, 
1175.50. HRMS (ESI) m/z calculated for C13H13O3F3Br [M+H]+:  353.0000, found 
353.0004.  Previously reported compound.39 
 
(E)-methyl 6-phenylhex-5-enoate (and other isomers): To an 8 mL borosilicate vial 
was added catalyst 1 (0.1 mmol, 50.2 mg, 10 mol%), benzoquinone (2.0 mmol, 216.0 mg, 
2 equiv.), dioxane (3 mL, 0.33 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), methyl 
hex-5-enoate (1.0 mmol, 128.0 mg, 1 equiv.), phenylboronic acid (2.0 mmol, 244.0 mg, 
2.0 equiv.) and a stir bar sequentially under ambient conditions.  The vial as capped and 
stirred at room temperature for 24 hours. The mixture was diluted with diethyl ether (50 
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mL) and rinsed with 5% K2CO3 (50 ml).  The crude product was purified via silica 
chromatography (125 mL SiO2) with 5 % ether:petroleum ether as eluent to yield (E)-
methyl 6-phenylhex-5-enoate and other isomers as clear oil. Silica gel chromatography 
was performed with liberal fraction collection. Crude product ratios match those of the 
purified material.  E:Z selectivities were found to be >20:1 in all cases.  Run 1 (124.4 mg, 
0.61 mmol, 61%, internal:terminal 9:1, styrenyl:allylic 2:1); run 2 (120.4 mg, 0.59 mmol, 
59%, internal:terminal 9:1, styrenyl:allylic 2:1).  Average yield = 60%.  1H NMR (500 
MHz, CHCl3) δ Styrenyl: 6.42 (d, J = 16 Hz, 1H), 6.20 (dt, J = 16, 6.5 Hz, 1H) Allylic: 
5.68-5.62 (m, 1H), 5.56-5.50 (m, 1H) Terminal: 5.31 (d, J = 1.5 Hz), 5.09 (d, J = 1.5 Hz, 
1H). 
 
(E)-1-(undec-1-enyl)benzene (and other olefin isomers):  To an 8 mL borosilicate vial 
was added catalyst 1 (0.1 mmol, 50.2 mg, 10 mol%), benzoquinone (2.0 mmol, 216.0 mg, 
2 equiv.), dioxane (3 mL, 0.33 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), 1-
undecene (1.0 mmol, 154.0 mg, 1 equiv.), phenylboronic acid (1.5 mmol, 183.0 mg, 1.5 
equiv.) and a stir bar sequentially under ambient conditions.  The vial as capped and 
stirred at room temperature for 4 hours. The mixture was diluted with diethyl ether (50 
mL) and rinsed with 5% K2CO3 (50 ml).  The aqueous layer was extracted with diethyl 
ether (50 mL) and the combined organic layers were dried over MgSO4.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 100% petroleum ether as eluent to yield (E)-1-(undec-1-enyl)benzene  and other 
olefin isomers as a clear oil.  Silica gel chromatography was performed with liberal 
fraction collection.  Crude product ratios match those of the purified material. E:Z 
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selectivities were found to be >20:1 in all cases. Run 1 (0.154 g, 0.67 mmol, 67%, 
internal:terminal 8:1, styrenyl:allylic 1:1), run 2 (0.156 g, 0.68 mmol, 68%, 
internal:terminal 8:1, styrenyl:allylic 1:1).  Average yield = 68%.  1H NMR (400 MHz, 
CDCl3) δ Styrenyl: 6.43 (d, J = 15.6 Hz, 1H), 6.28 (dt, J = 16, 6.8 Hz, 1H).  Allylic:  
5.66-5.52 (m, 2H), 3.38 (d, J = 6 Hz, 2H).  Terminal: 5.31 (s, 1H), 5.10 (s, 1H), 2.55 (t, J 
= 6.8 Hz, 2H). 
 
 tert-butyl (S,3E,5E)-1,6-diphenylhexa-3,5-dien-2-
ylcarbamate:  To an 8 mL borosilicate vial was added catalyst 1 
(0.1 mmol, 50.2 mg, 10 mol%), 2,6-dimethylbenzoquinone (2.0 mmol, 272.0 mg, 2 
equiv.), dioxane (1 mL, 1.0 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), (S)-tert-butyl 
1-phenylbut-3-en-2-ylcarbamate (1.0 mmol, 248.0 mg, 1 equiv., derived from L-
phenylalanol), (E)-4,4,5,5-tetramethyl-2-styryl-1,3,2-dioxaborolane (1.5 mmol, 348.0 
mg, 1.5 equiv.) and a stir bar sequentially under ambient conditions.  The vial was capped 
and stirred at room temperature for 48 hours.  The mixture was diluted with ethyl acetate 
(50 ml) and rinsed with H2O (50 ml).  The aqueous layer was extracted with ethyl acetate 
(50 ml) and the combined organic layers were thoroughly rinsed with 5% aq. K2CO3 and 
sat. aq. NaHSO3 (Careful! Rapid Gas Evolution!) then dried over MgSO4.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 5% ethyl acetate/hexanes as eluent to yield tert-butyl (S,3E,5E)-1,6-diphenylhexa-
3,5-dien-2-ylcarbamate as a white solid.  Run 1 (283.5 mg, 0.81 mmol, 81%, >20:1 E:Z, 
>20:1 int.:term.); run 2 (277.9 mg, 0.75 mmol, 75%, >20:1 E:Z, >20:1 int.:term.).  
Average Yield = 80%.  1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 7.5 Hz, 2H), 7.33 (t, J 
Ph
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= 8 Hz, 4H), 7.23 (m, 4H), 6.75 (dd, J = 15.5, 10.5 Hz, 1H), 6.52 (d, J = 15.5 Hz, 1H), 
6.29 (dd, J = 15, 10.5 Hz, 1H), 5.77 (m, 1H), 4.55 (br s, 2H), 2.91 (br s, 2H), 1.45 (s, 9H).  
13C NMR (125 MHz, CDCl3) 155.35, 137.55, 137.39, 133.95, 132.60, 130.86, 129.80, 
128.81, 128.60, 128.43, 127.73, 126.73, 126.53, 79.69, 53.16, 41.98, 28.55.  IR (neat, cm-
1) 3079.13, 3059.71, 3027.59, 2979.74, 2929.05, 1699.26. HRMS (ESI) m/z calculated for 
C23H28O2N [M+H]+:  350.2120, found 350.2121.  [α]27D = -21.3o (c = 1.0, CHCl3).  
Spectral data matches that of the reported compound.40 
 
 tert-butyl (R,3E,5E)-6-phenylhexa-3,5-dien-2-ylcarbamate: To 
an 8 mL borosilicate vial was added catalyst 1 (0.1 mmol, 50.2 mg, 
10 mol%), 2,6-dimethylbenzoquinone (2.0 mmol, 272.0 mg, 2 equiv.), dioxane (1 mL, 
1.0 M), acetic acid (4.0 mmol, 240.0 mg, 4 equiv.), (R)-tert-butyl but-3-en-2-ylcarbamate 
(1.0 mmol, 172.0 mg, 1 equiv., derived from R-(-)-2-amino-1-propanol via tempo 
oxidation and wittig olefination), (E)-4,4,5,5-tetramethyl-2-styryl-1,3,2-dioxaborolane 
(1.5 mmol, 348.0 mg, 1.5 equiv.) and a stir bar sequentially under ambient conditions.  
The vial was capped and stirred at room temperature for 48 hours.  The mixture was 
diluted with ethyl acetate (50 ml) and rinsed with H2O (50 ml).  The aqueous layer was 
extracted with ethyl acetate (50 ml) and the combined organic layers were thoroughly 
rinsed with 5% aq. K2CO3 and sat. aq. NaHSO3 (Careful! Rapid Gas Evolution!) then 
dried over MgSO4. After concentration, the crude product was purified via silica 
chromatography (125 mL SiO2) with 10% ethyl acetate/hexanes as eluent to yield tert-
butyl (R,3E,5E)-6-phenylhexa-3,5-dien-2-ylcarbamate as a clear oil.  Run 1 (223.3 mg, 
0.82 mmol, 82%, >20:1 E:Z, >20:1 int.:term.); run 2 (216.5 mg, 0.79 mmol, 79%, >20:1 
NHBoc
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E:Z, >20:1 int.:term.).  Average Yield = 81%.  1H NMR (500 MHz, CDCl3)  δ 7.38 (d, J 
= 7.5 Hz, 2H), 7.31 (t, J = 8 Hz, 2H), 7.21 (t, J = 7 Hz, 1H), 6.74 (dd, J = 15.5, 10.5 Hz, 
1H), 6.53 (d, J = 15.5 Hz, 1H), 6.31 (dd, J = 15, 10.5 Hz, 1H), 5.77 (dd, J = 15, 5 Hz, 
1H), 4.50 (br s, 1H), 4.34 (br s, 1H), 1.46 (s, 9H), 1.26 (d, J = 6.5 Hz, 3H). 13C NMR (100 
MHz, CDCl3) δ 155.30, 137.42, 136.11, 132.46, 129.82, 128.80, 128.55, 127.68, 126.51, 
79.57, 47.78, 28.62, 21.23.  IR (neat, cm-1) 3374.93, 3361.91, 3021.85, 2976.24, 2928.38, 
2973.63, 1687.12. HRMS (ESI) m/z calculated for C17H23NO2Na [M+Na]+:  296.1626, 
found 296.1627.  [α]27D = +70.4 (c = 1.0, CHCl3).  Previously reported compound 
however no spectral data is given.41 
 
 ((R, 1E, 3E)-1-(2-bromophenyl)non-1,3-dien-5-yloxy)(tert-
butyl)dimethylsilane: To a 2 mL borosilicate vial was added 
Catalyst 1 (0.025 mmol, 12.5 mg, 10 mol%), dimethylbenzoquinone (0.5 mmol, 68.0 mg, 
2 equiv.), dioxane (0.25 mL, 1.0 M), acetic acid (1.0 mmol, 60.0 mg, 4 equiv.), (R)-tert-
butyl(hept-1-en-3-yloxy)dimethylsilane (0.25 mmol, 57.0 mg, 1 equiv.), (E)-2-(2-
bromostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.375 mmol, 115.5 mg, 1.5 
equiv.) and a stir bar sequentially under ambient conditions.  The vial was capped and 
stirred at room temperature for 48 hours.  The mixture was diluted with methylene 
chloride (50 mL) and rinsed with water (50 ml).  The aqueous layer was extracted with 
methylene chloride (50 mL) and the combined organic layers were dried over MgSO4.  
After concentration, the crude product was purified via silica chromatography (125 mL 
SiO2) with 2 % ether:petroleum ether as eluent to yield ((R, 1E, 3E)-1-(2-
bromophenyl)non-1,3-dien-5-yloxy)(tert-butyl)dimethylsilane as clear oil.  Run 1 (122.1 
nBu
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mg, 0.30 mmol, 60%, >20:1 E:Z, >20:1 int.:term.); run 2 (120.0 mg, 0.29 mmol, 59%, 
>20:1 E:Z, >20:1 int.:term.).  Average yield = 60% 1H NMR (400 MHz, CHCl3) δ 7.55 
(m, 2H), 7.26 (t, J = 5.6 Hz, 1H), 7.06 (dt, J = 7.6, 1.6 Hz, 1H), 6.86 (d, J = 15.6 Hz, 1H), 
6.72 (dd, J = 15.6, 10.8 Hz, 1H), 6.35 (dd, J = 15.2, 10.8 Hz, 1H), 5.83 (dd, J = 15.6, 6.8 
Hz, 1H), 4.19 (q, J = 6.0 Hz, 1H), 1.55 – 1.47 (m, 2H), 1.35 – 1.25 (m, 4H), 0.91 (s, 9H), 
0.90 – 0.86 (m, 3H), 0.07 (s, 3H), 0.05 (s, 3H).  13C NMR (125 MHz, CDCl3) δ 139.65, 
137.22, 133.28, 131.60, 130.13, 129.37, 128.70, 127.60, 126.59, 123.96, 73.42, 38.27, 
27.62, 26.13, 22.90, 18.50, 14.28, -4.05, -4.55.  IR (neat, cm-1): 3055.22, 3030.17, 
2954.31, 2929.11, 2857.55.  HRMS (EI) m/z calculated for C21H33BrOSi [M+H]+: 
408.14841, found 408.14855. [α]27D = +6.9o (c = 0.42, CHCl3).  Previously reported 
compound however no spectral data was given.42 
 
 (E)-tert-butyl 5-(5-hydroxypent-1-enyl)-1H-indole-1-
carboxylate: To an 8 mL borosilicate vial was added 
Catalyst 1 (0.04 mmol, 20.9 mg, 10 mol%), benzoquinone (0.82 mmol, 89.0 mg, 2 
equiv.), dioxane (1.2 mL, 0.33 M), acetic acid (1.65 mmol, 96.1 mg, 4 equiv.), boric acid 
(0.82 mmol, 51.0 mg, 2 equiv.), 4-penten-1-ol (0.41 mmol, 35.0 mg, 1 equiv.), 1-(tert-
butoxycarbonyl)-1H-indol-5-ylpotassium trifluoroborates (0.62 mmol, 200.0 mg, 1.5 
equiv.) and a stir bar sequentially under ambient conditions.  The vial was capped and 
stirred at room temperature for 4 hours.  The mixture was diluted with CH2Cl2 (50 ml) 
and rinsed with H2O (50 ml).  The aqueous layer was extracted with CH2Cl2 (50 ml) and 
the combined organic layers were dried over MgSO4. After concentration, the crude 
product was purified via silica chromatography (125 mL SiO2) with 30% ethyl 
N
O
O
HO
 83 
acetate/hexanes then further purified via silica chromatography (350 mL SiO2) with 5% 
MeOH/CH2Cl2 as eluent to yield (E)-tert-butyl 5-(5-hydroxypent-1-enyl)-1H-indole-1-
carboxylate as an oil.  Run 1 (102.3 mg, 0.34 mmol, 82%, >20:1 E:Z, 16:1 int.:term., 
>20:1 int.:allyl.); run 2 (104.0 mg, 0.35 mmol, 84%, >20:1 E:Z, 16:1 int.:term., >20:1 
int.:allyl.).  Average Yield = 83%.  1H NMR (500 MHz, CDCl3) δ 8.06 (br d, J = 2.5 Hz, 
1H), 7.57 (br d, J = 2.5 Hz, 1H), 7.51 (s, 1H), 7.35 (dd, J = 8.5, 1.5 Hz, 1H), 6.54 (d, J = 
3.5 Hz, 1H), 6.52 (d, J = 15 Hz, 1H), 6.24 (dt, J = 16, 6.5 Hz, 1H), 3.74 (t, J = 6 Hz, 2H), 
2.35 (ap q, J = 7 Hz, 2H), 1.79 (ap p, J = 7 Hz, 2H), 1.68 (s, 9H), 1.40 (br s, 1H).  13C 
NMR (125 MHz, CDCl3) δ 149.91, 134.58, 132.64, 131.07, 130.82, 128.97, 126.48, 
122.61, 118.55, 115.30, 107.57, 83.86, 62.71, 32.59, 29.60, 28.41. IR (neat, cm-1) 
3384.92, 3340.65, 3013.25, 2977.21, 2927.04, 2872.68, 1732.50. HRMS (ESI) m/z 
calculated for C18H24NO3 [M+H]+:  302.1756, found 302.1753.  Previously reported 
compound however no spectral data was given.43 
 
 (S,E)-1-(4-fluorophenyl)-5,6-dimethyl-5-styryl-4,5-dihydro-
1H-indazole: To a 2 mL borosilicate vial was added Catalyst 1 
(0.0099 mmol, 5.0 mg, 10 mol%), benzoquinone (0.18 mmol, 
21.6 mg, 2 equiv.), dioxane (.3 mL, 0.33 M), acetic acid (0.4 
mmol, 24.0 mg, 4 equiv.), (S)-1-(4-fluorophenyl)-5,6-dimethyl-5-vinyl-4,5-dihydro-1H-
indazole (0.099 mmol, 26.5 mg, 1 equiv.), phenylboronic acid (0.2 mmol, 24.4 mg, 2 
equiv.) and a stir bar sequentially under ambient conditions.  The vial was capped and 
stirred at 45oC for 3 days.  The mixture was diluted with methylene chloride (50 mL) and 
rinsed with 3M NaOH (50 ml).  The aqueous layer was extracted with methylene chloride 
N
N
F
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(50 mL) and the combined organic layers were dried over MgSO4.  After concentration, 
the crude product was purified via silica chromatography (125 mL SiO2) with 15 % 
ether:pentroleum ether as eluent to yield (S,E)-1-(4-fluorophenyl)-5,6-dimethyl-5-styryl-
4,5-dihydro-1H-indazole as white solid.  Run 1 (178.0 mg, 0.052 mmol, 52%, >20:1 
E:Z); run 2 (187.0 mg, 0.054 mmol, 54%, >20:1 E:Z).  Average yield = 53% 1H NMR 
(500 MHz, CDCl3) δ 7.50 (m, 2H), 7.44 (s, 1H), 7.35 (d, J = 8.0 Hz, 2H), 7.31 (t, J = 8.0 
Hz, 2H), 7.20 (m, 3H), 6.42 (d, J = 16.0 Hz, 1H), 6.33 (s, 1H), 6.24 (d, J = 16.0 Hz, 1H), 
2.86 (d, J = 16.0 Hz, 1H), 2.73 (d, J = 16.0 Hz, 1H), 1.87 (d, J = 1.5 Hz, 3H), 1.35 (s, 
3H).  13C NMR (125 MHz, CDCl3) δ 161.66 (d, J1 C-F = 245.1 Hz), 145.49, 138.01, 
137.82, 137.55, 136.13, 135.28, 128.75, 127.53, 127.47, 126.46, 125.50 (d, J3 C-F = 8.3 
Hz), 116.26 (d, J2 C-F = 22.8 Hz), 114.66, 112.30, 42.32, 34.30, 23.48, 20.87.  19F  NMR 
(400 MHz, CDCl3) δ -115.31.  IR (neat, cm-1): 3079.86, 3057.86, 3028.31, 2964.05, 
2930.56, 2873.81, 2851.54, 2831.39, 1618.52, 1600.06.  HRMS (ESI) m/z calculated for 
C23H22FN2 [M+H]+: 345.1767, found 345.1776.  [α]25D = +95.0o (c = 0.38, CHCl3, derived 
from 41.4% ee Hagemann’s ester.  See “Starting Material Synthesis for compound 21 on 
page S-15).  Previously reported compound however no spectral data was given.44 
 
 (E)-1-(3,3-dimethylbut-1-enyl)benzene: To a 40 mL borosilicate vial 
was added the following: catalyst 1 (0.1 mmol, 50.3 mg, 10 mol%), 
benzoquinone (2 mmol, 216.2 mg, 2 equiv.), 3,3-dimethyl-1-butene (1 mmol, 84.2 mg, 1 
equiv.) in dioxane (3mL), acetic acid (4 mmol, 240 mg, 4 equiv.), tributylphenyltin (1.5 
mmol, 550.7 mg, 1.5 equiv.), and a stir bar. The mixture was stirred at room temperature 
for 4 hours. The mixture was diluted with 40 mL of sat. aq. NH4Cl and extracted with 
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hexanes (2 x75 mL) and rinsed with 5% K2CO3 (1 x 75 mL). The organic layers were 
combined and dried over MgSO4. After concentration, the crude product was purified via 
silica gel chromatography (125 mL SiO2) with 100% hexanes as eluent to yield (E)-1-
(3,3-dimethylbut-1-enyl)benzene as a clear oil. Run 1 (0.097 g, 0.60 mmol, 60%, >20:1 
E:Z); run 2 (0.096 g, 0.60 mmol, 60%, 20:1 E:Z). Average yield = 60%. 1H NMR (400 
MHz, CDCl3) δ 7.39 (d, J = 7.6 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.22 (t, J = 7.2 Hz, 
1H), 6.34 (d, J = 16 Hz, 1H), 6.28 (d, J = 16 Hz, 1H), 1.16 (s, 9H). 13C NMR (100 
MHz, CDCl3) δ 142.0, 138.2, 128.7, 126.9, 126.2, 124.7, 33.6, 29.8. IR (neat, cm-1) 
3025.38, 2960.48, 2903.23, 2866.92. HRMS (CI) m/z calculated for C12H17 [M+H]+: 
161.1330, found 161.1330. 
 
Internal Olefin: To an 8 mL borosilicate vial was added catalyst 1 (0.1 mmol, 50.2 mg, 
10 mol%), benzoquinone (2.0 mmol, 216.0 mg, 2 equiv.), dioxane (3 mL, 0.33 M), acetic 
acid (4.0 mmol, 240.0 mg, 4 equiv.), trans-4-decene (1.0 mmol, 140.0 mg, 1 equiv.), 
phenylboronic acid (1.5 mmol, 183.0 mg, 1.5 equiv.) and a stir bar sequentially under 
ambient conditions.  The vial as capped and stirred at room temperature for 4 hours.   
Nitrobenzene was used as an internal standard.  NMR analysis of the crude mixture 
shows no conversion of the starting material. 
 
%EE DETERMINATION 
 (R)-hept-1-en-3-yl acetate:  Enantiopurity of the lipase resolved alcohol 
intermediate was determined by acetylation and chiral GC with a J&W 
Scientific Cyclodex-B, 30 meter, 0.25 mm diameter, 0.25 µm film column on a 5890 
nBu
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Hewlett Packard Series II GC, with a column flow rate 3.80 mL/min.  Retention time of 
acetylated R-isomer was 8.187 min (S-isomer, 9.474 min) at an isothermal 65oC.  
Enantiopurity was determined to be >99%. 
   
 ((R, 1E, 3E)-1-(2-bromophenyl)non-1,3-dien-5-yloxy)(tert-
butyl)dimethylsilane:  Enantiopurity of the product was 
determined by TBAF deprotection to the corresponding alcohol 
followed by HPLC analysis with a Daicel Chemical Industries, LTD chiral OD-H, 0.46 
cm x 25 cm column.  A flow rate of 1.0 mL/min and 45 psi with 4% i-PrOH/hexanes 
eluent gave the R-isomer at 15.109 min and the S-isomer at 26.766 min.  Enantiopurity 
was determined to be >99%. 
 
 (S)-3,3,3-trifluoro-2-methoxy-2-phenyl-N-(1-phenylbut-3-en-2-
yl)propanamide:  All ratios reported from the crude spectrum.  No 
chromatography performed.  Diagnostic NMR peaks:  1H (500 MHz, CDCl3) 
δ 6.85 (br d, J = 9.0 Hz, 1H), 6.64 (br d, J = 8.5 Hz, 1H), 5.90 (m, 1H), 5.81 (m, 1H), 
5.22 (d, J = 17.5 Hz, 1H), 5.17 (d, J = 10.5 Hz, 1H), 5.09 (d, J = 10.5 Hz), 5.02 (d, J = 
17.0 Hz, 1H).  19F (376 MHz, CDCl3) δ -69.16 (s, 3F), -69.39 (s, 3F). 
 
 (S)-3,3,3-trifluoro-2-methoxy-2-phenyl-N-((S)-1-phenylbut-3-en-2-
yl)propanamide:  All ratios reported from the crude spectrum.  No 
chromatography performed.  Diagnostic NMR peaks:  1H (500 MHz, CDCl3) 
nBu
Br
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δ 6.64 (br d, J = 8.5 Hz, 1H), 5.81 (m, 1H), 5.09 (d, J = 10.5 Hz), 5.02 (d, J = 17.0 Hz, 
1H).  19F (470 MHz, CDCl3) δ -69.16 (s, 3F).  Enantiopurity was determined to be 98%. 
 
(S)-N-((3E,5E)-1,6-diphenylhexa-3,5-dien-2-yl)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanamide: All ratios reported from the crude 
spectrum.  No chromatography performed.  Diagnostic NMR peaks:  
1H (400 MHz, CDCl3) δ 6.51 (d, J = 15.6 Hz, 1H), 6.36 (d, J = 16.0 Hz, 1H), 6.34 (m, 
1H), 6.10 (m, 1H), 5.81 (dd, J = 15.2, 6.0 Hz, 1H), 5.72 (dd, J = 15.2, 6.4 Hz, 1H).  19F 
NMR (376 MHz, CDCl3) δ -69.14 (s, 3F), -69.37 (s, 3F). 
 
(S)-N-((S,3E,5E)-1,6-diphenylhexa-3,5-dien-2-yl)-3,3,3-trifluoro-
2-methoxy-2-phenylpropanamide: All ratios reported from the 
crude spectrum.  No chromatography performed.  Diagnostic NMR 
peaks:  1H (400 MHz, CDCl3) δ 6.36 (d, J = 16.0 Hz, 1H), 6.10 (m, 1H), 5.72 (dd, J = 
15.2, 6.4 Hz, 1H).  19F NMR (376 MHz, CDCl3) δ -69.12 (s, 3F).  Enantiopurity was 
determined to be 98%. 
 
(S,E)-6-phenylhex-5-en-2-ol:  Enantiopurity was determined by 
HPLC analysis with a Daicel Chemical Industries, LTD chiral OD-
H, 0.46 cm x 25 cm column.  A flow rate of 1.0 mL/min and 45 psi with 5% i-
PrOH/hexanes eluent gave the S-isomer at 16.598 min and the R-isomer at 18.678 min.  
Enantiopurity was determined to be >99%.  
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 (S,E)-methyl 5-(4-bromophenyl)-2-(2,6-
difluorobenzamido)pent-4-enoate: Enantiopurity was 
determined via Heck-arylation beginning from opposite enantiomers, followed by HPLC 
analysis with a Daicel Chemical Industries, LTD chiral OD-H, 0.46 cm x 25 cm column.  
A flow rate of 1.0 mL/min and 45 psi with 5.0% i-PrOH/hexanes eluent gave the R-
isomer at 19.67 min and the S-isomer at 18.19 min.  Enantiopurity was determined to be 
>99%. 
 
 (S,E)-methyl 5-(phenyl-3-(bromo-3-phenyl))-2-((S)-
3,3,3-trifluoro-2-methoxy-2-
phenylpropanamido)pent-4-enoate: All ratios 
reported from the crude spectrum.  No chromatography preformed.  Diagnostic NMR 
peaks:  1H (500 MHz, CDCl3) δ 6.57 (d, J = 15.0 Hz, 1H), 6.15 (dt, J = 15.5, 7.5 Hz, 1H), 
4.82 (ap q, J = 6.5 Hz, 1H).  19F NMR (470 MHz, CDCl3) δ -69.36 (s, 3F).  Enantiopurity 
was determined to be >95%. 
 
 (R,E)-methyl 5-(phenyl-3-(bromo-3-phenyl))-2-((S)-
3,3,3-trifluoro-2-methoxy-2-
phenylpropanamido)pent-4-enoate: All ratios 
reported from the crude spectrum.  No chromatography preformed.  Diagnostic NMR 
peaks:  1H (500 MHz, CDCl3) δ 6.31 (d, J = 15.5 Hz, 1H), 6.01 (dt, J = 15.5, 7.5 Hz, 1H), 
4.89 (m, 1H), .  19F NMR (470 MHz, CDCl3) δ -69.15 (s, 3F).  Enantiopurity was 
determined to be >95%. 
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STARTING MATERIALS SYNTHESIS REFERENCES: 
 
1-(tert-butoxycarbonyl)-1H-indol-5-ylpotassium 
trifluoroborate:  A 50 mL round bottomed flask (RBF) was 
charged with a stir bar, tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-
indole-1-carboxylate (0.805 g, 2.3 mmol), ether (4 mL), and methanol (7 mL). Aqueous 
3M KF2H (4.4 mL, 13.1 mmol) was added dropwise at room temperature.  The mixture 
was stirred for 2 hours.  The stir bar was removed and the solvents removed via rotary 
evaporation.  Boiling acetone was added, and the hot solution was filtered.  The filtrate 
was concentrated and dissolved in <20 mL of warm acetone.  Petroleum ether (200 mL) 
was added to the mixture and the solution was undisturbed for 2 hours.  The white 
precipitate was filtered off and rinsed with cold petroleum ether (50 mL) to award the 
title compound as a white solid (0.650 g, 2.0 mmol, 86%).  1H NMR (500 MHz, d6-
acetone) δ 7.92 (d, J = 8.0 Hz, 1H), 7.70 (s, 1H), 7.51 (d, J = 8.5 Hz, 1H), 7.49 (d, J = 4 
Hz, 1H), 6.52 (d, J = 4 Hz, 1H), 1.68 (s, 9H).  19F NMR (470 MHz, d6-acetone) δ -142.24.  
13C NMR (125 MHz, (CH3)2CO) δ 150.65, 135.13, 130.53, 129.30, 125.01, 124.81, 
113.92, 108.59, 83.50, 28.30, (C ipso to B not observed). IR (neat, cm-1): 3033.33, 
2974.38, 2930.04, 1730.97, 992.97.  HRMS (CI) m/z calculated for C13H14NO2BF3K 
[M+H]+: 284.1070, found 284.1071.30 
 
*Enantiomeric excess (%ee) was determined based off of optical rotation according to the 
equation %ee = (100 [α]obs)/[α]lit. ref 31,  %ee = (100 [53.4]23D)/[129]23D = 41.4 % ee. 
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CHAPTER 3 
 
AN INTERMOLECULAR OXIDATIVE HECK VINYLATION WITH LIMITING 
α-OLEFIN 
 
 
3.1 INTRODUCTION 
 
Polyenes are prevalent moieties in natural products and pharmaceuticals.  The 
synthesis of polyenes have several important synthetic requirements:1  (1) Mild 
conditions are necessary due to problematic isomerizations in the presence of light, 
oxygen and many synthetic reagents.2  (2) Broad functional group tolerance is needed 
because polyenes are generally installed late in synthetic routes amid diverse 
functionality due to their sensitive nature.  (3) Highly stereoselective methods are a 
prerequisite for polyene synthetic strategies because olefin isomers are often inseparable.   
Current polyene synthetic strategies require either (1) carbonyl olefinations or (2) 
transition metal based cross-coupling reactions (figure 24).1,3 The Wittig, Horner-
Wadsworth-Emmons (HWE), and Julia olefination reactions are commonplace when 
constructing polyene segments; however, E:Z selectivities are frequently problematic. 
The Stille, Suzuki, Negishi, and Sonagashira cross-coupling reactions are mild, functional  
 R PR''3
R'
R
[M]
X
R'
[M] = B, Si, Sn
         Zn, Mg
X = halide
      OTf
R S
Ph
O O
O R'
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H R X
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Cross CouplingJulia OlefinationWittig/HWE Sonogashira
Figure 24.  Polyene synthetic strategies for complex molecule synthesis.
 
group tolerant and give excellent selectivities for polyene synthesis.  Yet these cross-
couplings, like olefination strategies, require prior activation of both coupling partners 
(and a subsequent reduction for the Sonogashira reaction specifically). 
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  The intermolecular Heck reaction is unique among palladium-based cross-
coupling reactions due to the direct formation of C-C bonds from the vinylic C-H bonds 
of α-olefins, which necessitates prior activation of only one coupling partner.4  Mild, 
selective C-H bond transformations in the presence of valuable, diverse functionality are 
known to simplify and streamline synthetic sequences when compared to methods 
dependant on pre-functionalization.5  In the Heck vinylation, the activated coupling 
partner may be either a vinyl halide or a vinyl transmetalating reagent. The direct 
synthesis of stereodefined vinyl halides is often problematic without first synthesizing a 
carbon-metalated intermediate.  Significantly, oxidative Heck vinylations6 forego the 
synthesis of stereodefined vinyl halide coupling partners which are often formed through 
intermediate vinyl boron species.7   These vinyl boron transmetalating reagents may be 
coupled directly and are easily synthesized with high stereoselectivities through a variety 
of methods.8 
Despite the tremendous advantages of polyene synthesis via the intermolecular 
Heck vinylation, application in complex molecule synthesis has not been realized due to 
(1) a large excess of the α-olefin coupling partner being needed and (2) limited α-olefin 
substrate scope (figure 25).  Generally, resonance bias of the terminal olefin is necessary  
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O
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X
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S S
O O
Ph Ph
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Figure 25.  Comparison of Heck vinylations.
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to control the regioselectivity of insertion, to control direction of β-hydride elimination, 
and to increase reactivity of the α-olefin.  These requirements limit the olefin scope to 
primarily α,β-unsaturated-carbonyls and styrenes.9  We reported the development of a 
palladium II-based intermolecular oxidative Heck vinylation which proceeds in good 
yields and selectivities with a wide range of non-resonance stabilized terminal olefins as 
the limiting reagent.  
3.2 RESULTS AND DISCUSSION  
3.2.1 Development of an Oxidative Heck Strategy for Polyene Synthesis with Limiting 
Terminal Olefin 
 The oxidative Heck vinylation reported herein is promoted by commercial 
palladium (II)/bis-sulfoxide catalyst 1 under oxidative, mild conditions which generate 
polyene products in preparatively useful yields with excellent regio- and E/Z 
stereoselectivities.10 Previously, we reported a palladium (II)/bis-sulfoxide catalyzed 
arylation of non-resonance activated α-olefins with arylboronic acids.11 Attempts to  
entry
1
2
3
4
5
6
7
 quinone
(equiv.)
BQ (2.0)
BQ (2.0)
Me2BQ (2.0)
Me2BQ (2.0)
Me2BQ (1.1)
Me2BQ (1.1)
Me2BQ (1.1)
isolated
yielda,b
0%
16%
43%
49%
55%
41%
9%
solvent
(molarity)
THF (0.33 M)
THF (0.33 M)
THF (0.33 M)
THF (2.0 M)
DMF (2.0 M)
DMF (2.0 M)
DMF (2.0 M)
a Average of 2 runs. b >20:1 E:Z and >20:1 internal:terminal selectivities 
determined by crude NMR for all entries unless otherwise noted.
quinone, solvent
AcOH (4 equiv.)
(10 mol%)
pent
OMe
Bu
S S
O O
Ph Ph
Pd(OAc)2
Bpin
Bu
OMe
pent
+
Table 7.  Optimization of an oxidative Heck-vinylation.
variable
boronic acid
---
---
---
O2 atmosphere
20 mol% H2O
no ligand
 
utilize vinyl boronic acids resulted in complete consumption of the vinyl boron and no 
desired product formation (table 7, entry 1).  However, the more stable vinyl pinacol 
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boronic ester gave the desired product in 15% yield (table 7, entry 2).  We hypothesized 
side reactions with benzoquinone could be problematic since insertion is favorable with 
sterically accessible activated olefins, and we observed depletion of the boronic ester.  
Accordingly, changing the benzoquinone oxidant to the more hindered 2,6-
dimethylbenzoquinone gave a dramatic increase in yield to 43% (table 7, entry 3).  
Standard optimizations of molarity, oxidant equivalents and solvent further increased the 
yield to 55% (table 7, entries 4 and 5).  Water was found to be detrimental, and oxygen 
atmosphere had no adverse effects when compared to inert atmosphere (table 7, entries 5 
and 6).  Bis-sulfoxide ligand also proved crucial for this reaction, whereas Pd(OAc)2 gave 
only 9% yield (table 7, entry 7).   
Examination of the vinyl boron component indicated a wide range of vinyl boron 
reagents couple under these optimized conditions (figure 26). In addition to trans  
pent
OMe
R
R'
Bpin
R
R'OMe
pent
+
Figure 26.  Vinylboronic ester coupling partner scope.
Bpin
Bpin pent
OAc
Bpin Bu
Pr
Oct
Bpin
71% 62%
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79%
PdII/bisSO cat.
(14:1 E:Z)
Bpin BpinBpin
(5:1 Z:E)
0% 0%42%
 
disubstituted boron reagents, trisubstituted boronic esters couple smoothly. Vinyl boron 
reagents with substitution in the allylic position are also excellent coupling partners. 
Interestingly, increasing steric bulk closer to the reactive vinyl boron site increased 
product yield, presumably by slowing homo-coupling pathways.  Higher order polyene 
products are synthetically accessible in preparative yields by coupling polyunsaturated 
vinylic boronic esters.  Importantly, E:Z ratios were >10:1 and internal:terminal olefin 
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ratios >14:1 in all examined cases of trans monosubstituted, disubstituted and 
polyunsaturated vinylic boron reagents.  Under these conditions cis monosubstituted 
vinylic boronic esters gave low yield and lower stereoselectivity (from >20:1 Z:E [boron 
reagent] to 5:1 Z:E [product]).  Furthermore, all attempts to couple 1-substituted vinyl 
boron starting materials gave no conversion of the boron coupling partner or terminal 
olefin, even at elevated temperatures.  Presumably, catalyst 1 is highly sensitive to steric 
bulk alpha to the boron atom since the only cases where transmetalation fails are on 
boron reagents with alpha substitution present. 
 
3.2.2 Accessing Medicinally Interesting Motifs with a Novel Oxidative Heck Vinylation 
Complex polyene products are not commonly accessed through Heck reactions 
due to the necessity of a resonance activated α-olefin in excess (typically 3-5 equiv.). In 
contrast, the 1 catalyzed oxidative Heck reaction operates with limiting α-olefin; the use 
of coupling stoichiometries allows the streamlining potential of the Heck reaction to be 
utilized in the synthesis of complex, medicinally relevant molecules (figures 27-30).  
Furthermore, both resonance activated and non-resonance activated α-olefins with allylic 
substitution proved effective coupling partners (figure 27). Molecules important for cell 
growth and differentiation (47) as well as a segment of a complex antibiotic (48) with 
epimerizable α-keto- and allylic ether stereocenters retained stereochemical information 
during the oxidative Heck coupling.12  Compounds 50 and 51, which utilize valuable 
boron coupling partners, are practically synthesized because only a slight excess of vinyl 
boron starting material is needed.13  Both of these molecules are being pursued for their 
biological activities toward insects and microbes respectively. An ethylene TIPS boronic 
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Figure 27.  Synthetic intermediates accessable through oxidative Heck vinylation.
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ester coupled in synthetically useful yields to give the ethylene homologated TIPS 
product 49, which is amenable to further reactions.   
 
3.2.3 Synthetic Comparison of the Oxidative Heck to Olefination and Transition Metal 
Cross-Coupling Reactions 
We sought to compare 1 catalyzed Heck based synthetic strategies to each type of 
prominent polyene formation strategies.  Intermediates to two complex natural products, 
amphidinolide C (52) and macrolactin A (53), were chosen as targets (figure 28).  The 
amphidinolide C segment was synthesized through an olefination method, while the 
macrolactin A segment was formed through a transition metal mediated cross-coupling 
reaction.   
Amphidinolide C is a scarce, potent anticancer agent which has drawn attention 
synthetically because of both the importance of analogues to understand its bioactivity, 
and its interesting macrocyclic structure.  A previous synthesis of the highlighted 
segment of amphidinolide C was undertaken to prove the absolute stereochemistry of 
each stereocenter in the segment.  The key disconnect for the highlighted fragment of 52 
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Figure 28.  Complex natural products with highlighted diene segments.
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was a Julia olefination, which requires installation of sulfur functionality, condensation 
with an aldehyde, and elimination of the sulfur motif.  As previously mentioned, the 
stereoselectivity of the alkene formed during this olefination is often difficult to predict.  
Beginning from olefin intermediate 54, protecting group changes were necessary to 
achieve good E:Z selectivities for the desired diene segment (figure 29).   
When compared to a carbonyl olefination route, the power of this oxidative Heck 
reaction to streamline synthesis was observed by synthesizing the C17-C29 segment of 
Amphidinolide C, 52 (figure 29).14  Beginning from the same α-olefin intermediate 54 
Figure 29.  Amphidinolide C segment synthesis: Julia olefination vs oxidative Heck route.
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used in the olefination route, the diene moiety 55 was synthesized in a single step in 69% 
yield, which compares favorably to the 36% yield over 7-steps achieved via a Julia 
olefination route.  As mentioned, Julia olefination selectivities are often dependant on 
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protecting group choice, as is observed in this case. Strikingly, the oxidative Heck 
vinylation gave good selectivities (>20:1 E:Z) with no protecting group manipulations. 
 Macrolactin A is a biologically active molecule with possible anti-cancer and 
anti-viral applications; however, complete biological studies have not been realized due 
to an unreliable natural supply.  The synthesis of the highlighted segment of macrolactin 
A in figure 28 was previously undertaken with the key bond forming step being a 
Sonagashira coupling/alkyne reduction sequence to form intermediate 56 (figure 30).  
When synthesizing the stereodefined vinyl bromide 57, only modest stereoselectivity was 
achieved (4:1 E:Z).  Furthermore, the vinyl halide 57 was synthesized through a carbon-
metalated intermediate which under oxidative transition metal mediated conditions could 
possibly be coupled directly.  Furthermore, the reduction of the ene-yne functionality to a 
diene requires conditions which are not compatible with several protecting groups, as 
evidenced by the necessary switch from an allylic acetate to the desired allylic PMB ether 
later in the sequence. 
Figure 30.  Macrolactin A intermediate synthesis: Sonogashira vs oxidative Heck route.
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We compared the recently developed oxidative Heck vinylation to this common 
transition metal based cross-coupling strategy for polyene formation.  Beginning again 
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from identical starting materials 58 and 59, the C12-C24 segment of macrolactin A, 56, 
was synthesized in 10 fewer steps and 8 times greater yield (figure 30).15  Significantly, 
the stereodefined vinyl boron intermediate 60 was accessed in better yields, fewer steps, 
and higher regioselectivities than the analogous vinyl bromide 57 for the Sonagashira 
route.  It is often beneficial to expose conjugated polyunsaturated functionality to 
minimal reagents since isomerizations are often problematic.  Importantly, the delicate 
polyunsaturated functionality is installed later in the Heck route for the synthesis of 56 
than in the Sonagashira route (2 steps vs. 4 steps to 56 after the key coupling).   
Members of the retinoid family such as 61 have been synthesized through a large 
number of palladium mediated cross coupling reactions including Suzuki, Stille, Hiyama, 
Negishi, and Kumada couplings.16  However, the Heck reaction has yet to be used to 
access a member of this family since polyene functionality is not conventionally installed 
using this method.  Also, accessing a member of the retinoid family requires a coupling 
reaction with near equimolar stoichiometry of the coupling partners, since both fragments 
are complex.  As shown in figure 25, previous intermolecular Heck reactions required an 
excess of the terminal olefin coupling partner.  The excess complex fragment precluded 
the use of a practical Heck reaction to access the retinoid family.  With our new oxidative 
manifold, a terminal olefin may be used as the limiting reagent; additionally our mild 
conditions allow for the synthesis of large, delicate polyenes with good selectivities.  The 
tetraene retinoid 61 was formed in synthetically useful yield with catalyst 1, giving to the 
best of our knowledge the longest contiguous polyene synthesized via Heck reaction to 
date (figure 31). 
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Notably, an unprotected diol was successfully coupled with a trienyl boronic ester 
furnishing a single isomer of 61.  The observed selectivities testify to the mild, selective 
nature of this manifold. 
 
3.3 CONCLUSIONS 
The oxidative Heck reaction reported in this chapter offers an alternative synthetic 
strategy to polyene formation which requires activation of only one vinylic carbon.  This 
method is amendable to complex molecule synthesis as demonstrated by 13 examples 
that only require coupling quantities of each partner.  Limiting equivalents of terminal 
olefin compares favorably to the excessive amounts of α-olefin coupling partner typically 
required of the Heck reaction.  Importantly, this mild manifold allows for installation of 
delicate polyene functionality late in synthetic sequences, with good stereoselectivity. 
 
 
3.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the Heck arylation 
reaction were used as received: 1,4-benzoquinone and 2,6-dimethylbenzoquinone 
(Sigma-Aldrich); 1,2-Bis(phenylsulfinyl)ethane palladium(II) acetate “Catalyst 1” 
(Strem, TCI, Sigma-Aldrich). Catalyst 1 was stored in a glove box under an argon 
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atmosphere and weighed out in air prior to use.  Solvents dioxane, tetrahydrofuran (THF), 
diethyl ether (Et2O), and methylene chloride (CH2Cl2) were purified prior to use by 
passage through a bed of activated alumina (Glass Contour, Laguna Beach, California).  
Anhydrous N,N-dimethylformamide (DMF) (Sure Seal) was obtained from Sigma-
Aldrich and used as received.  All Heck vinylation reactions were run under N2 with 
minimal exposure to moisture.  Thin-layer chromatography (TLC) was conducted with E. 
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV and 
potassium permanganate staining.  Flash column chromatography was performed as 
described by Still using EM reagent silica gel 60 (230-240 mesh).17 1H NMR spectra were 
recorded on a Varian Unity-400 (400 MHz) or Varian Unity-500 (500 MHz) 
spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 
ppm).  Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = 
multiplet, b = broad, ap = apparent; coupling constant(s) in Hz; integration.  Proton-
decoupled 13C NMR spectra were recorded on a Varian Unity-400 (100 MHz) or Varian 
Unity-500 (125 MHz) spectrometer and are reported in ppm using solvent as an internal 
standard (CDCl3 at 77.23 ppm).   19F NMR spectra were recorded on a Varian Unity-400 
(376 MHz) or Varian-500 (470 MHz) spectrometer and are reported in ppm using a 1% 
C6F6/CDCl3 standard referenced to -164.3 ppm.  Regioselectivity of the Heck addition was 
determined by NMR analysis of the crude mixture.  IR spectra were recorded as thin 
films on NaCl plates on a Perkin-Elmer Spectrum BX and are reported in frequency of 
absorption (cm-1).  High-resolution mass spectra were obtained at the University of 
Illinois Mass Spectrometry Laboratory.  Optical rotations were obtained using a JAS.CO 
DIP-370 digital polarimeter and a 3.5 x 100 mm cell. 
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General Procedure: To a flame dried 2 mL borosilicate vial with a N2 balloon was 
rapidly added catalyst 1 (0.1 mmol, 10 mol%) and 2,6-dimethylbenzoquinone (1.1 mmol, 
1.1 equiv.) in one portion.  The following liquids were added via syringe through the 
septum sequentially:  DMF (0.5 mL, 2.0 M), acetic acid (4.0 mmol, 4 equiv.), terminal 
alkene coupling partner (1.0 mmol, 1.0 equiv.) and vinylic boronic ester coupling partner 
(1.5 mmol, 1.5 equiv.). A stir bar was added and the head spaced flushed with N2 prior to 
removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  After 72 
hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% K2CO3 
(aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing of the 
biphasic layers for 30 minutes.  The organics were separated and rinsed once with 5% 
K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
concentration, the crude product was purified via silica chromatography.  The crude 
selectivities were determined by 1H NMR. 
 
 (5E,7E)-9-methoxytetradeca-5,7-diene: To a flame 
dried 2 mL borosilicate vial with a N2 balloon was rapidly 
added catalyst 1 (0.05 mmol, 25.0 mg, 10 mol%) and 2,6-dimethylbenzoquinone (0.55 
mmol, 75.0 mg, 1.1 equiv.).  The following liquids were added via syringe through the 
septum sequentially:  DMF (0.25 mL, 2.0 M), acetic acid (2.0 mmol, 132.0 mg, 4.0 
equiv.), 3-methoxyoct-1-ene (0.50 mmol, 71.0 mg, 1.0 equiv.) and (E)-2-(hex-1-enyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.75 mmol, 158.0 mg, 1.5 equiv.). A stir bar 
was added and the head spaced flushed with N2 prior to removing the balloon and sealing 
O
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the vial with stirring at 40oC for 72 hours.  After 72 hours the mixture was diluted with 
diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) and N2SO3 (sat. aq.) [50 mL] was 
added and stirred rapidly to ensure mixing of the biphasic layers for 30 minutes.  The 
organics were separated and rinsed once with 5% K2CO3 (50 mL).  The organic layer was 
dried with MgSO4 and filtered.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 3% ethyl acetate/hexanes as eluent to yield 
(5E,7E)-9-methoxytetradeca-5,7-diene as a clear oil.  The crude selectivities determined 
by 1H NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (63.8 mg, 0.29 mmol, 57%); run 2 
(61.6 mg, 0.28 mmol, 55%); run 3 (60.5 mg, 0.27 mmol, 54%).  Average Yield = 55%.  
1H NMR (400 MHz, CDCl3) δ 6.14−5.99 (m, 2H), 5.67 (dt, J = 14.8, 6.8 Hz, 1H), 5.35 
(dd, J = 14.8, 8.4 Hz, 1H), 3.48 (apt. q, J = 6.4, 1H), 3.22 (s, 3H), 2.06 (apt. q, J = 6.8 Hz, 
2H), 1.62-1.50 (m, 2H), 1.48-1.18 (m, 10H), 0.92-0.80 (m, 6H). 13C NMR (100 MHz, 
CDCl3) δ 135.4, 133.1, 131.7, 129.7, 82.6, 56.3, 35.9, 32.5, 32.1, 31.6, 25.3, 22.8, 22.5, 
14.3, 14.2. IR (neat, cm-1) 3016, 2956, 2929, 2872, 2860, 2819. HRMS (EI) m/z 
calculated for C15H28O [M]+:  224.2140, found 224.2140. 
 
(E)-6-methoxy-2-methylundeca-2,4-diene: To a flame dried 2 
mL borosilicate vial with a N2 balloon was rapidly added 
catalyst 1 (0.05 mmol, 25.0 mg, 10 mol%) and 2,6-dimethylbenzoquinone (0.55 mmol, 
75.0 mg, 1.1 equiv.).  The following liquids were added via syringe through the septum 
sequentially:  DMF (0.25 mL, 2.0 M), acetic acid (2.0 mmol, 132.0 mg, 4.0 equiv.), 3-
methoxyoct-1-ene (0.50 mmol, 71.0 mg, 1.0 equiv.) and 4,4,5,5-tetramethyl-2-(2-
methylprop-1-enyl)-1,3,2-dioxaborolane (0.75 mmol, 136.5 mg, 1.5 equiv.). A stir bar 
O
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was added and the head spaced flushed with N2 prior to removing the balloon and sealing 
the vial with stirring at 40oC for 72 hours.  After 72 hours the mixture was diluted with 
diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) and N2SO3 (sat. aq.) [50 mL] was 
added and stirred rapidly to ensure mixing of the biphasic layers for 30 minutes.  The 
organics were separated and rinsed once with 5% K2CO3 (50 mL).  The organic layer was 
dried with MgSO4 and filtered.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 3% ethyl acetate/hexanes as eluent to yield 
(E)-6-methoxy-2-methylundeca-2,4-diene as a clear oil.  The crude selectivities 
determined by 1H NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (68.6 mg, 0.35 mmol, 
70%); run 2 (69.6 mg, 0.36 mmol, 71%). Average Yield = 71%.  1H NMR (400 MHz, C-
DCl3) δ 6.33 (dd, J = 15.2, 10.8 Hz, 1H), 5.82 (d, J = 11.2 Hz, 1H), 5.34 (dd, J = 15.2, 
8.4 Hz, 1H), 3.52 (apt. q, J = 8.0 Hz, 1H), 3.23 (s, 3H), 1.76 (s, 3H), 1.73 (s, 3H), 1.62-
1.50 (m, 1H), 1.48-1.37 (m, 1H), 1.37-1.18 (m, 6H), 0.85 (t, J = 7.2 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ 135.9, 131.4, 129.3, 124.6, 82.9, 56.2, 36.0, 32.1, 26.2, 25.3, 22.8, 
18.5, 14.3. IR (neat, cm-1) 3018, 2958, 2929, 2858, 2817. HRMS (EI) m/z calculated for 
C13H24O [M]+:  196.1827, found 196.1825. 
 
 
 (6E,8E)-10-methoxy-5-propylpentadeca-6,8-diene: 
To a flame dried 2 mL borosilicate vial with a N2 
balloon was rapidly added catalyst 1 (0.05 mmol, 25.0 mg, 10 mol%) and 2,6-
dimethylbenzoquinone (0.55 mmol, 75.0 mg, 1.1 equiv.).  The following liquids were 
added via syringe through the septum sequentially:  DMF (0.25 mL, 2.0 M), acetic acid 
O
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(2.0 mmol, 132.0 mg, 4.0 equiv.), 3-methoxyoct-1-ene (0.50 mmol, 71.0 mg, 1.0 equiv.) 
and (E)-4,4,5,5-tetramethyl-2-(3-propylhept-1-enyl)-1,3,2-dioxaborolane (0.75 mmol, 
200.0 mg, 1.5 equiv.). A stir bar was added and the head spaced flushed with N2 prior to 
removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  After 72 
hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% K2CO3 
(aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing of the 
biphasic layers for 30 minutes.  The organics were separated and rinsed once with 5% 
K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 3% ethyl acetate/hexanes as eluent to yield (6E,8E)-10-methoxy-5-propylpentadeca-
6,8-diene as a clear oil.  The crude selectivities determined by 1H NMR are int.:term. 20:1 
and E:Z >20:1.  Run 1 (110.6 mg, 0.40 mmol, 79%); run 2 (110.6 mg, 0.40 mmol, 79%). 
Average Yield = 79%.  1H NMR (500 MHz, CDCl3) δ 6.13 (dd, J = 15.0, 10.5 Hz, 1H), 
5.99 (dd, J = 15.0, 10.0 Hz, 1H), 5.44 (dd, J = 15.0, 9.0 Hz, 1H), 5.38 (dd, J = 15.5, 8.5 
Hz, 1H), 3.52 (apt. q, J = 7.5 Hz, 1H), 3.27 (s, 3H), 2.02-1.94 (m, 1H), 1.66-1.56 (m, 
1H), 1.52-1.42 (m, 1H), 1.42-1.16 (m, 16H), 0.96-0.82 (m, 9H). 13C NMR (125 MHz, 
CDCl3) δ 140.2, 133.2, 131.5, 129.3, 82.6, 56.3, 42.8, 37.8, 35.9, 35.3, 32.1, 29.7, 25.3, 
23.1, 22.8, 20.6, 14.4, 14.3 (2C). IR (neat, cm-1) 3016, 2954, 2929, 2872, 2860, 2818.  
HRMS (EI) m/z calculated for C19H36O [M]+:  280.2766, found 280.2775. 
 
 
 (7E,9E)-11-methoxyhexadeca-7,9-dien-6-yl 
acetate: To a flame dried 2 mL borosilicate vial with 
O
O
O
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a N2 balloon was rapidly added catalyst 1 (0.05 mmol, 25.0 mg, 10 mol%) and 2,6-
dimethylbenzoquinone (0.55 mmol, 75.0 mg, 1.1 equiv.).  The following liquids were 
added via syringe through the septum sequentially:  DMF (0.25 mL, 2.0 M), acetic acid 
(2.0 mmol, 132.0 mg, 4.0 equiv.), 3-methoxyoct-1-ene (0.50 mmol, 71.0 mg, 1.0 equiv.) 
and (E)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oct-1-en-3-yl acetate (0.75 mmol, 
222.0 mg, 1.5 equiv.). A stir bar was added and the head spaced flushed with N2 prior to 
removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  After 72 
hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% K2CO3 
(aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing of the 
biphasic layers for 30 minutes.  The organics were separated and rinsed once with 5% 
K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 7% ethyl acetate/hexanes as eluent to yield (7E,9E)-11-methoxyhexadeca-7,9-dien-
6-yl acetate as a clear oil.  The crude selectivities determined by 1H NMR are int.:term. 
>20:1 and E:Z >20:1.  Run 1 (93.0 mg, 0.30 mmol, 60%); run 2 (97.7 mg, 0.32 mmol, 
63%). Average Yield = 62%.  1H NMR (400 MHz, CDCl3) δ 6.26−6.04 (m, 2H), 5.57 
(dd, J = 15.2, 7.2 Hz, 1H), 5.51 (dd, J = 14.8, 7.6 Hz, 1H), 5.23 (apt. q, J = 6.8 Hz, 1H), 
3.51 (apt. q, J = 7.6 Hz, 1H), 3.23 (s, 3H), 2.03 (s, 3H), 1.68-1.48 (m, 3H), 1.48-1.36 (m, 
1H), 1.36-1.16 (m, 12H), 0.90-0.80 (m, 6H). 13C NMR (125 MHz, CDCl3) δ 170.6, 135.6 
(d), 131.9 (d), 131.6, 131.5, 82.3, 74.6 (d), 56.5, 35.8, 34.6, 32.0, 31.8, 25.2 (d), 25.0, 
22.8, 22.7, 21.6, 16.5, 14.3 (d). IR (neat, cm-1) 3023, 2956, 2931, 2860, 2819, 1739.  
HRMS (EI) m/z calculated for C19H34O3 [M]+:  310.2508, found 310.2508. 
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 (7E,9E,11E)-6-methoxyicosa-7,9,11-
triene: To a flame dried 2 mL borosilicate 
vial with a N2 balloon was rapidly added catalyst 1 (0.05 mmol, 25.0 mg, 10 mol%) and 
2,6-dimethylbenzoquinone (0.55 mmol, 75.0 mg, 1.1 equiv.).  The following liquids were 
added via syringe through the septum sequentially:  DMF (0.25 mL, 2.0 M), acetic acid 
(2.0 mmol, 132.0 mg, 4.0 equiv.), 3-methoxyoct-1-ene (0.50 mmol, 71.0 mg, 1.0 equiv.) 
and 2-((1E,3E)-dodeca-1,3-dienyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.75 mmol, 
219.0 mg, 1.5 equiv.). A stir bar was added and the head spaced flushed with N2 prior to 
removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  After 72 
hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% K2CO3 
(aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing of the 
biphasic layers for 30 minutes.  The organics were separated and rinsed once with 5% 
K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 3% ethyl acetate/hexanes as eluent to yield (7E,9E,11E)-6-methoxyicosa-7,9,11-
triene as a clear oil.  The crude selectivities determined by 1H NMR are int.:term. >20:1 
and E:Z 14:1.  Run 1 (78.0 mg, 0.26 mmol, 51%); run 2 (81.1 mg, 0.27 mmol, 53%). 
Average Yield = 52%.  1H NMR (400 MHz, CDCl3) δ 6.26−5.86 (m, 4H), 5.73 (dt, J = 
14.8, 7.2 Hz, 1H), 5.47 (dd, J = 14.4, 8.0 Hz, 1H), 3.55 (apt. q, J = 8.4 Hz, 1H), 3.26 (s, 
3H), 2.10 (apt. q, J = 6.8 Hz, 2H), 1.68-1.54 (m, 1H), 1.52-1.16 (m, 19H), 0.96-0.83 (m, 
6H). 13C NMR (100 MHz, CDCl3) δ 136.3, 133.5 (2C), 133.0, 130.3, 129.8, 82.6, 56.3, 
35.9, 33.0, 32.1 (2C), 29.7, 29.5, 29.4, 25.3, 22.9, 22.8, 14.3 (2C). IR (neat, cm-1) 3016, 
O
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2956, 2927, 2854.  HRMS (EI) m/z calculated for C21H38O [M]+:  306.2923, found 
306.2931. 
 
 (S)-tert-butyl 4-((2E,4E)-hexadeca-2,4-dienoyl)-2,2-
dimethyloxazolidine-3-carboxylate:   To a flame dried 2 mL 
borosilicate vial with a N2 balloon was added (S)-tert-butyl 4-
acryloyl-2,2-dimethyloxazolidine-3-carboxylate (0.20 mmol, 50.0 mg, 1.0 equiv.) and 
(E)-4,4,5,5-tetramethyl-2-(tridec-1-enyl)-1,3,2-dioxaborolane (0.30 mmol, 90.3 mg, 1.5 
equiv.) via pipet.  DMF (0.1 mL, 2.0 M) and acetic acid (0.78 mmol, 46.8 mg, 4.0 equiv.) 
were added via syringe through the septum.  The vial was rapidly opened followed by 
quick addition of catalyst 1 (0.02 mmol, 9.8 mg, 10 mol%) and 2,6-
dimethylbenzoquinone (0.22 mmol, 29.4 mg, 1.1 equiv.) in one portion.  A stir bar was 
added and the head spaced flushed with N2 prior to removing the balloon and sealing the 
vial with stirring at 40oC for 72 hours.  After 72 hours the mixture was diluted with 
diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) and N2SO3 (sat. aq.) [50 mL] was 
added and stirred rapidly to ensure mixing of the biphasic layers for 30 minutes.  The 
organics were separated and rinsed once with 5% K2CO3 (50 mL).  The organic layer was 
dried with MgSO4 and filtered.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 7% ethyl acetate/hexanes as eluent to yield 
(S)-tert-butyl 4-((2E,4E)-hexadeca-2,4-dienoyl)-2,2-dimethyloxazolidine-3-carboxylate 
as a clear oil.  The crude selectivities determined by 1H NMR are int.:term. >20:1 and E:Z 
>20:1.  Run 1 (46.5 mg, 0.11 mmol, 54%); run 2 (45.2 mg, 0.10 mmol, 52%).  Average 
Yield = 53%.  1H NMR (400 MHz, C6D6) δ major rotamer: 7.32 (dd, J = 15.6, 11.2 Hz, 
O
NBoc
O C11H23
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1H), 6.15 (d, J = 15.2 Hz, 1H), 5.89 (dd, J = 14.8, 11.2 Hz, 1H), 5.73 (dt, J = 14.8, 7.2 
Hz, 1H), 4.27 (dd, J = 7.2, 4.4 Hz, 1H), 3.66 (m, 2H), 1.88 (s, 3H), 1.80 (m, 2H), 1.55 (s, 
3H), 1.33 (s, 9H), 1.3-1.0 (m, 18H), 0.84 (t, J = 7.2, 3H).  minor rotamer: 7.30-7.20 (m, 
1H), 6.10 (d, J = 15.2 Hz, 1H), 5.90-5.80 (m, 1H), 5.70-5.58 (m, 1H), 4.56 (m, 1H), 3.75 
(m, 2H).  13C NMR (100 MHz, C6D6) δ major rotamer: 196.6, 152.3, 147.1, 146.5, 144.8, 
129.8, 123.8, 96.0, 80.5, 66.6, 65.6, 33.9, 32.9, 30.7, 30.6, 30.4 (2C), 30.1, 29.5, 28.9, 
26.2, 25.0, 23.7, 14.9 minor rotamer: 196.1, 152.9, 148.7, 146.0, 144.7, 129.9, 125.0, 
95.0, 66.2, 65.4.  IR (neat, cm-1) 3011, 2927, 2855, 1710. HRMS (ESI) m/z calculated for 
C26H46NO4 [M+H]+:  436.3427, found 436.3426. [α]27D = -41.8o (c = 2.5, CHCl3).  
Spectral data has previously been reported and is in agreement.18 
 
 
 
 (2E,4E)-7-(benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-
yl)hepta-2,4-dien-1-one:   To a flame dried 2 mL 
borosilicate vial with a N2 balloon was added 1-(piperidin-1-yl)prop-2-en-1-one (0.15 
mmol, 21.3 mg, 1.0 equiv.) and (E)-2-(4-(benzo[d][1,3]dioxol-5-yl)but-1-enyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (0.23 mmol, 69.5 mg, 1.5 equiv.) via pipet.  DMF (0.08 
mL, 2.0 M) and acetic acid (0.61 mmol, 36.7 mg, 4.0 equiv.) were added via syringe 
through the septum.  The vial was rapidly opened followed by quick addition of catalyst 1 
(0.015 mmol, 7.5 mg, 10 mol%) and 2,6-dimethylbenzoquinone (0.17 mmol, 23.0 mg, 
1.1 equiv.) in one portion.  A stir bar was added and the head spaced flushed with N2 
prior to removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  
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After 72 hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% 
K2CO3 (aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing 
of the biphasic layers for 30 minutes.  The organics were separated and rinsed once with 
5% K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 30% ethyl acetate/hexanes as eluent to yield (2E,4E)-7-(benzo[d][1,3]dioxol-5-yl)-
1-(piperidin-1-yl)hepta-2,4-dien-1-one as a crystalline solid.  The crude selectivities 
determined by 1H NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (31.1 mg, 0.10 mmol, 
65%); run 2 (31.6 mg, 0.10 mmol, 66%).  Average Yield = 66%.  1H NMR (400 MHz, 
CDCl3) δ 7.19 (dd, J = 14.4, 10.8 Hz, 1H), 6.70 (d, J = 7.6 Hz, 1H), 6.64 (s, 1H), 6.58 (d, 
J = 7.6 Hz, 1H), 6.24 (d, J = 14.8 Hz, 1H), 6.16 (dd, J = 15.2, 10.8 Hz, 1H), 6.02 (dt, J = 
15.2, 6.4 Hz, 1H), 5.90 (s, 2H), 3.58 (br s, 2H), 3.45 (br s, 2H), 2.63 (t, J = 6.8 Hz, 2H),  
2.39 (apt. q, J = 7.6 Hz, 2H), 1.67-1.58 (m, 2H), 1.58-1.48 (m, 4H).  13C NMR (100 MHz, 
CDCl3) δ 165.8, 147.8, 145.9, 142.7, 141.1, 135.4, 129.7, 121.4, 119.3, 109.0, 108.4, 
101.0, 47.0, 43.4, 35.2, 36.9, 25.8, 24.9. IR (neat, cm-1) 3016, 2995, 2935, 2854, 1651.  
HRMS (ESI) m/z calculated for C19H24NO3 [M+H]+:  314.1756, found 314.1750.  Spectral 
data has previously been reported and is in agreement.19 
 
 
 
 (R,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-methoxyocta-
2,4-dienyl benzoate:   To a flame dried 2 mL borosilicate 
vial with a N2 balloon was added (R)-tert-butyl(3-methoxypent-4-enyloxy)dimethylsilane 
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(0.21 mmol, 48.3 mg, 1.0 equiv.) and (E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl benzoate (0.42 mmol, 121.0 mg, 2.0 equiv.) via pipet.  DMF (0.11 mL, 2.0 M) 
and acetic acid (0.84 mmol, 50.4 mg, 4.0 equiv.) were added via syringe through the 
septum.  The vial was rapidly opened followed by quick addition of catalyst 1 (0.02 
mmol, 10.5 mg, 10 mol%) and 2,6-dimethylbenzoquinone (0.23 mmol, 31.4 mg, 1.1 
equiv.) in one portion.  A stir bar was added and the head spaced flushed with N2 prior to 
removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  After 72 
hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% K2CO3 
(aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing of the 
biphasic layers for 30 minutes.  The organics were separated and rinsed once with 5% 
K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 10% ethyl acetate/hexanes as eluent to yield (R,2E,4E)-8-(tert-
butyldimethylsilyloxy)-6-methoxyocta-2,4-dienyl benzoate as a clear oil.  The crude 
selectivities determined by 1H NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (41.0 mg, 
0.11 mmol, 50%); run 2 (41.8 mg, 0.11 mmol, 50%).  Average Yield = 50%.  1H NMR 
(400 MHz, CDCl3) δ 8.04 (d, J = 6.8 Hz, 2H), 7.54 (t, J = 7.6 Hz, 1H), 7.42 (t, J = 7.6 
Hz, 2H), 6.37 (dd, J = 15.2, 10.4 Hz, 1H), 6.20 (dd, J = 15.2, 10.8 Hz, 1H), 5.86 (dt, J = 
15.2, 6.4 Hz, 1H), 5.58 (dd, J = 15.2, 8.0 Hz, 1H), 4.84 (d, J = 6.0 Hz, 2H), 3.76 (apt. q,  
J = 7.6 Hz, 1H), 3.73-3.65 (m, 1H), 3.60 (dt, J = 10.0, 6.0 Hz, 1H), 3.24 (s, 3H), 1.82-
1.71 (m, 1H), 1.70-1.56 (m, 1H), 0.87 (s, 9H), 0.02 (s, 6H).  13C NMR (100 MHz, CDCl3) 
δ 166.5, 135.7, 133.7, 133.2, 131.3, 130.4, 129.8, 128.6, 127.0, 78.7, 65.2, 59.4, 56.6, 
38.9, 26.1, 18.5, -5.1, -5.2. IR (neat, cm-1) 3033, 3016, 2953, 2929, 2858, 2819, 1722.  
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HRMS (ESI) m/z calculated for C22H34O4SiNa [M+Na]+:  413.2124, found 413.2121.  
Enantiopurity of the product was determined by synthesis of the racemic product 
followed by HPLC analysis with a Daicel Chemical Industries, LTD chiral OD-H, 0.46 
cm x 25 cm column.  A flow rate of 1.0 mL/min and 43 psi with 10% i-PrOH/hexanes as 
eluent gave the R-isomer at 4.783 min and the S-isomer at 5.179 min.  Enatiopurtiy was 
determined to be >99%.  [α]24D = +2.4, c = 1.0, CHCl3.  Spectral data has previously been 
reported and is in agreement.20 
 
 
(2E,4E)-6-(benzyloxy)-5-methylhexa-2,4-dienyl 2,5-
dimethoxybenzoate:   To a flame dried 2 mL 
borosilicate vial with a N2 balloon was added allyl 2,5-dimethoxybenzoate (0.23 mmol, 
51.1 mg, 1.0 equiv.) and (E)-2-(3-(benzyloxy)-2-methylprop-1-enyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (0.35 mmol, 99.4 mg, 1.5 equiv.) via pipet.  DMF (0.12 mL, 2.0 M) 
and acetic acid (0.92 mmol, 55.2 mg, 4.0 equiv.) were added via syringe through the 
septum.  The vial was rapidly opened followed by quick addition of catalyst 1 (0.023 
mmol, 11.6 mg, 10 mol%) and 2,6-dimethylbenzoquinone (0.25 mmol, 34.4 mg, 1.1 
equiv.) in one portion.  A stir bar was added and the head spaced flushed with N2 prior to 
removing the balloon and sealing the vial with stirring at 40oC for 72 hours.  After 72 
hours the mixture was diluted with diethyl ether (50 mL) and a solution of 5% K2CO3 
(aq.) and N2SO3 (sat. aq.) [50 mL] was added and stirred rapidly to ensure mixing of the 
biphasic layers for 30 minutes.  The organics were separated and rinsed once with 5% 
K2CO3 (50 mL).  The organic layer was dried with MgSO4 and filtered.  After 
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concentration, the crude product was purified via silica chromatography (125 mL SiO2) 
with 20% ethyl acetate/hexanes as eluent to yield (2E,4E)-6-(benzyloxy)-5-methylhexa-
2,4-dienyl 2,5-dimethoxybenzoate as a clear oil.  The crude selectivities determined by 
1H NMR are int.:term. >20:1 and E:Z 10:1.  Run 1 (62.4 mg, 0.16 mmol, 71%); run 2 
(63.3 mg, 0.17 mmol, 72%).  Average Yield = 72%.  1H NMR (500 MHz, CDCl3) 
δ 7.40-7.28 (m, 6H), 7.05 (dd, J = 9.0, 3.0 Hz, 1H), 6.94 (d, J = 9.5 Hz, 1H), 6.67 (dd, J = 
15.0, 11.5 Hz, 1H), 6.15 (d, J = 11.0 Hz, 1H), 5.90 (dt, J = 15.0, 6.5 Hz, 1H), 4.89 (d, J = 
6.5 Hz, 2H), 4.50 (s, 2H), 4.00 (s, 2H), 3.89 (s, 3H), 2.82 (s, 3H),  1.85 (s, 3H).  13C NMR 
(125 MHz, CDCl3) δ 165.9, 153.7, 153.1, 138.5, 136.5, 130.1, 128.5, 127.8, 127.7, 126.8, 
125.7, 120.7, 119.7, 116.1, 114.0, 75.5, 71.9, 65.6, 56.9, 56.0, 14.6. IR (neat, cm-1) 3062, 
3030, 2999, 2935, 2914, 2850, 2837, 1728.  HRMS (ESI) m/z calculated for C23H26O5Na 
[M+Na]+:  405.1678, found 405.1670.  This molecule has previously been reported; 
however, no spectral data was available.21 
 
Triisopropyl((1E,3E)-5-methoxydeca-1,3-dienyl)silane:   
To a flame dried 2 mL borosilicate vial with a N2 balloon 
was added 3-methoxyoct-1-ene (0.28 mmol, 39.8 mg, 1.0 equiv.) and (E)-triisopropyl(2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)silane (0.42 mmol, 130.2 mg, 1.5 
equiv.) via pipet.  DMF (0.14 mL, 2.0 M) and acetic acid (1.12 mmol, 67.2 mg, 4.0 
equiv.) were added via syringe through the septum.  The vial was rapidly opened 
followed by quick addition of catalyst 1 (0.028 mmol, 14.1 mg, 10 mol%) and 2,6-
dimethylbenzoquinone (0.31 mmol, 41.9 mg, 1.1 equiv.) in one portion.  A stir bar was 
added and the head spaced flushed with N2 prior to removing the balloon and sealing the 
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vial with stirring at 40oC for 72 hours.  After 72 hours the mixture was diluted with 
diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) and N2SO3 (sat. aq.) [50 mL] was 
added and stirred rapidly to ensure mixing of the biphasic layers for 30 minutes.  The 
organics were separated and rinsed once with 5% K2CO3 (50 mL).  The organic layer was 
dried with MgSO4 and filtered.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 2% ethyl acetate/hexanes as eluent to yield 
triisopropyl((1E,3E)-5-methoxydeca-1,3-dienyl)silane as a clear oil.  The crude 
selectivities determined by 1H NMR are int.:term. 17:1 and E:Z >20:1.  Run 1 (56.2 mg, 
0.17 mmol, 62%); run 2 (56.6 mg, 0.17 mmol, 62%).  Average Yield = 62%.  1H NMR 
(400 MHz, CDCl3) δ 6.55 (dd, J = 18.8, 10.0 Hz, 1H), 6.16 (dd, J = 15.2, 10.0 Hz, 1H), 
5.74 (d, J = 18.8 Hz, 1H), 5.49 (dd, J = 15.2, 8.0 Hz, 1H), 3.53 (apt. q, J = 7.6 Hz, 1H), 
3.25 (s, 3H), 1.66-1.52 (m, 1H), 1.52-1.39 (m, 1H), 1.39-1.10 (m, 6H),  1.14-0.94 (m, 
21H), 0.86 (t, J = 6.4 Hz, 3H).  13C NMR (100 MHz, CDCl3) δ 145.6, 135.9, 134.3, 
128.9, 82.3, 56.5, 35.8, 32.1, 25.3, 22.8, 18.9, 14.3, 11.1. IR (neat, cm-1) 2956, 2941, 
2891, 2866.  HRMS (EI) m/z calculated for C20H40OSi [M]+:  324.2849, found 324.2840. 
 
Cis boron coupling 
partners lost 
stereochemistry when coupled with the terminal olefin substrate in Table 1 of the 
manuscript. 
 
The following boron compounds did not react with the terminal 
olefin substrate in Table 1 of the manuscript. 
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(2-(((R,E)-1-((2R,5R)-5-(2-(4-
methoxybenzyloxy)ethyl)tetrahydrofuran-2-
yl)-5-methylhexa-2,4-
dienyloxy)methoxy)ethyl)trimethylsilane:   To a flame dried 2 mL borosilicate vial 
with a O2 balloon was added (2-(((R)-1-((2R,5R)-5-(2-(4-methoxybenzyloxy) 
ethyl)tetrahydrofuran-2-yl)allyloxy)methoxy)ethyl)trimethylsilane (0.10 mmol, 42.2 mg, 
1.0 equiv.) and 4,4,5,5-tetramethyl-2-(2-methylprop-1-enyl)-1,3,2-dioxaborolane (0.20 
mmol, 36.4 mg, 2.0 equiv.) via pipet.  DMF (0.05 mL, 2.0 M) and acetic acid (0.40 
mmol, 24.0 mg, 4.0 equiv.) were added via syringe through the septum.  The vial was 
rapidly opened followed by quick addition of catalyst 1 (0.02 mmol, 10.0 mg, 20 mol%) 
and 2,6-dimethylbenzoquinone (0.11 mmol, 15.0 mg, 1.1 equiv.) in one portion.  A stir 
bar was added and the head spaced flushed with O2 prior to removing the balloon and 
sealing the vial with stirring at 50oC for 72 hours.  After 72 hours the mixture was diluted 
with diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) [50 mL] was added.  The 
organics were separated and rinsed once more with 5% K2CO3 (50 mL).  The organic 
layer was dried with MgSO4 and filtered.  After concentration, the crude product was 
purified via silica chromatography (125 mL SiO2) with 15% ethyl acetate/hexanes as 
eluent to yield (2-(((R,E)-1-((2R,5R)-5-(2-(4-methoxybenzyloxy)ethyl)tetrahydrofuran-2-
yl)-5-methylhexa-2,4-dienyloxy)methoxy)ethyl)trimethylsilane as a clear oil.  The crude 
selectivities determined by 1H NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (32.8 mg, 
0.062 mmol, 69%); run 2 (32.4 mg, 0.068 mmol, 68%).  Average Yield = 69%.  1H 
NMR (500 MHz, CDCl3) δ 7.27 (d, J = 9.0 Hz, 2H), 6.89 (d, J =  8.5 Hz, 2H), 6.47 (dd, J 
= 15.0, 11.0 Hz, 1H), 5.85 (d, J = 11.0 Hz, 1H), 5.41 (dd, J = 15.0, 7.5 Hz, 1H), 4.76 (d, J 
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= 6.5 Hz, 1H), 4.71 (d, J = 6.5 Hz, 1H), 4.48-4.40 (m, 2H), 4.12-4.00 (m, 3H), 3.82 (s, 
3H), 3.82-3.75 (s, 1H), 3.62-3.52 (m, 3H),  2.10-1.84 (m, 3H), 1.80 (s, 3H), 1.78 (s, 3H), 
1.78-1.62 (m, 2H), 1.62-1.48 (m, 1H), 0.95 (dt, J = 8.5, 1.0 Hz, 2H), 0.04 (s, 9H).  13C 
NMR (100 MHz, CDCl3) δ 159.3, 136.5, 131.0, 130.9, 129.4, 126.9, 124.7, 113.9, 92.3, 
80.9, 79.3, 77.1, 72.8, 67.8, 65.1, 55.5, 36.0, 32.3, 28.5, 26.2, 18.6, 18.3, -1.2.  IR (neat, 
cm-1) 3041, 3010, 2951, 2916, 2895, 2873, 2860.  HRMS (ESI) m/z calculated for 
C27H44O5SiNa [M+Na]+:  499.2856, found 499.2859. [α]25D = -56.1, c = 1.0 CHCl3.  
 
 (2R,6E,8E,10R)-10-((4-methoxybenzyl)oxy)-11-
((R)-1,4-dioxaspiro[4.5]decan-2-yl)undeca-6,8-dien-
2-yl acetate:   To a flame dried 2 mL borosilicate vial 
with a N2 balloon was added (R)-2-((R)-2-(4-
methoxybenzyloxy)but-3-enyl)-1,4-dioxaspiro[4.5]decane (0.10 mmol, 33.2 mg, 1.0 
equiv.) and (R,E)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hept-6-en-2-yl acetate 
(0.15 mmol, 42.3 mg, 1.5 equiv.) via pipet.  DMF (0.05 mL, 2.0 M) and acetic acid (0.40 
mmol, 24.0 mg, 4.0 equiv.) were added via syringe through the septum.  The vial was 
rapidly opened followed by quick addition of catalyst 1 (0.01 mmol, 5.0 mg, 10 mol%) 
and 2,6-dimethylbenzoquinone (0.11 mmol, 15.0 mg, 1.1 equiv.) in one portion.  A stir 
bar was added and the head spaced flushed with N2 prior to removing the balloon and 
sealing the vial with stirring at 40oC for 72 hours.  After 72 hours the mixture was diluted 
with diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) [50 mL] was added.  The 
organics were separated and rinsed once more with 5% K2CO3 (50 mL).  The organic 
layer was dried with MgSO4 and filtered.  After concentration, the crude product was 
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purified via silica chromatography (75 mL SiO2) with 20% ethyl acetate/hexanes as 
eluent to yield (2R,6E,8E,10R)-10-((4-methoxybenzyl)oxy)-11-((R)-1,4-
dioxaspiro[4.5]decan-2-yl)undeca-6,8-dien-2-yl acetate as a clear oil.  The crude 
selectivities determined by 1H NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (24.8 mg, 
0.051 mmol, 51%); run 2 (24.0 mg, 0.051 mmol, 51%).  Average Yield = 51%.  1H 
NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.4 Hz, 2H), 6.84 (d, J =  8.8 Hz, 2H), 6.15 (dd, J 
= 14.8, 10.8 Hz, 1H), 6.03 (dd, J = 15.2, 10.8 Hz, 1H), 5.67 (dt, J = 15.2, 6.8 Hz, 1H), 
5.45 (dd, J = 15.2, 8.0 Hz, 1H), 4.88 (apt q, J = 5.6 Hz, 1H), 4.48 (d, J = 11.2 Hz, 1H),  
4.24 (d, J = 11.6 Hz, 1H), 4.25-4.15 (m, 1H), 4.01 (dd, J = 8.0, 6.0 Hz, 1H), 3.93 (dt, J = 
8.4, 4.4 Hz, 1H), 3.78 (s, 3H),  3.48 (t, J = 8.0 Hz, 1H), 2.08 (q, J = 6.8 Hz, 2H), 2.01 (s, 
3H), 1.80-1.72 (m, 2H), 1.64-1.30 (m, 14H), 1.24-1.14 (m, 3H).  13C NMR (125 MHz, 
CDCl3) δ 171.0, 159.3, 135.1, 132.8, 131.7, 130.9, 130.0, 129.5, 114.0, 109.1, 73.2, 71.0, 
70.2, 69.9, 55.5, 40.7, 36.8, 35.7, 32.6, 25.4, 25.2, 24.2, 24.1, 21.6, 20.2.  IR (neat, cm-1) 
3012, 2937, 2860, 1736.  HRMS (ESI) m/z calculated for C29H42O6Na [M+Na]+:  
509.2879, found 509.2878. [α]24D = +32.8, c = 1.0 CHCl3.  
 
(2R,3R,4E,6E,8E)-2,3-dihydroxy-3,7-
dimethyl-9-(2,6,6-trimethylcyclohex-1-
enyl)nona-4,6,8-trienyl 4-methoxybenzoate:   To a flame dried 2 mL borosilicate vial 
with a N2 balloon was added (2R,3R)-2,3-dihydroxy-3-methylpent-4-enyl 4-
methoxybenzoate (0.14 mmol, 37.2 mg, 1.0 equiv.) and 4,4,5,5-tetramethyl-2-((1E,3E)-2-
methyl-4-(2,6,6-trimethylcyclohex-1-enyl) buta-1,3-dienyl)-1,3,2-dioxaborolane (0.21 
mmol, 66.4 mg, 1.5 equiv.) via pipet.  DMF (0.07 mL, 2.0 M) and acetic acid (0.56 
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mmol, 33.6 mg, 4.0 equiv.) were added via syringe through the septum.  The vial was 
rapidly opened followed by quick addition of catalyst 1 (0.014 mmol, 7.0 mg, 10 mol%) 
and 2,6-dimethylbenzoquinone (0.15 mmol, 20.9 mg, 1.1 equiv.) in one portion.  A stir 
bar was added and the head spaced flushed with N2 prior to removing the balloon and 
sealing the vial with stirring at 40oC for 72 hours.  After 72 hours the mixture was diluted 
with diethyl ether (50 mL) and a solution of 5% K2CO3 (aq.) and N2SO3 (sat. aq.) [50 mL] 
was added and stirred rapidly to ensure mixing of the biphasic layers for 30 minutes.  The 
organics were separated and rinsed once with 5% K2CO3 (50 mL).  The organic layer was 
dried with MgSO4 and filtered.  After concentration, the crude product was purified via 
silica chromatography (125 mL SiO2) with 30% ethyl acetate/hexanes as eluent to yield 
(2R,3R,4E,6E,8E)-2,3-dihydroxy-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-
4,6,8-trienyl 4-methoxybenzoate as a clear oil.  The crude selectivities determined by 1H 
NMR are int.:term. >20:1 and E:Z >20:1.  Run 1 (31.8 mg, 0.07 mmol, 51%); run 2 (34.3 
mg, 0.08 mmol, 54%).  Average Yield = 53%.  1H NMR (400 MHz, CDCl3) δ 7.97 (d, J 
= 8.8 Hz, 2H), 6.89 (d, J =  8.8 Hz, 2H), 6.74 (dd, J = 15.2, 11.2 Hz, 1H), 6.15 (d, J = 
16.4 Hz, 1H), 6.03 (d, J = 16.4 Hz, 1H), 6.01 (d, J = 10.8 Hz, 1H), 5.79 (d, J = 15.2 Hz, 
1H), 4.48 (dd, J = 12.0, 3.2 Hz, 1H), 4.31 (dd, J = 11.6, 7.6 Hz, 1H), 3.89-3.83 (m, 1H), 
3.83 (s, 3H), 2.74 (br d, J = 3.2 Hz, 1H),  2.31 (br s, 1H), 1.98 (t, J = 6.4 Hz, 2H), 1.92 (s, 
3H), 1.67 (s, 3H), 1.64-1.52 (m, 2H), 1.48-1.39 (m, 2H), 1.38 (s, 3H), 0.99 (s, 6H).  13C 
NMR (125 MHz, CDCl3) δ 167.0, 163.8, 138.0, 137.6, 136.9, 136.1, 132.0, 129.5, 128.8, 
127.5, 126.6, 122.3, 113.9, 76.3, 74.5, 66.0, 55.7, 39.8, 34.4, 33.2, 29.1, 23.6, 21.9, 19.5, 
12.9. IR (neat, cm-1) 3450 (br), 3032, 2956, 2926, 2864, 1712.  HRMS (ESI) m/z 
calculated for C28H38O5Na [M+Na]+:  477.2617, found 477.2607. [α]27D = +15.2, c = 
 123 
0.036 MeOH; [α]26D = +11.1, c = 1.0 MeOH. Spectral data has previously been reported 
and is in agreement.22 
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